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ABSTRACT: 
 
Background and Aims: Temporomandibular disorders are clinical conditions that often 
involve pain in the masticatory muscles, the temporomandibular jaw joint and/or 
associated structures. The association between muscle pain and muscle activity is 
often explained by uniform increases or decreases in motor unit activity throughout a 
muscle but recent evidence suggests more complex changes within a painful muscle. 
The general aim of this study was to determine if experimentally induced masseter 
muscle pain modifies temporalis muscle activity.  
Methods: 20 healthy participants received experimental pain through hypertonic saline 
(5% NaCl) infusion into the right masseter; pain intensity was maintained at 40-60/100 
mm on a visual analogue scale (VAS). Standardized biting tasks were performed with 
an intraoral force transducer while single motor unit (SMU) activity was recorded from 
2 intramuscular electrodes (right masseter and right temporalis). The tasks were 
repeated in 4 blocks: baseline 1, hypertonic saline infusion, isotonic saline infusion, 
baseline 2. Each block had 3 isometric biting tasks: a slow and a fast ramp jaw closing 
task and a 2 step-levels jaw closing task (2 force levels: step 1 and step 2). 
Results: 83 SMUs were discriminated from the temporalis and 58 from the masseter 
muscle. This study demonstrated that induced muscle pain in the right masseter can 
be associated with the activation of new SMUs and the silencing of other single motor 
units in the painful masseter muscle as well as in the right temporalis muscle, which 
did not receive noxious stimulation with the hypertonic saline. No differences between 
pain and no pain trials were found in thresholds and firing rates of SMUs from the 
temporalis muscle.  
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Discussion and conclusion: The present findings are consistent with previous findings 
from the limb (Hodges and Tucker 2011; Tucker et al. 2009) and rather than supporting 
uniform increases or decreases in motor unit activity throughout a muscle, suggest that 
there is a reorganization of motor unit activity across the entire jaw motor system in 
experimental pain. 
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RATIONALE FOR THE THESIS: 
 
Temporomandibular disorders (TMDs) are clinical conditions that often involve pain in 
the masticatory muscles, the temporomandibular or jaw joint and/or associated 
structures. They impose significant personal and economic burdens on ~5% of the 
population (Blyth et al. 2001; Sessle 2000). The cause is only partly understood and 
some current treatments are based on little scientific evidence.  
 
For many years, there was thought to be a Vicious Cycle between pain and muscle 
activity that perpetuated the pain. This theory and a more recent theory, the Pain 
Adaptation Model, however are not strongly supported by the literature. For example, 
both theories propose uniform increases or decreases in activity throughout a painful 
muscle but recent evidence in the spinal motor system suggests that there are likely 
to be complex changes of activity within a painful muscle (these changes indicate a re-
organization of activity) instead of uniform changes in activity throughout the painful 
muscle.  
 
The principal investigators and research staff in our research unit have recently 
demonstrated this re-organization within one of the jaw muscles, the masseter muscle 
(Malik 2016; Minami et al. 2013). The new data suggest the need to re-assess 
management strategies based on models that propose uniform effects of pain on 
muscle activity. It is well known that TMDs are frequently characterized by pain in a 
number of jaw muscles. It is unclear however whether this pain-induced reorganization 
of activity that has been demonstrated within one jaw muscle also occurs in other jaw 
muscles and whether indeed this reorganization in other jaw muscles could contribute 
to spread of the pain condition. This information would assist in understanding the 
pathophysiology of TMDs. 
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Another issue with these earlier theories is that they do not take psychological factors 
into consideration and yet psychological factors are known to be important in TMDs. 
Recent studies from our group (Akhter et al. 2014) have provided evidence that one 
psychological factor (namely, catastrophizing) may be a factor that influences the 
effects of pain on jaw muscle activity. The question arises whether psychological 
factors might influence the reorganization that appears to be occurring within the jaw 
muscles during pain, and thereby possibly influence symptoms.  
 
The present study has used electromyographic (EMG) recordings from the jaw 
muscles to assess whether complex changes in activity can occur throughout the jaw 
muscles during experimentally induced jaw muscle pain. We also employed 
questionaries, namely, the Depression, Anxiety and Stress Scales (DASS) (Lovibond 
and Lovibond 1995a), the McGill Pain Questionnaire (MPQ) (Melzack 1975) and the 
Pain Catastrophizing Scale (PCS) (Sullivan MJL 1995), to look for associations 
between any changes in muscle activity patterns and one or more of these 
psychological factors. 
 
The information obtained from these studies may help to improve our understanding 
of the effects of pain on jaw muscle activity and thereby may have implications for 
understanding changes in jaw muscle activity in TMD and the spread of symptoms. 
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1 REVIEW OF THE LITERATURE 
 
1.1  Jaw motor system 
 
The jaw motor system is anatomically and physiologically a very complex structure 
consisting of the maxillae and mandible, teeth, periodontium, tongue, 
temporomandibular joints and orofacial muscles. Because of its complexity, the jaw 
system is able to generate large compressive forces during mastication and also to 
achieve very fine motor control with precise positioning of the upper and lower teeth 
whenever it is required (Peck et al. 2010). Given the frequent demands imposed on 
the jaw motor system from, for example, the need for clearly articulated speech and 
efficient masticatory activities, then it may be not surprising that this highly complex 
motor system can develop pain and/or dysfunction. 
 
1.2 Pain and temporomandibular disorders (TMDs)  
 
The development of a universally accepted definition of pain and related concepts was 
indicated by John J Bonica as one of the main goals of the then recently formed 
International Association for the Study of Pain (IASP) (Classification of chronic pain. 
Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the 
international association for the study of pain, subcommittee on taxonomy  1986) 
(Raffaeli and Arnaudo 2017).  
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Therefore, pain has been defined, according to IASP as ‘‘an unpleasant, sensory and 
emotional experience associated with actual or potential tissue damage, or described 
in terms of such damage’’ (Lipton 1991). This definition includes the sensory aspect of 
pain as well as the emotional and interpretive or cognitive aspects. 
 
In fact, the attempt to understand pain represents one of the oldest challenges in the 
history of medicine (Raffaeli and Arnaudo 2017). It leads patients to seek medical relief, 
perhaps more than any other one symptom of disease (Wagner 1906). 
 
Orofacial pain refers to pain in the face and/or oral cavity. Studying one population 
dataset from the UK Biobank between 2006 and 2010, researchers reported an 
overall prevalence of self-reported facial pain as 1.9% (women 2.4%, men 1.2%) of 
which 48% was chronic pain (Macfarlane et al. 2014).  Another study, analysing the 
prevalence of orofacial pain (OFP) among young adults (30-31 years old), reported 
the prevalence of OFP as high as 23% (Macfarlane et al. 2009).  
 
Despite the fact that it is very prevalent in the population, pain also includes different 
types, for example, associated with pulpal and periodontal processes, sinusitis, 
trigeminal neuralgia, and pain in any of the masticatory muscles or temporomandibular 
joints (TMJ) (Conti et al. 2012).  
 
Temporomandibular disorders (TMDs) are clinical conditions that often involve pain in 
the masticatory muscles, the temporomandibular jaw joint and/or associated 
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structures. The most common symptom is pain, but often patients with TMD present 
other symptoms such as limited or asymmetric mandibular movements and/or joint 
sounds (Yap et al. 2002) and which vary in severity from case to case.  
 
Temporomandibular disorders are a very common problem affecting up to 33% of 
individuals within their lifetime (Wright and North 2009). However, this prevalence can 
vary from study to study as the number of patients suffering from TMD seems to be 
increasing worldwide. Temporomandibular disorders are in fact one of the most 
common chronic pain conditions, along with headaches and back pain (Ghurye and 
McMillan 2015).  
 
Epidemiological studies show that nearly 10% to 15% of the general population has 
some kind of TMD, and from those, around 5% require treatment (Tournavitis et al. 
2017). They impose significant personal and economic burdens on ~5% of the 
population (Blyth et al. 2001; Sessle 2000) and also have working related impacts. 
Treatments often require a multi-disciplinary approach and they represent a significant 
health-care cost with non-surgical treatments often costing over $1,000 per episode.  
 
In general, TMDs are more prevalent in women during their reproductive years than 
men and post-menopausal women. Some authors have suggested that TMDs can 
have estrogen as a risk factor as it could contribute to enhanced central sensitization 
processes (see section 1.4.10 below) and which might predispose to the development 
of painful TMD (Ribeiro-Dasilva et al. 2017). In support of this idea, another study 
showed no difference in the prevalence of TMD between boys and girls during the pre-
puberty phase of their lives (Ghurye and McMillan 2015).   
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Nowadays, there are a large number of therapeutic options that can help with the 
elimination or reduction of the symptoms in muscles and jaw joints. For example, some 
therapeutic options include the occlusal oral plates (Restrepo et al. 2011), physical 
therapy (Morell 2016; Tuncer et al. 2013), cognitive-behavioural therapy (CBT) (Dura-
Ferrandis et al. 2017), acupuncture (Fernandes et al. 2017), stress reduction strategies 
(Reissmann et al. 2012), physical exercises (Haggman-Henrikson et al. 2017b), 
attention to the improvement of sleep quality (Babiec 2017), pharmacotherapy 
(Haggman-Henrikson et al. 2017a), counselling and self-care management (Henien 
and Sproat 2017; Nilsson and Willman 2016), laser therapy (Demirkol et al. 2017) or 
even a combination of two or more of these options depending on the case and the 
recommendation of the dentist. However it has been reported that there is a lack of 
therapeutic confidence in the treatment of pain related to TMD among dentists 
(Kakudate et al. 2017). 
 
The stabilization appliance using a flat occlusal splint made of hard acrylic or 
polycarbonate material is among the most popular current treatment worldwide (Altok 
et al. 2016; Shukla and Muthusekhar 2016). Yet, insufficient evidence for its effects on 
musculature is found on the literature (Al-Ani et al. 2004; Dahlstrom et al. 1982) and 
further studies are recommended in regards to occlusal stabilization as a TMD 
treatment (Kuzmanovic Pficer et al. 2017).  
 
Although it has been widely discussed by researchers and clinicians, the cause and 
pathophysiology of TMD remains unclear and many current treatments are based on 
little scientific evidence, and there is a significant placebo effect.  Therefore, patients 
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with TMD can go from one clinician to the next in a desperate attempt to obtain 
symptom relief. Besides, not much is known about the reason and mechanisms 
whereby acute TMD episodes became chronic TMD. 
 
Chronic pain is usually defined as pain lasting more than 3 months and almost certainly 
has some element of central sensitization (Crofford 2015; Gil-Martinez et al. 2016). It 
is a complex sensory and emotional experience that varies widely between people 
depending on the context and meaning of the pain and the psychological state of the 
person (Bushnell et al. 2013). It can be really disabling with a negative impact on 
people’s quality of life. The value of this definition is its ability to describe all the 
conditions that can be defined as chronic pain even if it does not refer to the impairment 
brought about by the pain, the presence of specific symptoms, and the supposed 
etiologic framework. This is also because chronic pain is a term employed to define 
several diverse conditions whose common feature is the presence of persistent pain 
(Raffaeli and Arnaudo 2017).  
 
In this context, TMD may also be associated with other problems of general health, 
depression and anxiety, or psychological disabilities that affect the patient’s quality of 
life or even elevated levels of suicidal ideation (Bertoli and de Leeuw 2016; Stohler 
1999). In fact, it is frequently associated with physical symptoms of other chronic pain 
disorders and comorbidities, as generalised muscle and joint pain (Beiter et al. 2015; 
Moreno-Fernandez et al. 2017), or irritable bowel syndrome (IBS) (Gallotta et al. 
2017), for example. TMD actually shares similarities with other chronic pain conditions 
such as chronic tension-type headache or migraine, low back pain, and fibromyalgia 
in physiopathologic mechanisms (Sessle 2009). Also, one study found no differences 
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between TMD patients and non-TMD patients with a chronic pain disorder in terms of 
the use of medicines, levels of depression, anxiety, somatization, hostility, 
psychoticism, behavior in their social surroundings, ratings of problems with work, 
family, self-esteem, or impulses for suicide (McKinney et al. 1990). 
 
1.3 TMD and diagnoses 
 
The diagnosis of TMD is complex. Most current research recognizes that TMD is not 
caused by a single factor but it is multifactorial. Temporomandibular Disorders are 
complex disorders that are best viewed from a biopsychosocial perspective, that is, 
they exhibit a range of different physical signs and symptoms, as well as changes in 
behaviours, and emotional and social interactions (Slade et al. 2016; Svensson and 
Kumar 2016). This has led to acceptance of a multifactorial ethology of TMD pain.  
 
There are several diagnostic systems proposed for TMD. 
 
The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) was 
published in 1992 and it was the first classification that incorporated the 
biopsychosocial pain model. It has been translated into 22 languages with a Dual-axis 
system: clinical conditions (Axis I) with the purpose of finding possible abnormalities of 
structures and functions of the masticatory muscles and temporomandibular joints, and 
pain-related disability and psychological status (Axis II) (Dworkin and LeResche 1992).  
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The RDC/TMD has been the most extensively used diagnostic protocol for TMD 
research since its publication.  The intent was to provide simultaneously a physical 
diagnosis and to identify other relevant aspects of the patient that could influence the 
expression of TMD and maybe help with the management of their pain (Schiffman et 
al. 2014). 
 
A series of studies has been done since its publication to verify its diagnostic validity 
and to identify some points of conflict. In this context, the Diagnostic Criteria for TMD 
(DC/TMD) is the revised version of the RDC/TMD and evaluations indicate that it is 
reliable and valid. This diagnostic protocol cover the most frequent kinds of TMD, such 
as disorders related with pain (e.g., myalgia, TMD-related headache and arthralgia) 
and disorders linked to the TMJ (e.g., disc displacements and degenerative disease) 
(List and Jensen 2017). 
 
While the new DC/TMD protocol promises to be an important tool for future clinical 
diagnosis and management as well as clinical research projects, a limitation of the new 
DC/TMD is that it only partly addresses TMD mechanisms and etiologies. Furthermore, 
it is now recognized that TMD are a heterogenous group with manifestations well 
beyond the signs and symptoms associated with the current Axis I diagnoses. More 
comprehensive medical assessment of comorbid physical disorders and biobehavioral 
status with expansion of Axis II risk determinants for TMD will facilitate the identification 
of subpopulations of patients based on underlying pathophysiological mechanisms 
(Schiffman, Eric et al 2014). 
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1.4 Single Motor Unit (SMU) and electromyography (EMG) activity 
 
Knowledge of the anatomy and physiology of the motor mechanism that is required to 
produce muscle contractility in human beings and other animals is essential in order to 
understand the variety of disturbances that can occur in human motion and locomotion. 
Therefore, electromyography is the study of the electrical activity of the muscle 
(Pruzansky 1952) and is used for studying muscular functioning – See figure 1-1.  
 
 
Figure 1-1: Schematic illustration of the origination, myoelectric recording and subsequent 
decomposition of five superimposed motor-unit action potential. M.u.a.p.: motor unit action potentials 
From: (De Luca et al. 1982). 
 
 
Consequently, EMG analysis might be helpful to elucidate the normal function of the 
masticatory muscles as well as how the muscles adapt in patients with TMD Svensson 
and Graven-Nielsen 2000. 
13 
 
 
Movement is accomplished by the controlled activation of motor unit populations. The 
motor unit is mostly under the control of the central nervous system (CNS). The motor 
unit is the final common pathway whereby converging sensory and descending neural 
inputs are translated into forces to generate movement. It is therefore a 
neuromechanical transducer.  
 
1.4.1 Definition of a motor unit 
 
The motor unit (Figure 1-2) consists of two components:  
(i) One α-motoneurone and  
(ii) The muscle fibres innervated by that motoneurone (Heckman and Enoka 
2012).  
 
Each muscle fibre is innervated by only one motoneurone, and each motoneurone can 
innervate between ten and thousands of muscle fibres. The muscles that act on the 
largest body masses have motor units that contain more muscle fibres, whereas 
smaller muscles contain fewer muscle fibres in each motor unit (Buchthal and 
Schmalbruch 1980). Jaw muscle motor units contain several hundred muscle fibres 
(Lenman and Ritchie 1987). 
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Figure 1-2: The organization of a motor unit from the spinal motor system. The motor unit consists of a 
motoneurone (motor neuron in the figure) and all the muscle fibres it innervates. From (Hamilton et al. 
2011). 
 
1.4.2 Fibre types 
 
Skeletal muscles are composed of numerous fibres that range from 10 to 80 
micrometers in diameter. These fibres contain myofibrils, which can be defined as the 
real force generators. Each myofibril consists of sarcomeres, the final functional units 
of the muscle contraction. The sarcomeres, in turn, contain mainly thick (myosin) and 
thin (actin) filaments. Nonetheless, there are also other proteins called troponin and 
tropomyosin –See figure 1-3. The interaction between all these filaments is the 
cornerstone for muscle contraction (Bottinelli and Reggiani 2000). 
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Figure 1-3: Organization of skeletal muscle (A and B), from the gross to the molecular level. Each muscle 
fibre (C) can contain from several hundred up to several thousand myofibrils (D). The sarcomere (E) is 
the part of the myofibril between two successive Z discs. (F), (G), (H), and (I) are cross sections at the 
levels indicated.  Each myofibril is composed of around 1500 adjacent myosin  and 3000 actin filaments, 
which are large polymerized protein molecules responsible for the actual muscle contraction (J), (K), 
(L), (M), (N). From: (Hall 2016). 
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Scientists have been aware that skeletal muscles can be distinguished on the basis of 
their colour as red or white and their contractile properties as fast and slow since the 
first half of the 19th century (Schiaffino and Reggiani 2011). 
 
Initially, three types of muscle fibres were histochemically distinguished exclusively on 
the basis of qualitative differences in their actomyosin ATPase which could distinguish 
them between type I (slow) and type II (fast) fibres (Guth and Samaha 1970). Later on, 
type II fibres were subdivided into IIA and IIB and some new fibre types (IIX, IIC and 
IM) were also identified by this method (Staron and Pette 1986).  
 
Also, based on histochemical techniques using both mitochondrial enzyme and myosin 
adenosine triphosphatase (ATPase) activities to differentiate fibres, muscle fibres can 
be classified as slow oxidative (SO), fast oxidative glycolytic (FOG), and fast glycolytic 
(FG) (Delp and Duan 1996; Pette and Staron 1990).  
 
In addition, the structural and functional properties of the fibres, which are generally 
referred to as fibre phenotype, can change in response to hormonal and neural 
influences, nerve-activity being a major determinant of the fibre type profile. This 
property is defined muscle plasticity or malleability (Schiaffino and Reggiani 2011).  
 
The association of different muscle fibre types with motor neurones of different sizes 
is the basis of an elegantly simple mechanism for grading the force of muscle 
contraction. 
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1.4.3 Small x large motor units 
 
Motor units may vary in size.  The size of a motor unit in a muscle is defined by the 
innervation ratio, which is the ratio between the number of muscle fibres in a muscle 
and the number of supplying motoneurone axons. Small motor units have small-
diameter axons typically innervating slow muscle fibres that are resistant to fatigue. 
Those motor units play one important role in activities that require sustained muscular 
contraction, as, for example, in the maintenance of an upright posture. Large motor 
units have, on the other hand, large-diameter axons that typically innervate faster 
muscle fibres that are more fatigable and play an important role in brief exertions that 
require large forces, as for example running or jumping. Lastly, there is also an 
intermediate-size motor unit called fast intermediate fatigable or fast fatigue-resistant 
–See figure 1-4 (Burke 1967; Burke et al. 1970; Burke et al. 1973; Purves D 2001).  
 
The size of a motor-unit is especially important in determining the magnitude of the 
motor-unit force and the amplitude of the motor-unit action potential (Goldberg and 
Derfler 1977).   
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Figure 1-4: Three different types of motor units and their force and fatigability. (A), (B) and (C) shows 
the change in muscle tension due to (A): A single motor neurone action potential. (B): Repetitive 
stimulation of the motor neurones. (C): Repeated stimulation at a level that evokes maximum tension. 
The ordinate represents the force generated by each stimulus with the different fatigue rates. From: 
(Purves D 2001). 
 
1.4.4 Motor unit variability 
 
Most information on the physiological properties of single motor units comes from 
animal experiments involving stimulation of motoneurones directly by insertion of 
electrodes into the motor nucleus supplying the limb muscles (Freund 1983). 
 
SMUs can vary in morphology (innervation ratio, cross-sectional area, geometric 
distribution of muscle fibres) and in physiological and biochemical properties (force 
output, contraction velocity, resistance to fatigue, oxidative and glycolytic capacities, 
ATPase activities, and myosin heavy-chain (MyHC) isoform contents) (van Eijden and 
Turkawski 2001). Masticatory muscles contain, therefore, a large variety of motor units 
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with different physiological and morphological properties (Turkawski and van Eijden 
2000). 
 
Many differences can be found between and within the jaw muscles. In fact, a 
comparison of jaw opening muscles with jaw closing muscles shows that jaw openers 
are simpler with respect to activation, architecture and fibre type composition than the 
jaw closing muscles (Tsuruyama et al. 2002). In a study analyzing fibre type 
compositions and fibre cross-sectional areas of masticatory muscles in eight cadavers 
(Korfage et al. 2000), it was demonstrated that the temporalis, masseter and pterygoid 
muscles could be characterized by a relatively large number of fibres containing more 
than one MyHC isoform (hybrid fibres) with a large number of fibres expressing MyHC-
I, MyHC-fetal and MyHC-cardiac alpha. Besides, in these muscles type I fibres had 
larger cross-sectional areas than type II fibres. In the meantime, the mylohyoid, 
geniohyoid and digastric muscles were characterized by less fibres expressing MyHC-
I, MyHC-fetal, and MyHC-cardiac alpha, and by more fibres expressing MyHC-IIA; the 
cross-sectional areas of type I and type II fibres in these muscles did not differ 
significantly. Furthermore, jaw closer muscles contain 40% of hybrid muscle fibres as 
opposed to only 10% of these fibres in jaw opener muscles (Korfage et al. 2001).  
   
1.4.5 Orderly recruitment of motor units 
 
Adrian and Bronk (Adrian and Bronk 1929) initially discussed that increases in force 
were achieved by the recruitment of additional motor units and an increase in discharge 
rate of motor units that had already been recruited. Derek Denny-Brown (1901–1981) 
and Joseph Pennybacker (1907–1982) reported later, in 1938, that “a particular 
voluntary movement appears to begin with discharge of the same motor unit. More 
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intense contraction is secured by the addition of more and more units added in a 
particular sequence. This ‘recruitment’ of motor units into willed contraction is identical 
to that occurring in certain reflexes. The early motor units in normal graded voluntary 
contraction are always in our experience small ones. The larger and more powerful 
units, each controlling many more muscle fibres, enter contraction late” (Denny-Brown 
1938).  
 
Elwood Henneman et al. (Henneman 1957; Henneman et al. 1965) finally proposed 
that, with increasing levels of motor activation, motor units would be recruited in order, 
starting from the smallest to the largest and this is termed the Size Principle of Motor 
Unit activation. On the basis of this, the recruitment of the smallest, most fatigue-
resistant motor units would be recruited in tasks requiring fine motor control over long 
periods of time, while the larger motor units would be required for brief bursts of high 
force production – See figure 1-5 (Mendell 2005).  
 
 
Figure 1-5: The recruitment of motor neurones in the cat medial gastrocnemius muscle under different 
behavioural conditions. Slow motor units, for instance, provide the tension necessary for standing. Fast 
fatigue-resistant (FR) units, in turn, provide additional force required for activities such as walking and 
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light running. Lastly, fast fatigable units are recruited for the most demanding activities. From: (Purves 
D 2001). -After (Walmsley et al. 1978). 
 
1.4.6 Motor unit territories  
 
In humans the size of the individual motor unit is investigated by electrophysical 
delineation of the territory occupied by the fibres of a motor unit. Fibres are identified 
as belonging to the same motor unit when their potentials have identical time 
relationships irrespective of the frequency of discharge (Buchthal and Schmalbruch 
1980). In this technique, an electrode is moved through the territory of an active motor 
unit. The length of the path over which motor unit activity is registered is used as an 
estimation of motor unit width (van Eijden and Turkawski 2001). 
 
In animal muscles, motor unit territories can be mapped with the glycogen-depletion 
method that was originally described by Edstrom and Kugelberg (1968). In this method, 
a neurone is stimulated until the muscle fibres it innervates are depleted of glycogen. 
These depleted fibres can then be visualized in a muscle histological section, where 
they are the only ones that are not stained by the periodic acid Schiff (PAS) method 
(van Eijden and Turkawski 2001). 
 
Muscle fibres of motor units are intermixed with each other and are restricted to a 
particular region of the muscle, named the motor unit territory.  Within the territory of a 
motor unit, motor units of human limb muscles have an average territory of 5-10 mm 
in diameter; this allows space for the fibres of 15-30 other motor units to be 
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intermingled (Buchthal and Schmalbruch 1980). The distance between fibres of a 
particular motor unit varies from zero (fibres in contact) to hundreds of micrometres. 
 
In two muscles with equal average territory of the motor units (e.g., the brachial biceps 
and the extensor digitorum communis), the maximum amplitude of the motor-unit 
potential is highest in the muscle with the greatest number of fibres per motor units 
(Buchthal and Schmalbruch 1980). 
 
Motor unit territories in masticatory muscles seem to be smaller than territories in limb 
muscles, and this would indicate a more localized organization of motor control in 
masticatory muscles. Motor unit cross-sectional areas show a wide range of values, 
which explains the large variability of motor unit force output. The proportion of motor 
unit muscle fibres containing more than one MHC isoform is considerably larger in 
masticatory muscles than in limb and trunk muscles. In fact, in trunk and limb muscles, 
this phenomenon is primarily observed in elderly subjects (Andersen et al. 1999). 
Hence, in masticatory muscles, a finer gradation of force and contraction speeds 
appears when compared to limb and trunk muscles (van Eijden and Turkawski 2001).  
 
The presence of localized motor unit territories and task-specific motor unit activity 
facilitates differential control of separate muscle portions. This gives the masticatory 
muscles the capacity of producing a large diversity of mechanical actions (van Eijden 
and Turkawski 2001). 
1.4.7 Motor units and the contraction of the muscles 
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The ability of a motor unit to produce force depends upon the cross sectional area of 
the constituent muscle fibres whereas the speed of contraction of a motor unit is 
dependent on the heavy-chain of the myosin protein in the muscle fibres. 
 
When the motoneurone is excited to discharge action potentials, the muscle fibres of 
the motor unit are activated. The motor unit’s action potential is the sum of action 
potentials propagated by all the muscle fibres that belong to that unit. The action 
potentials of the single fibres differ in amplitude and in frequency content, and they are 
temporally and spatially dispersed (van Eijden and Turkawski 2002). 
  
After the synaptic transmission that occurs at the neuromuscular junction and which 
results in muscle contraction, action potentials are generated and which propagate 
along all the muscle fibres of a motor unit. All the muscle fibres of the motor unit 
contract approximately at the same time to result in a twitch contraction. Thus, the 
associated motor unit action potentials contribute to extracellular currents that sum to 
generate a field potential. This field can easily be recorded with electrodes placed on 
the skin over the muscle or via intramuscular electrodes (De Luca and Forrest 1973; 
Heckman and Enoka 2012). 
 
The gradation of contraction of a muscle is controlled by two factors. First, the number 
of motor units that are recruited to participate in the act, and where more motor units 
are recruited, there will be a larger force generated from the muscle. Second, the 
frequency with which each motor unit fires action potentials determines the amount of 
force that each motor unit generates. Force summation occurs with increased firing of 
motor unit action potentials (van Eijden and Turkawski 2002). There is a threshold 
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value for the force required to activate the motoneurone where if force required in a 
movement or action is below this threshold value, then none of the muscle fibres in the 
unit will contract and if the force required in a movement or action is at the threshold 
value, then all the muscle fibres will contract (Hamilton et al. 2011). 
 
1.4.8 Firing rates 
 
As already mentioned, the magnitude of force produced by a muscle can be modulated 
by the central nervous system by two mechanisms:  
(1) Varying the numbers of motor units that are recruited (recruitment gradation) and 
(2) Varying the discharge rates of action potentials of each motor unit (rate gradation) 
(van Eijden and Turkawski 2001). 
 
The second way by which the force of a contraction can be modulated is, therefore, by 
changing the firing rates (FRs) of active motor neurones. By accurately decomposing 
the EMG signal into its constituent motor unit action potential trains (MUAPTs), it is 
possible to image the firing behaviour of motor units (Nawab et al. 2008). 
 
In general, the firing rate of individual motor units is reported to increase with force 
increases. De Luca carried out studies (De Luca and Erim 1994) in which motor unit 
firing rates during ramp contractions (force trajectory that increased linearly from 0 to 
the target force at 10% MVC) were recorded and they observed that the firing-rate-
force relationship can be characterized into three contiguous regions in the whole EMG 
activity. 
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1- Where the motor unit is newly recruited – the firing rate increases rapidly with 
force 
2- Where a motor unit increases its firing rate more slowly as force increases and 
this coincides with the recruitment of new motor units 
3- Where motor units increase their firing rates much faster than in the previous 
regions probably to compensate for the fact that motor unit recruitment is not 
available.  
 
The decline in firing rate from recruitment to de-recruitment has been seen previously 
by recording single motor units during voluntary isometric contractions (Milner-Brown 
et al. 1973a) and is evidence of motoneuronal adaptation. And the de-recruitment order 
was orderly and the opposite of recruitment order (De Luca et al. 1982). 
 
1.4.9 Recruitment threshold 
 
A parameter which is commonly used to characterize motor unit recruitment as a 
function of motor unit size is the recruitment threshold (also force or activation 
threshold), in other words, the level of voluntary force for the first recruitment of a motor 
unit  (Milner-Brown et al. 1973b).  
 
In individual masticatory muscles, generally, the force produced cannot be measured 
directly, and the recruitment threshold is routinely defined by the bite force level at 
which the unit is activated (van Eijden and Turkawski 2001). For movements, the value 
of the threshold was defined as the magnitude (mm) of the jaw displacement at the 
point between the incisal edges of the lower central incisor teeth, namely, the mid-
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incisor-point reference point of lower jaw movement in relation to the maxillae, along 
the most relevant axis for the analyzed movement phase. This definition has been used 
in a recent study of the medial pterygoid muscle (Chen et al. 2017) and in the lateral 
pterygoid muscle (Phanachet et al. 2001). 
 
In fact, the recruitment threshold of a motor unit is not fixed but depends on several 
parameters, including contraction velocity (Budingen and Freund 1976), where studies 
show that with an increase in the speed of muscle contraction, the motor unit 
recruitment threshold force decreases (Budingen and Freund 1976; Duchateau and 
Enoka 2011; Freund et al. 1975; Tanji and Kato 1973), and muscle length (Miles et al. 
1986). In fact, in their study, Pasquet et al. (Pasquet et al. 2005) actually found that 
motor units were activated at lower threshold at shorter muscle lengths. Another factor 
to be considered is the bite force direction (Hattori et al. 1991) and the duration of 
muscle contraction (Nordstrom and Miles 1991). Therefore, care is needed in using 
the bite force recruitment threshold as the only criterion for characterizing motor units.  
 
 
1.4.10 Motoneurones driven by higher centres 
 
The various functions related to the jaw muscles such as mastication and swallowing 
and the role they play in respiration and communication, are controlled by a complex 
sensorimotor system. This means that sensory imputs to the central nervous system 
provide feedback to guide and modulate those functions – See Figure 1-6 (Avivi-Arber 
and Sessle 2017). 
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Figure 1-6: Principal inputs and outputs to and from face MI and face SI. There are considerable 
interconnections (excitatory and inhibitory), between the different cortical and subcortical regions, and 
commissural fibres are responsible for bilateral coordination. From: (Avivi-Arber et al. 2011). 
 
 
Orofacial tissues have somatosensory receptors (including muscles spindles, Golgi 
tendon organs, other encapsulated endings and free nerve endings), which transduce 
external stimuli into action potentials that are conducted to the trigeminal brainstem 
sensory nuclear complex (VBSNC) for transmission to higher centres and further 
processing (Avivi-Arber and Sessle 2017). 
  
Among those types of receptors, the free nerve endings usually are nociceptors and 
mostly respond to noxious (pain inducing) and thermal stimuli - morphologically, these 
receptors they lack specialized receptor cells or encapsulations. Because of this lack 
of specialization, the basis for their submodality specificity is unclear (Warren et al. 
2013). The muscle spindles, in turn, have two types of primary afferent neurones (type 
Ia – that gives a sense of body position, namely proprioception, and a sense of body 
movement, namely kinaesthesia and type II – related with discharge when the muscle 
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is static). Lastly, the Golgi tendon is innervated by type Ib afferents and relates to signal 
contractile muscle tension (Avivi-Arber and Sessle 2017). Therefore, the muscle 
spindles and Golgi tendon organs respond to stretch and contractile tension, 
respectively but may also contribute with some nociceptive input into the CNS after 
some tissue injuries (Sessle 1999a; 2006). 
 
Numerous primary afferents have neurone synapses on second-order neurones within 
the trigeminal brainstem sensory nuclear complex and other nuclei, such as the 
adjacent solitary tract nucleus (STN). The second-order neurones project to several 
other brainstem regions such as cranial nerve motor nuclei or adjacent interneuronal 
sites as well as to higher brain areas in the thalamus and the cerebral cortex for 
perceptual functions as well as for modulating orofacial movements. 
 
The cerebral cortex, in particular the sensorimotor cortex (primary somatosensory 
cortex – S1 – and the primary motor cortex – M1) have important roles for sensorimotor 
functions. There are studies in the literature employing intracortical microstimulation 
(ICMS) or recordings of peripherally evoked responses and activity patterns related to 
movement of single neurones in the M1 and S1 of the cerebral cortex in monkeys 
(Huang et al. 1989; Martin et al. 1999), cats (Hiraba et al. 2007) and rats (Neafsey et 
al. 1986). In humans, stimulation, recording or imaging studies (Martin et al. 2004; 
Nordstrom 2007; Svensson et al. 2006) have also contributed for the understanding of 
the sensorimotor cortex function. This studies have shown the important role of the M1 
in the planning, initiation and execution of limb movements and the contribution of the 
S1 to the control of the movements, and that both of them (M1 and S1) are fundamental 
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in the acquisition of new motor skills involving the limbs (Avivi-Arber et al. 2011; Sessle 
2011).  
 
In regards to the face area, studies in animals also show the importance of face M1 
and face S1 in the generation and control of automatic, semiautomatic, and voluntary 
orofacial movements. M1 neurones project to the cranial nerve motor nuclei and are 
organised in somatotopic manner and as result of this, each microzone of the M1 
represents a muscle (s) or movement (s). In fact, each microzone of the face M1 is 
intermingled with and frequently overlaps with other orofacial microzones as well as 
being next to microzones of the limbs and neck. Therefore, groupings of M1 
microzones control movements involving the activation of more than one muscle, and 
intracortical electrical stimulation within different face M1 sites can also evoke different 
patterns of swallowing and/or mastication (Avivi-Arber et al. 2011). 
 
A few factors suggest that some of the movement-related face M1 neuronal activity is 
a reflection of the sensory inputs generated by the orofacial movement and projected 
either directly or indirectly to the face M1. Therefore, a few factors reflect the important 
role of face M1 in the integration of sensorimotor information and the subsequent 
control of orofacial movements and semiautomatic movements (e.g., mastication and 
swallowing), previously mainly attributed to the CMA/swallow cortex and brainstem 
control mechanismsthe: the fact that the face M1 relays to sensory inputs both from 
directly (through the thalamic somatosensory or motor nuclei) or indirectly through the 
face S1 and the fact that blockade of somatosensory inputs to the face M1 by either 
peripheral nerve block, injury, S1 cold block or ablation can severely impair motor 
function (Avivi-Arber et al. 2011). 
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One of the unique features of mastication and swallowing are the central pattern 
generators (CPGs) that drive these movements. The CPGs involve a complex 
neuronal circuitry whereby the output of the involved neurones collectively provide the 
time-locked, patterned drive to the different motor neurone pools supplying the 
muscles that participate in chewing and swallowing.  
 
The face M1 can also be related with pain. Imaging studies showed that painful 
electrical tooth stimulation (Jantsch et al. 2005) or hot stimulation of the skin overlying 
the masseter (de Leeuw et al. 2006) can elicit activation of the face M1. However, 
although hypertonic saline induced acute cutaneous pain may activate face S1 but not 
face M1, the same saline injections that induce acute pain in the muscle may activate 
face M1 as well as face S1 (Henderson et al. 2006; Kupers et al. 2004; Nash et al. 
2010).  
 
Neuroplasticity reflects the ability of the brain to adapt to peripheral alterations, recover 
from peripheral traumas or CNS injuries and to acquire motor skills and learning. This 
phenomenon can happen during the childhood, as an infant that develops new motor 
skills, as for example, in crawling or walking, or during adulthood as reflected by, for 
example, the ability to learn how to play a new sport or regain lost sesorimotor functions 
after peripheral or central injuries (Avivi-Arber et al. 2011).  
 
However, it is important to elucidate that the neuroplasticity does not necessarily 
represent a beneficial adpatative modification. For instance, maladaptation that may 
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lead to chronic dysfunctions can happen and one example of such maladaptation is in 
TMD (Avivi-Arber et al. 2011).  
 
There is some evidence that the primary motor cortex is involved in a redistribution of 
this motor activity during noxious stimulation (Murray and Peck 2007). It is well-known 
that neuroplastic changes occur in sensorimotor cortical areas following peripheral 
manipulations of sensory inputs into and motor outputs from the brain (Sanes and 
Donoghue 2000; Sessle 2006; Toldi 2008). Spinal pain-imaging (Casey 1999; Graven-
Nielsen et al. 1997d) and electrophysiological (Farina et al. 2001; Le Pera et al. 2001; 
Valeriani et al. 2001; Valeriani et al. 1999) studies show that nociceptive activity inhibits 
limb primary motor cortical excitability. There is recent evidence that the face area of 
the primary motor cortex (that drives voluntary orofacial movements) is markedly 
affected by noxious stimulation. For example, tongue mucosal pain interferes with 
motor cortex neuroplasticity associated with novel tongue-task motor training 
(Boudreau et al. 2007). Noxious lingual stimulation results in prolonged (>4 hours) 
neuroplastic changes manifested as profound decreases (300% increases in 
thresholds) in the excitability of the somatotopically relevant region of the face primary 
motor cortex in the rat (Adachi et al. 2008) and analogous findings have been reported 
in limb motor cortex studies (Farina et al. 2001; Le Pera et al. 2001). We have also 
shown, through functional magnetic resonance imaging (fMRI) (Nash et al. 2010) that 
noxious stimulation of human facial skin or masseter muscle evoke long-duration (>6 
minutes) decreases in face motor cortex activity.  
 
Face M1 neuroplasticity has also been reported in chronic orofacial pain conditions 
such as trigeminal neuralgia (DaSilva et al. 2008) and patients reporting parafunctional 
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oral motor habits such as clenching and grinding have decreased fMRI activation within 
M1 during clenching (Byrd et al. 2009). Therefore, as it was already mentioned that 
motor training may produce M1 neuroplasticity, applying training to reorganize the 
sensorimotor cortex can possibly be an effective approach to improve motor control in 
chronic orofacial pain patients (Sessle 2011). 
 
The pathophysiology and mechanism of pain are explained further on section 1.7 
 
1.5 Concepts of the relation between pain and muscle activity 
 
For many years, clinical diagnosis and management of musculoskeletal pain 
conditions have been influenced by the notion of a simple, reflex-like association 
between pain and muscle activity (Murray and Lavigne 2014; Svensson and Graven-
Nielsen 2001). 
 
 
1.5.1 The Vicious Cycle Theory (VCT) 
 
The Vicious Cycle Theory (VCT), often cited in clinical practice, proposes a positive 
interrelationship between pain and so-called muscle “hyperactivity” (Figure 1-7). 
Therefore, an initiating factor such as an abnormality in structure, posture, movement, 
or stress results in pain that causes what is called “muscle hyperactivity,” which, in 
turn, leads to spasm or fatigue and further pain and dysfunction, and perpetuating the 
cycle (Travell et al. 1942).  
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Figure 1-7: Schematic figure of how the Vicious Cycle Theory works to perpetuate pain. 
 
Management strategies based on this theory attempt to break this cycle by, e.g., 
irreversible and often expensive changes to the anatomy (e.g. surgery, tooth 
adjustments) (Stohler 1999). 
 
However, the validity of the idea proposed by the theory is controversial and not 
clinically proven. Contrary to the theory’s fundamental key assumption that painful 
muscle is hyperactive, the literature has shown a considerable amount of evidence 
from clinical and experimental studies in the spinal and trigeminal systems, revealing 
only small differences (either increases or decreases or no change) in resting EMG 
activity between painful and non-painful muscle (Ahern et al. 1988; Bodere et al. 2005; 
Carlson et al. 1993; Collins et al. 1982; Graven-Nielsen and Arendt-Nielsen 2008; 
Graven-Nielsen et al. 1997d; Madeleine and Arendt-Nielsen 2005; Majewski and Gale 
1984; Peck et al. 2008; Sae-Lee et al. 2008b; Sherman 1985; Simons and Mense 
1998; Stohler 1999; Stohler et al. 1996; Svensson et al. 1998; Thomas Graven-Nielsen 
et al. 2000; van Dieen et al. 2003; Xu et al. 2010). And the clinical significance of any 
of these small changes is questionable. 
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1.5.2 The Pain Adaptation Model (PAM) 
 
The Pain Adaptation Model (PAM) (Figure 1-8) (Lund 2008; Lund et al. 1991) on the 
other hand, is another widely cited model that proposes that pain results in slower and 
smaller movements so as to minimise further injury and therefore aids healing 
(Campbell et al. 2010; Lund 2008; Stohler 1999). According to this model, pain would 
change the excitability of motoneurones and therefore cause an alteration in muscle 
activity, namely an inhibition of agonist muscle activity and facilitation of antagonist 
muscle activity (Lund et al. 1991). The net effect of this is to decrease the force 
produced by the muscle and thereby lead to a decrease in movement velocity and 
amplitude during pain (Lund et al. 1991). 
 
 
Figure 1-8: Schematic figure of how the adaptation proposed by the Pain Adaptation Model would help 
to aid in healing. 
 
Management strategies based on this model invoke pharmacological and behavioral 
strategies to reduce pain and minimize movement to allow the jaw motor system to 
heal and recover (Fricton and Schiffman 2008). This model, however, does not explain 
the possible origin of the pain. In addition, studies in both the spinal and trigeminal 
systems provide limited evidence in support of this model (Hodges et al. 2015; Hodges 
and Tucker 2010; Murray and Peck 2007). For example, an earlier study of 
experimental masseter muscle pain induced by hypertonic saline injections was 
unsuccessful in confirming the uniform inhibition of agonist muscle activity and 
facilitation of antagonist muscle activity as proposed by the model (Sae-Lee et al. 
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2008a). Another study showed reduced activity in both the agonistic and antagonistic 
muscles during muscle pain, without significantly impairing the movement amplitude 
or acceleration (Ervilha et al. 2004). Recordings from the knee extensor and flexor 
muscles in a force-control and a position-control task during pain have demonstrated 
increased agonist muscle activity while the antagonist muscle EMG activity only 
increased in the force-control task (Poortvliet et al. 2015). Antagonist muscle 
activity did not increase in other studies (Birch et al. 2000; Falla et al. 2007). 
 
In fact, accumulating evidence indicate that neither of these earlier theories provides 
an adequate explanation of the association between pain and muscle activity (Lund 
2008; Murray and Lavigne 2014; Murray and Peck 2007; Murray et al. 2014; Stohler 
1999; Svensson and Graven-Nielsen 2001). As indicated below, other factors may be 
playing a role in influencing the relation between pain and motor activity, e.g. 
psychological factors. 
 
 
1.5.3 Reorganization of single motor unit activity within muscles during pain 
 
A major problem with the proposals of these earlier theories is that they propose 
uniform increases or decreases of activity within a painful muscle. However, it is difficult 
to reconcile such uniform changes in muscle activity with the clinical observations of 
localised tenderness within painful jaw muscles in many TMD patients.  
 
Recent experimental muscle pain studies in limb muscles, however, have provided 
good evidence that complex, non-uniform changes in activity can occur within 
36 
 
individual muscles. For example, a slowing and/or de-recruitment of one population of 
motor units, together with a recruitment of a new population of units, has been 
demonstrated within painful limb muscles (Hodges and Tucker 2011; Tucker et al. 
2009). It is also important to mention that muscle function may also affect the pain due 
to an impact on the volume injected / infused. For example, Kumar et al., 2015 in their 
study, reported that the possibility of diffusion of the injected monosodium glutamate 
into the muscle during muscle contraction for the performance of the behavioral task, 
may lead to an enhanced washout of the solution and thereby reduce the effect of 
the painful stimulus (Kumar et al. 2015). 
In a study of limb muscle behaviour in pain (Tucker et al. 2009), a total of 52 SMUs 
were discriminated in the quadriceps and 34 SMUs were discriminated in the flexor 
pollicis longus (FPL) muscle during low-force contractions in both pain into the 
infrapatellar fat pad and no-pain trials. Of these, 20 quadriceps and 9 FPL units were 
identified during both pain and no-pain trials (see Figure 1-9).  All remaining units 
discharged only with or without pain, but not in both conditions. One-third of the 
additional units were recruited during pain – See figure 1-9 and 1-10. 
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Figure 1-9: Number of discriminated motor units in quadriceps (A) and flexor pollicis longus (B) during 
three contraction conditions (no-pain lower force, no-pain higher force, pain lower force). Observe in 
black the number of units that were recruited for all the conditions and an arrow was placed to point out 
the units that were recruited only for the pain condition. From: (Tucker et al. 2009). 
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Figure 1-10: Recordings of motor unit activity from a fine-wire electrode inserted into the FPL of one 
subject. SMUs are shown with their respective discharge rates [mean (SD)]. A red circle points out the 
units that were recruited in the lower force pain condition (units B, F, G) and that were de-recruited 
during the lower force pain condition (Unit D). From: (Tucker et al. 2009). 
 
There is more evidence in the literature that muscles other than the painful one can 
change their activity to maintain the motor output (Ervilha et al. 2005; Muceli et al. 
2014). For example, Muceli, Falla and Farina, in 2014 published a study where they 
injected hypertonic saline into the right anterior deltoid muscle and which resulted in a 
decrease in its activity with pain. But the saline injection also resulted in alterations in 
the activity (increase or decrease) of muscles other than the one injected with saline 
and the effects were subject specific (Muceli et al. 2014). Other studies have also 
identified changes in EMG activity (greater activity or decrease in activity) in different 
non-painful leg muscles with noxious stimulation of the spinous process or 
gastrocnemius medialis (van den Hoorn et al. 2015). 
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Changes in non-painful jaw muscle activity have also been observed with algesic 
chemical injections into isolated jaw muscles (Costa et al. 2017; Kumar et al. 2015a; 
Sae-Lee et al. 2008a; Svensson et al. 1996a). Also, Shimada, Hara and Svensson in 
2013, studying the masseter and temporalis muscles, injected hypertonic solution into 
the right masseter muscle and observed that EMG activity decreased in the painful 
muscle and increased in other muscles at different levels of clenching (Shimada et al. 
2013). Sae lee et al in 2008 studying the EMG activity of bilateral masseter, and right 
posterior temporalis, anterior digastric, and inferior head of lateral pterygoid muscles 
also found that EMG activity were significantly effected by hypertonic saline-
induced pain in the masster depending on the task in which the muscle participated 
irrespective of whether the muscle was an agonist or an antagonist in the tasks (Sae-
Lee et al. 2008a). 
 
 
While studies of the effects of noxious stimulation of the jaw muscles have focussed 
on surface EMG recordings from the jaw muscles and which provide evidence for 
overall changes in jaw muscle activity in pain, there is very little information as to 
whether the reorganization of motor unit activity which has been demonstrated in the 
spinal motor system (for review – See Hodges et al., 2015) also operates in the 
trigeminal motor system.  
 
We have recently provided evidence that the presence of experimental pain in the 
masseter muscle (a jaw closing muscle) results in a reorganization of activity, that is, 
increases and decreases of motor unit activity occurs within the same painful muscle 
(Minami et al. 2013). In this study, Minami at al in 2013 discriminated 36 SMUs, and 
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from these, 21 were present in both conditions (pain and no-pain), while 5 were present 
only in the no-pain condition and 10 were present in the pain condition only (see Figure 
1-11) (Minami et al. 2013). 
 
Figure 1-11: Top left: Bland-Altman plot showing mean difference in force levels between pain and no-
pain trials. Lower left: Injection site (arrow), needle electrodes for recording single motor unit activity, 
pain maps during hypertonic saline infusions; Right panel: single motor units P, Q, R were present under 
no pain trials, but during pain trials, single motor units P, R, S and T were present. Therefore, 2 SMUs 
were recruited in pain and 1 SMU was de-recruited (reproduced from (Minami et al. 2013). 
 
Also, Malik (Malik 2016)  recorded SMU activity at 2 sites within the right masseter 
muscle (a superior/anterior site - RMS/RMA, and an inferior/posterior site - RMI/RMP) 
during isometric biting tasks under 3 sessions: baseline (no infusion), 5% hypertonic 
saline infusion (pain), and isotonic saline infusion (control). At the RMI/RMP site and 
for the comparison of hypertonic saline infusion with isotonic saline infusion, of the 58 
instances where all the SMUs were tested for recruitment or de-recruitment in a task, 
there were 7 instances of recruitment of new SMUs and 7 occurrences of de-
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recruitment of SMUs. For the 68 instances where SMUs were tested at the RMS/RMA 
site, there was 1 recruitment and 2 de-recruitments. 
 
These data from these recent studies (Malik 2016; Minami et al. 2013) represent the 
first demonstration of reorganization of SMU activity within the masseter muscle in the 
jaw muscle system. These single motor unit studies in the jaw motor system have, 
however been restricted to studies of motor unit activity within the muscle that is 
receiving the algesic chemical injection. However, as summarized above, studies in 
the limb motor system have demonstrated a reorganization of SMU activity can occur 
even in non-painful muscles (Tucker et al. 2009). To date, there have been no studies 
as to whether the reorganization of single motor unit activity that has been 
demonstrated within the masseter muscle during noxious stimulation of the masseter 
(Malik 2016; Minami et al. 2013) leads to a reorganization of single motor unit activity 
within other jaw muscles, e.g. the temporalis muscle, another major jaw closing 
muscle. This is important to study because patients with TMD frequently have pain and 
tenderness not only in the masseter muscle but also other jaw muscles, such as the 
temporalis and medial pterygoid muscles. Studying the activity patterns of SMUs in 
non-painful muscles in an experimental muscle pain paradigm might provide possible 
insights into the spread of pain in TMD if some of these possible changes in muscle 
activity might predispose to further pain and tenderness in these non-painful muscles. 
Such possible pain effects associated with changes in motor activity have been 
proposed in the spinal motor system (Hodges et al. 2003) and also suggested in the 
jaw motor system (Murray and Peck 2007).  
 
Nonetheless, these new data (Malik, 2016; Minami et al., 2013) point to the need to re-
assess management strategies for patients with jaw muscle pain conditions which are 
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based on the earlier theories (i.e. Vicious Cycle Theory, Pain Adaptation Model) (Lund 
2008; Murray and Lavigne 2014) and which propose generalized reductions or 
generalized increases in EMG activity within muscles and where pain is present either 
within the muscle or in adjacent structures. Rather than supporting these earlier 
models, the findings tend to support other models that propose that in the presence of 
pain muscle activity undergoes a reorganization (Hodges and Tucker 2011; Murray 
and Lavigne 2014; Murray and Peck 2007).  
 
1.5.4 Possible role of psychological factors in the relation between pain and muscle activity 
 
Another problem with the earlier theories (namely, the Vicious Cycle, the Pain 
Adaptation Model) is that they take no account of the possible role of psychological 
factors in the relation between pain and muscle activity. In recent years, there is 
increasing acceptance that psychological factors play an essential role in this 
interaction (Hall et al. 2011; Murray and Peck 2007; Ohrbach et al. 2011) as well as 
playing an important role in the onset and progression of chronic pain conditions (Innes 
2005; Kuch 2001). In many case-control studies, investigators have compared pain-
free controls and patients with chronic pain conditions and a common finding from all 
studies shows that patients with chronic pain conditions show elevations on measures 
of psychosocial distress, environmental stress, catastrophizing, and somatic 
awareness (Fillingim et al. 2011; Gatchel et al. 2007; Hirsch and Turp 2010; Keefe et 
al. 2004; Nevalainen et al. 2016; Tournavitis et al. 2017).   
 
The psychological factors have been implicated particularly in the transition from acute 
to chronic pain and disability in chronic low back pain (Hall et al. 2011). Patients with 
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TMD also report higher levels of affective distress (Reissmann et al. 2008), somatic 
awareness (Lei et al. 2015), psychosocial stress (Ajilchi and Nejati 2017) and pain 
catastrophizing (Nilges and Essau 2015).  
 
Pain catastrophizing is one psychological variable that has received considerable 
attention in recent years (Leeuw et al. 2007; Nicholas et al. 2011; Sullivan et al. 2001; 
Sullivan MJL 1995). Pain catastrophizing is the cognitive element of the fear network 
and refers to the process whereby pain is interpreted as being extremely threatening. 
High catastrophizing individuals have a tendency to focus excessively on a pain 
sensation (rumination), to exaggerate its threat (magnification), and to experience a 
sense of helplessness (Leeuw et al. 2007; Sullivan et al. 2001). 
 
One of the theoretical models incorporating catastrophizing is the Fear Avoidance 
Model of musculoskeletal pain (Figure 1-12) (Leeuw et al. 2007; Sullivan et al. 2001; 
Wideman et al. 2013). This model proposes that high catastrophizing individuals react 
to an acute pain episode by becoming fearful about movements and therefore develop 
safety seeking or avoidance behaviours (i.e. new movements and muscle activity 
patterns) that can be adaptive in the acute stage (by reducing pain briefly) but 
paradoxically can lead to disuse, disability, depression and further pain in the long term 
(Figure 1-12, left side of figure) (Leeuw et al. 2007; Sullivan et al. 2001). 
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Figure 1-12: Fear Avoidance Model. Reproduced from: (Wideman et al. 2013). 
 
 
Low catastrophizing individuals, on the other hand, according to the Model (Figure 1-
12, right side), perceive acute pain as non-threatening, do not develop an unrealistic 
fear of movement and they confront the pain and this promotes functional recovery. 
 
Despite the attention given to catastrophizing in explaining trunk and limb 
musculoskeletal pain problems, much less attention has been given to catastrophizing 
and fear of movement in the jaw musculoskeletal system, although there is emerging 
evidence for pain catastrophizing in pain persistence, disability and treatment failure in 
TMD (Nicholas et al. 2008; Velly et al. 2011; Visscher et al. 2010). 
 
Therefore, this Fear Avoidance Model may be useful in explaining the transition from 
acute to chronic TMD. However, we do not know how well the Model provides a 
theoretical basis for understanding the progression of TMD. For example, we do not 
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know whether pain catastrophizing influences the effects of orofacial pain on jaw 
movements and jaw muscle activity patterns (i.e. avoidance behaviours), and whether 
these activity patterns can actually contribute to the progression of the TMD pain 
condition, a key proposal of the Fear Avoidance Model. 
 
There is some evidence in the trigeminal system, however, that pain catastrophizing 
plays a role in the initiation and/or progression of orofacial pain or plays a role in the 
interaction between pain and motor activity. This evidence includes clinical studies 
(Turner et al. 2002) and experimental pain studies (Akhter et al. 2014; Henderson et 
al. 2016; Kristiansen et al. 2014; Trost et al. 2015). Akhter et al., 2014 investigated 
differences between higher and lower pain catastrophizers in the effects of hypertonic 
saline-evoked jaw muscle pain and found an increased report of pain intensity, pain 
areas and McGill Pain Questionnaire pain rating indices consistent with enhanced 
central sensitization processes in higher catastrophizing individuals.  
 
Catastrophizing, fear-avoidance and depression have also been shown to correlate 
significantly with subjective or objective measures of motor performance. (Alschuler et 
al. 2008; Castaneda et al. 2008; Leeuw et al. 2007; Thomas et al. 2008; Turner et al. 
2001). For example, individuals with high pain-related fear have smaller peak velocities 
and accelerations of the lumbar spine and hip joints in reaching trials (Thomas et al. 
2008). There is recent evidence that catastrophizing and depression contribute to the 
progression of chronic TMD pain and disability, (Velly et al. 2011) and that high 
intensity muscle pain is a predictor for the development of chronic TMD (Epker et al. 
1999). We have also recently demonstrated significant correlations between 
psychological variables (e.g. catastrophizing, depression, and orofacial pain intensity 
and quality) and jaw muscle and jaw movement features and brain activity features 
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(Akhter et al. 2014; Brandini et al. 2011; Henderson et al. 2016; Murray and Peck 
2007). 
 
There is little information however whether some of these psychological variables, 
such as pain catastrophizing, plays a role in influencing the relationship between pain 
and motor unit activity at the single motor unit level in terms of, for example, the 
reorganization of single motor unit activity that appears to be occurring within painful 
jaw muscles or within non-painful muscles during painful jaw muscle stimulation.  
 
1.6 The Integrated Pain Adaptation Model (IPAM) 
 
Given the limitations of the earlier models of pain-motor interaction, it has been 
proposed that there is a more complex explanation for the effect of pain on motor 
activity. In fact, according to The Integrated Pain Adaptation Model (IPAM), the effect 
of pain on motor activity depends on the interaction of the individual’s biopsychosocial 
variables with the individual’s pain experience (i.e., the multidimensional nature of 
pain) and the anatomical and functional complexity of the individual’s sensory-motor 
system (Figure 1-13) (Murray and Peck 2007; Sae-Lee et al. 2008b). 
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Figure 1-13: Diagram outlining essential components of the Integrated Pain Adaptation Model 
(IPAM). Extracted from (Sae-Lee et al. 2008b). 
 
For instance, the Integrated Pain Adaptation Model suggests that the interaction of 
those variables that are part of the complexity of the individual’s pain experience (e.g., 
acute/chronic, muscle/joint, beliefs based on past experience, catastrophizing, 
emotional contributions, motivation, social context, genetic factors) will singularly affect 
motor activity in a unique way. In other words, if the individual’s experience of pain 
varies, the individual’s motor response to pain will also be varied.  
 
Consequently, the way that motor units are recruited may be individually reorganized 
in order to preserve homeostasis or minimize an individual’s pain experience, yet 
maintaining the capacity of the individual to perform motor activities, e.g. a masticatory 
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action. Thus, when jaw muscles are painful, the motor unit recruitment strategy 
adopted to achieve mastication could vary among individuals depending on the 
interaction with these other variables. Further research is required to elucidate those 
pain-related variables that have important influences on jaw muscle function (Brandini 
et al. 2011; Sae-Lee et al. 2008b). 
 
Therefore, according to this model, it is not suitable to manage chronic pain patients in 
exactly the same way, regardless the fact that they might have the same physical 
diagnosis (Sae-Lee et al. 2008b).  As a matter of fact, individualizing management 
based on the multidimensional pain experience with a focus on psychosocial status 
rather than the physical pain experience by itself has demonstrated successful 
outcomes (Dworkin et al. 2002). 
 
1.7 Pathophysiology and mechanisms of pain 
 
Generally speaking, pain varies in character, location, duration and intensity. In order 
to have a better understanding of pain, it is important to recognize some definitions. 
Therefore, a noxious stimulus is considered to be a stimulus capable of inflicting 
damage or threatening to damage tissues (Warren et al. 2013). 
 
As already mentioned, receptors for touch, pressure, innocuous thermal stimuli, and 
nociceptive stimuli are distributed in the skin and in deep tissues. Sensory neurones 
that innervate the skin, viscera, deep muscle, and joints are called primary afferents. 
These neurones have their soma in the dorsal root or trigeminal ganglia and extend 
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axons into their peripheral targets and centrally into the spinal cord or brainstem. When 
peripheral body tissues are activated either by non-noxious thermal or mechanical 
stimuli or noxious stimuli, the somatosensations are conducted in the form of action 
potentials to the CNS via primary afferent nerve fibres which travel within peripheral 
nerves (L. Ingram 2017). 
 
The detection of the nociceptive environment and inflammatory mediators is 
accomplished through many specialized receptor proteins that are differentially 
expressed in primary afferents. Nociceptive activity generally occurs with tissue 
damage and is a result of the release of neurotransmitters, cytokines, and growth 
factors from adjacent blood vessels, damaged cells and others, which activate and 
sensitize nociceptive nerve terminals (Haas and Lennon 1995) – See figure 1-14. The 
transduction, therefore, starts when these proinflammatory mediators interact with the 
ion channels and receptors that are expressed on the peripheral nerve membrane of 
the nociceptor (Hunt and Mantyh 2001). 
 
 
Figure 1-14: The peripheral terminal of a nociceptor, showing some of the various ligand-gated ion 
channels and G protein-coupled receptors, and the inflammatory mediators that bind directly to 
them. From: (Basbaum and Woolf 1999). 
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Afferent nerve fibres convey information from somatosensory receptors in the head 
and body and ascend from their peripheral location through the trigeminal ganglion and 
dorsal root ganglia and on through relay centers to higher centres where the 
information is processed and the patient may perceive the neural information as the 
perception of heat or cold, touch or pressure or pain. The afferent fibres are classified 
into three main groups according to their conduction velocities, function and degree of 
myelination (Basbaum and Jessell 2000) –See Table 1-1 and figure 1-15.  
 
 A beta (Aβ) fibres are myelinated and have fast conduction velocities (35-120 
m/sec). These fibres transmit mechanosensory information and although this 
fibre type does not transmit nociceptive information, recent studies have 
demonstrated that they may have a role in chronic pain states.  
 Nerve fibres that transmit nociceptive and thermal information are known as A 
delta and C fibres. A delta (Aδ) fibres are lightly myelinated and have relatively 
fast conduction velocities (5-30 m/sec) when compared to C fibres and evoke 
sharp localized pain responses. 
 C fibres are unmyelinated and have slower conduction velocities (0.5-2 m/sec) 
and are responsible for the dull, diffuse, burning pain (L. Ingram 2017) (James 
et al. 2017).  
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Figure 1-15: Fibres conveying information from high-threshold mechanoreceptors (A) respond to the 
application of a punctate stimulus. Thermoreceptors show a response that increases while temperature 
increases ( B , left ), while burns caused by prolonged thermal stimulation, for example, evoke high-
frequency response in thermonociceptors ( B , right ). From: (Warren et al. 2013).  
 
Type of nerve 
fibre  
Information 
carried  
Myelin sheath  Diameter 
(micrometers)  
Conduction 
speed (m/s)  
A-beta  touch  myelinated  6-12  35-90  
A-delta  Pain 
(mechanical 
and thermal)  
myelinated  1-5  5-40  
C  Pain 
(mechanical, 
thermal and 
chemical)  
Un-myelinated  0.2-1.5  0.5-2  
Table 1-1: classifications of peripheral afferent nerve fibres (From Dubner et al. 1978). 
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These noxious stimuli that can evoke a sensation of pain in humans include 
mechanical stimuli (e.g. heavy pressure), algesic chemicals, and inflammatory agents 
(Sessle and Hu 1991). Ischemia also could act as a stimulus if it is prolonged enough 
and associated with muscle contractions (Sessle 1999a). 
 
Nociceptors, therefore, respond to noxious stimuli applied to the peripheral tissues, 
and are associated with A-δ and C fibres, which in turn, conduct information about 
these nociceptive events to the central nervous system for processing - for review see 
(Sessle 2009). It is important to mention that many C fibres have been found  to  act 
not only in respond to noxious stimuli, but also to multiple stimulus modalities such as 
non-noxious cool or warm stimuli (Lawson et al. 2008; Van Hees and Gybels 1981). 
 
In fact, multiple pathways in the CNS are involved in the processing of noxious stimuli 
for the perception of pain. Studies of human brain imaging have revealed consistent 
cortical and subcortical networks that are activated by noxious stimuli, including 
sensory, limbic and associative regions. The brain areas activated by noxious stimuli 
in human brain imaging studies are typically the primary somatosensory cortex (S1), 
secondary somatosensory cortex (S2), anterior cingulate cortex (ACC), insula, 
prefrontal cortex (PFC), thalamus and cerebellum – See figure 1-16. (Apkarian et al. 
2005; Bushnell et al. 2013). 
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Figure 1-16: “Afferent pain pathways and brain regions. Afferent nociceptive information enters the brain 
from the spinal cord. Afferent spinal pathways include the spinothalamic, spinoparabrachio–amygdaloid 
and spinoreticulo–thalamic pathways. Nociceptive information from the thalamus is projected to the 
insula, anterior cingulate cortex (ACC), primary somatosensory cortex (S1) and secondary 
somatosensory cortex (S2), whereas information from the amygdala (AMY) is projected to the basal 
ganglia (BG). See the main text for references. PAG: periaqueductal grey; PB: parabrachial nucleus; 
PFC: prefrontal cortex.” From: (Apkarian et al. 2005). 
 
The somatosensory cortices (S1 and S2) are thought to encode information about 
sensory features, such as the pain location and duration (Chudler et al. 1990; Kenshalo 
et al. 1988; Kenshalo and Isensee 1983). The ACC and insula, on the other hand, have 
been considered components of the limbic (emotional) part of the brain (Mac 1949), 
and consequently are more important for encoding the emotional and motivational 
aspects of pain. 
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Within the orofacial area, the majority of nociceptive information in the head and neck 
is transmitted via branches of the fifth cranial nerve—the trigeminal nerve, which is 
considered the largest of the cranial nerves (Dubner et al. 1978; Fields 1987; Sessle 
2005; Sessle 2009) – See figure 1-17. Other nerves including facial, glossopharyngeal, 
vagus, hypoglossal and the upper cervical spinal nerves (C1-C3) are also involved in 
conveying input to higher centres (Aghabeigi 2002). 
 
 
Figure 1-17: Schematic representation of the main mechanosensory pathways. The trigeminal portion 
of the mechanosensory system carries information from the face. From: (Purves D 2001). 
 
Subsequently after the initial nerve signals have been produced, the information travels 
along the trigeminal primary afferent nerve fibres which project to the VBSNC where 
they can go up or down in the trigeminal spinal tract. The afferent nerve fibres give rise 
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to collaterals that end up in one or more subdivisions of the VBSNC and may activate 
second order neurones within or next to the trigeminal brainstem complex. This 
complex also can receive afferent inputs from other cranial nerves and from upper 
cervical nerves that additionally transmit afferent inputs from the upper cervical dorsal 
horn (Darian-Smith 1966; Dubner et al. 1978; Sessle 2000; 2006; Sessle 2009). 
 
The VBSNC can be subdivided into the principal or main sensory nucleus and the 
spinal tract nucleus, which consist in three subnuclei: oralis, interpolaris, and caudalis 
(Sessle 2000) – See figure 1-18. 
 
Figure 1-18: The spinal tract nucleus pathways whereby trigeminal somatosensory information enters 
the brain can be subdivided from rostral to caudal into 3 categories: subnucleus oralis, interpolaris and 
caudalis. The nociceptive information from the orofacial area is transmitted via the branches of the 
trigeminal nerve (cranial nerve V), which cell bodies are located in the trigeminal ganglion. Information 
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is further processed as it courses through second-order neurones in the spinal trigeminal nuclear 
complex within the brainstem, and then the nociceptive information ascends to the thalamus and 
cerebral cortex (Sessle 2000). 
 
Research data show that most of the nociceptive information related to the trigeminal 
system is received by the subnucleus caudalis and it has a close structural and 
functional relationship with the spinal region (Sessle 1999a). Also, anatomical studies 
have indicated that the subnucleus caudalis extends into the cervical spinal cord and 
merges with the spinal cord dorsal horn which is an integral component for spinal 
nociceptive transmission. Both regions comprise a laminated structure with similar 
second-order neurone types that project to the thalamus. Thus, the term medullary 
dorsal horn is designated for the subnucleus caudalis considering these similarities  
(Hannam and Sessle 1994). 
 
The second-order nociceptive neurones are located in the superficial (e.g., lamina I) 
and deep (e.g., lamina V) layers of the medullary dorsal horn and could be divided, 
according to their cutaneous mechanoreceptive properties, into two types: wide 
dynamic range (WDR) or nociceptive specific (NS) neurones (Hannam and Sessle 
1994). These neurones can be activated by the stimulation of a range of afferents from 
articular and muscular tissues along with cutaneous and mucosal tissues (Sessle 
1999a).   
 
The WDR neurones can be activated by both noxious and innocuous stimuli while the 
NS neurones are activated entirely by noxious thermal and/or mechanical stimuli that 
are conveyed from the small diameter afferent fibres. The receptive fields of NS 
neurones tend also to be smaller than the WDR neurones which have larger receptive 
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fields. Still, these two types of nociceptive neurones subserve to indicate the intensity 
and location of a noxious stimulus (Lund and Sessle 1994) 
 
All the information from the medullary dorsal horn projects in part directly to the 
thalamus or some inputs involve multisynaptic pathways that relay in the reticular 
formation and adjacent brainstem regions. The ventrobasal thalamus, the 
ventroposterior nucleus, and part of medial thalamus are the thalamic regions that are 
involved in transmitting nociceptive information (Hannam and Sessle 1994). The 
ventrobasal thalamus comprises WDR and NS neurones also and its projection to the 
somatosensory cortex indicates that these neurone types might have a role in pain 
localization and discrimination. Those neurones in the medial thalamus project to the 
frontal cortex and limbic system and have properties involved with pain, but more with 
the affective aspects of pain.  Meanwhile, some information may be relayed to other 
parts of the nervous system including the reticular formation and the cranial nerve 
motor nuclei which contribute to autonomic and muscle reflex response to craniofacial 
noxious stimulation (Sessle 1999a). 
 
Before understanding the mechanism of referral of pain, it is fundamental to 
understand the phenomena of convergence. When primary afferent neurones enter 
into the central nervous system they synapse with second order neurones which carry 
the impulses to higher centres. When diverse primary afferent neurones synapse with 
one second order neurone, neural information travelling along these separate primary 
afferents converge onto the single second order neurone. This is called “convergence”, 
and it helps to explain why sometimes the site of pain can differ from the source of the 
pain. Primary afferent neurones also can branch and synapse with several second-
order neurones, and there is the possibility therefore that the pain can be referred from 
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one site to several remote regions, and one example of this is radiating pain (Aghabeigi 
2002). TMD patients very commonly present these features of spread and referral of 
pain with poor localization, and this is thought to be at least partly due to convergence 
and divergence as well as the exchange of afferent information between the trigeminal 
and other craniofacial nerves via interneurones (Lund and Sessle 1994). 
 
With repetitive or strong noxious stimulation of the tissues either through injury or 
through disease states, nociceptors are often sensitized to stimuli. The excitation 
threshold of nociceptors drops such that even usually innocuous stimuli can now 
activate the fibres, and silent nociceptors become excitable by both innocuous and 
noxious stimuli (Schaible and Richter 2004). This increased excitability of the 
nociceptive terminal is called peripheral sensitization (Basbaum and Jessell 2000; 
Basbaum and Woolf 1999; Fields 1987). The nociceptors become more sensitive to 
subsequent noxious stimuli (hyperalgesia) by lowering their threshold and even 
innocuous stimuli can provoke pain, which is referred as allodynia  (Merskey and 
Bogduk 1994). This change in nociceptor sensitivity occurs after tissue injury or with 
chronic pain conditions (Aghabeigi 2002). One potential role of peripheral sensitization 
is as a defence mechanism for protecting the injured tissue from further injury.  
 
If the stimulation of the first-order neurones lasts long enough, there will be persistent 
nociceptive input to the second-order neurones at the spinal tract nucleus or to higher-
order neurones at central levels.  The activation of nociceptors triggers a cascade of 
events in the central nervous system (CNS) together with functional changes in the 
spinal cord and brain that has been named central sensitization, and which may result 
in persistent pain (Fields 1987).  This change in the processing of neurones in the 
medullary dorsal horn, thalamus and higher centres is a special form of neuroplasticity 
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(Aghabeigi 2002; Lund and Sessle 1994; Mense et al. 2001) – See also section 1.4.10 
above. When the second-order neurones become more sensitized, they can respond 
to even innocuous stimuli (e.g., light touch to skin which usually is not painful) or may 
spontaneously produce action potentials because of the continued production of 
excitatory neurotransmitters in the synapse (Okeson 1995) – See figure 1-19.  
 
 
 
Figure 1-19: Manifestations of central sensitization. Primary and secondary hyperalgesia produced by 
peripheral and central sensitization. From: (Schaible 2015). 
 
Central sensitization can result from peripheral sensitization but also from pathological 
discharges in afferent nerve fibres (Schaible and Richter 2004). While this may occur 
within the thalamus and cortex, research has been primarily focused on the dorsal horn 
of the spinal cord. Electrophysiological and anatomic studies have demonstrated a 
change in the activity and responsiveness of dorsal horn neurones in response to 
persistent painful stimulation. It consists of the following phenomena:  
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(a) Increase of the responses to input from the injured or inflamed region;  
(b) Increase of the responses to input from regions adjacent to and even remote from 
the injured/inflamed region, although these areas are not injured/inflamed;  
(c) Expansion of the receptive fields of the spinal cord, i.e. the total area from which 
the neurone is activated, is enlarged (Schaible and Richter 2004; Sessle 2000; Woolf 
and Salter 2000).  
 
Furthermore, when the nociceptors in cutaneous tissues or in deep muscle structures 
are activated, the second-order neurones could continue to be sensitized longer than 
the stimulation itself (Lund and Sessle 1994). When these neurones are sensitized for 
a long period and, therefore, this neuroplasticity is prolonged, nociceptive input from 
the first-order neurones may no longer be essential to result in the experience of pain. 
This could be part of the explanation why chronic pain patients often suffer from pain 
despite the absence of any obvious tissue damage (Okeson 1995). 
 
In order to have a better understanding about the chronic pain condition, it is necessary 
to understand how these changes in threshold and response properties of both 
nociceptive neurones at the injured site and in the trigeminal brainstem play a crucial 
role in allodynia, hyperalgesia, radiation and referral of pain. However, the cause of 
pain is still not clearly understood and treatment options are often not based on the 
cause of the pain.    
 
1.8 Experimentally induced muscle pain 
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Exogenous and endogenous algesic substances have been widely used to induce 
experimental muscle pain in humans in an attempt to understand pain mechanisms 
and effects – see table 1-2 below. 
 
 
Table 1-2: Algesic substances commonly used for induction of experimental muscle pain. From: 
(Graven‐Nielsen 2006). 
 
The technique of inducing muscle pain with hypertonic saline has been used since 
the 1930s and this solution has been by far the most used chemical to induce muscle 
pain worldwide. This is probably due to its safety and lack of side effects reported in 
the literature (Jensen and Norup 1992).  
 
Thus, the intramuscular injection of 4–6% sodium chloride in volunteers is a widely 
used method to induce human muscle pain not only in the face region but in different 
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parts of the body (Graven-Nielsen et al. 1997b; Graven-Nielsen et al. 1997d). It is also 
worth mentioning that the solution injected (5% hypertonic saline) is only a higher 
concentration of normal saline that is routinely injected into individuals on a daily basis 
in hospitals throughout the world. 
 
It is important to mention that a recent review of human experimental studies 
demonstrated that there was no evidence of asymptomatic participants developing 
TMD following the introduction of an experimental intervention with occlusal 
interference (Le Bell et al. 2002). Also, even though the differences between short-
term experimental pain and chronic pain patients would be considered a limitation of 
this study (See section 7 – LIMITATIONS), there are sufficient similarities between 
experimental pain and chronic pain that should allow the generation of data and 
hypotheses for future studies of chronic pain patients and make inferences about the 
possible mechanisms involved in longer term pain.  
 
Louca et al. showed that hypertonic saline-induced myalgia results in levels of muscle 
biomarkers similar to those found in the muscles of chronic myalgia patients (Louca et 
al. 2014). Furthermore, other features of the pain, such as McGill Pain Questionnaire 
pain descriptors, pain intensity and the presence of referred pain reported for 
experimental jaw muscle pain (Sae-Lee et al. 2008b), are the same or similar to these 
features identified in chronic pain patients (Graven-Nielsen and Arendt-Nielsen 2003; 
Gustin et al. 2011; Sae-Lee et al. 2008b).  
 
The big advantage with experimental studies is the fact that it allows us to control 
carefully the intensity, duration, and modality of the noxious stimulus (Poulsen et al. 
63 
 
1995), whereas clinical studies with long-term pain patients can be easily confounded 
by many factors (e.g. cognitive, emotional, and social factors) that make it difficult to 
look at specific aspects of the disease. Therefore, it is hoped that these studies will 
generate important baseline information and hypotheses for future clinical studies.  
 
1.9 EMG recording methodology: 
 
There are two main kinds of EMG electrodes that have been described in the literature: 
needle (or intramuscular) electrodes and surface electrodes. Intramuscular electrodes 
are inserted into the muscle and therefore it is usually easier to detect single motor unit 
activity that is the activity of one or more single motor units. However, the discomfort 
from the needle insertion procedure is a factor in participation in these experiments. 
Another limitation of the intramuscular electrodes is that once the needle is placed, the 
only way to change the location of the electrode is by pulling the fine wires towards the 
skin (Duchateau and Enoka 2011). 
 
Surface electrodes, on the other hand, are easier to place and remove than 
intramuscular electrodes, are more comfortable and have the advantage of providing 
a signal that is more representative of the activity from the whole muscle rather than 
one specific spot within a muscle as is provided with intramuscular electrodes (Ahlgren 
et al. 1980). However, the background noise present with surface EMG recordings 
together with the large area over which the surface electrodes usually pick up activity 
from many motor unit action potentials, means that surface EMG recordings usually 
do not permit the discrimination of single motor units. This inability to discriminate 
single motor units with surface EMG recordings applies especially to the small single 
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motor units which are usually the first recruited in a motor action. In addition, surface 
EMG is usually unsuitable for recordings from deep muscles or muscles exhibiting low 
levels of activity (Duchateau and Enoka 2011). 
 
A history and clinical evaluation allows a diagnosis of TMD to be made, although it 
does not usually explain the causes of TMD, nor does it always make a significant 
contribution to developing a therapy plan. Assuming that EMG could aid in the 
diagnosis of TMD by assessing the electrical characteristics of the muscles and 
specific muscular dynamics, it is reasonable to suggest that it could possibly be used 
to monitor the effect of the therapy that is being used to detect subclinical TMDs, or 
even prevent this pathology before the beginning. However, the use of EMG in the 
diagnosis and management of orofacial pain, and TMD conditions in particular, has not 
been well substantiated in the literature, and it is important to mention that, at the 
present state of knowledge, EMG should never replace clinical examination (Gonzalez 
et al. 2008; Lund et al. 1991; Reid and Greene 2013). The use of EMG measurements 
for diagnostic purposes has low reliability and validity due to technical issues or 
different factors such as electrode placement, electrode position, inter-electrode 
distance, cross-talk, head or body movement by the person, or existing pain conditions 
and data interpretation problems (Gonzalez et al. 2008; Klasser and Okeson 2006). 
 
In fact, to distinguish real changes from biological and instrumental noise, 
standardization of the EMG recording technique itself including parameters should be 
recommended. Therefore, researchers have investigated the relationship between 
orofacial motor function and pain by means of EMG analysis, in standardized research 
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settings, and therefore by minimizing the effects of confounding factors Svensson and 
Graven-Nielsen 2000.  
 
Despite the advance in the area, until this point, no specific criteria or cut off point have 
been reported that can discriminate, with adequate sensitivity and specificity, between 
healthy individuals and those with TMD (Gonzalez et al. 2008; Lund et al. 1995). 
 
1.10 Masseter and temporalis muscles 
 
The four principal muscles of mastication are the medial and lateral pterygoid muscles, 
and the temporalis and masseter muscles- See table 1-3 and figure 1-20; their actions 
produce movements of the mandible around the temporomandibular joints.  
 
Table 1-3 : Summary of the muscles of mastication, their origins, insertions and main actions. From 
(Hansen 2014). 
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Figure 1-20: The masseter and temporalis muscles on the left side of the head. The lateral pterygoid 
and medial pterygoid muscles are also shown. From: (Hansen 2014) 
 
A detailed discussion regarding the masseter and temporalis muscles is in the next 
sections (1.10.1 and 1.10.2). 
 
1.10.1 The temporalis muscle 
 
The temporalis muscle arises from the whole of the temporal fossa up to the inferior 
temporal line and from the deep surface of the temporal fascia. The muscle is covered 
by two fascia layers  (Ahmed and Risal 2013) – See figure 1-21. 
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Figure 1-21: The facial layers of the temporal region. From: (Ahmed and Risal 2013). SMAS: superficial 
facial fascia.  
 
The temporalis fibres arise from the temporal fossa and the deep part of temporal 
fascia descend and converge into a tendon that passes through the gap between the 
side of the skull and the zygomatic arch. A temporal fascia is attached to the superior 
surface of the zygomatic arch, and covers the muscle. Using a horizontal section above 
the zygomatic bone, the muscle would be represented in a triangular shape, with a 
broad base at the front and a long-running tip at the rear (Schumacher 1961; Susan 
Standring M.B.E. et al. 2016). 
 
The temporalis muscle – figure 1-22 - is attached to the medial surface, apex, anterior 
and posterior borders of the coronoid process and to the anterior border of the 
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mandibular ramus nearly down to the third molar tooth. Its anterior fibres are oriented 
vertically, as opposed to the most posterior fibres that run almost horizontally and the 
intervening fibres have intermediate degrees of obliquity, almost like a fan – See figure 
1-23  (Susan Standring M.B.E. et al. 2016). Some fibres of the temporalis muscle may 
sometimes be attached to the articular disc.  
 
Figure 1-22: Temporalis muscle. From: (Ahmed and Risal 2013).  Dissection deep the temporalis 
muscle. The muscle can be left as part of the skin flap. This is a safe and easy plan if no exposure of 
the arch is needed.   
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Figure 1-23: The anterior fibres of temporalis descend vertically; traced posteriorly the fibres are 
increasingly oblique, while the most posterior fibres are almost horizontal. From:  (Reddy 2015). 
 
Table 1-4 summarizes the vascular supply, innervations and actions of the muscle. 
Vascular supply Innervation  Actions 
 
It is supplied by deep 
temporal branches from 
the second part of the 
maxillary artery, which 
enter on its deep aspect, 
and middle temporal 
branches from the 
superficial temporal 
artery, which enter on its 
lateral aspect.  
It is supplied by 
the anterior, 
middle and 
posterior deep 
temporal 
branches of the 
anterior trunk of 
the mandibular 
division of the 
trigeminal nerve. 
 
Temporalis elevates the mandible 
and so closes the mouth and 
approximates the teeth. The muscle 
also contributes to side-to-side 
grinding movements. The posterior 
fibres retract the mandible after it has 
been protruded. The posterior fibres 
of temporalis, which are almost 
horizontal, are one source of 
mandibular retrusion.  
Table 1-4: Vascular supply, innervation and actions of the temporalis muscle. Table based on  (Susan 
Standring M.B.E. et al. 2016). 
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Regarding the blood supply, the temporalis muscle receives its supply from the anterior 
and posterior deep temporal arteries. Those, in turn, arise from the maxillary artery and 
supply the muscle through its deep surface. The temporalis also receives a secondary 
blood supply from the middle temporal artery (Ahmed and Risal 2013). 
 
1.10.2 The masseter muscle 
 
The masseter – Figure 1-24- is a powerful masticatory muscle that elevates the 
mandible. It also plays an important morphological role in the lower facial contour (Lee 
et al. 2012). Its internal architecture has been described in rat (Nordstrom and Yemm 
1974), pig (Herring et al. 1979), rabbit (Weijs and van der Wielen-Drent 1983), monkey, 
orang-utan and gorilla (Yoshikawa et al. 1962), seal (Naito and Naito 1973) and human 
(van Eijden and Raadsheer 1992). 
 
 
Figure 1-24: Masseter muscle, it deep and superficial lawyers. From: (Reddy 2015). 
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This muscle seems to consist of three layers – See Figure 1-25, the superficial 
masseter, intermediate masseter and the deep masseter (Gaudy et al. 2000). The 
superficial layer is known to be the largest. It arises by a thick aponeurosis from the 
maxillary process of the zygomatic bone and from the anterior two-thirds of the inferior 
border of the zygomatic arch. The fibres of this layer pass downwards and backwards, 
to insert into the angle and lower posterior half of the lateral surface of the mandibular 
ramus. Its superficial fibres are angled approximately 10° from the vertical, as it can be 
visible in lean individuals. In the coronal (frontal) plane, the masseter forms an 
approximately 10° angle with the mandibular ramus. The ridges on the surface of the 
ramus are caused by intramuscular tendinous septa in this layer. The middle layer of 
masseter arises from the medial aspect of the anterior two-thirds of the zygomatic arch 
and from the lower border of the posterior third of this arch. It inserts into the central 
part of the ramus of the mandible. Finally, the deep layer of this muscle arises from the 
deep surface of the zygomatic arch and inserts into the upper part of the mandibular 
ramus and into its coronoid process. The deep fibres run vertically, and are evident 
just anterior to the temporomandibular joint, where they are not covered by the more 
superficial layers (Susan Standring M.B.E. et al. 2016). 
 
 
 
 
 
 
Table 1-5 summarizes the vascular supply, innervations and actions of the muscle. 
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Vascular suply Innervation  Actions 
 
Masseter is supplied by 
the masseteric branch of 
the maxillary artery, the 
facial artery and the 
transverse facial branch 
of the superficial 
temporal artery. 
Masseter is 
supplied by the 
masseteric 
branch of the 
anterior trunk of 
the mandibular 
division of the 
trigeminal nerve. 
Masseter elevates the mandible to 
occlude the teeth in mastication and 
has a small effect in side-to-side 
movements, protraction and 
retraction.  
Table 1-5: Vascular supply, innervation and actions of the masseter muscle. Table based on  (Susan 
Standring M.B.E. et al. 2016). 
 
 
Figure 1-25: General view of masseter m. Superficial m. (yellow needle), intermediate m. (green needle), 
deep m. (red needle) from: (Gaudy et al. 2000). 
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1.11 SUMMARY 
 
A number of theories have continued to accumulate knowledge regarding the 
relationship between pain and motor activity. As it was pointed out in this literature 
review, there are some major issues with the earlier theories that do not appear to take 
into account all of the observations of the interrelationships between pain and motor 
activity. These include that these earlier theories only operate at the brainstem level 
(the spinal cord or segmental level for the spinal system) and the fact that these 
theories have proposed a uniform effect of pain (either excitation or inhibition, but not 
both) on motor activity particularly throughout a muscle, and therefore cannot fully 
account for the interaction between pain and motor activity. Besides, these theories 
cannot take into account the influence of higher brain centres and psychological 
factors.  
 
Surface electromyography of masticatory muscles have been made both in clinical and 
experimental pain conditions to analyse muscle activity and generally propose only 
small or no effects on jaw muscle EMG activity as a result of pain. However, there have 
been far fewer studies of the effects of pain on single motor unit (the basic functional 
unit) activity within the painful muscle. 
 
Recent evidence in the jaw motor system provides evidence that experimental painful 
stimulation of the masseter muscle results in both increases and decreases in motor 
unit activity, in other words, a reorganization of motor unit activity during the generation 
of the same direction and level of force within the masseter muscle (Minami et al. 2013) 
and in different sites within the masseter muscle (Malik 2016). However, it is unclear 
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whether this reorganization occurs only within the painful muscle or whether it may 
also occur in other non-painful synergetic muscles. An understanding of these issues 
would add to our understanding of how motor unit activity within the masseter muscle 
and in other muscles changes in response to noxious stimulation and thereby may 
have implications for understanding changes in jaw muscle activity in TMD. This is very 
important as some management strategies for chronic orofacial pain are still based on 
prior simplistic models proposing uniform effects of pain on muscle activity and it may 
lead to the development of more reliable management strategies and more effective 
treatments to patients. 
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2 AIMS AND HYPOTHESIS  
 
Therefore, the main question of this study was whether the pain-induced 
reorganization of activity that has been previously demonstrated within one jaw muscle 
(right masseter) also occurs in other synergetic jaw muscles (in this thesis, the right 
temporalis muscle).  
 
This was investigated by recording muscle activity, in terms of single motor units, within 
the muscle receiving the noxious stimulus as well as in another non-painful muscle. 
The design of the experiment involved a comparison of the motor effects of hypertonic 
saline infusion (painful) with isotonic saline infusion (minimal or no pain). This 
comparison allowed us to conclude whether any changes observed in muscle activity 
are due to pain. 
 
2.1 Aims: 
 
1- To determine whether experimental noxious stimulation of the right masseter 
muscle, in comparison with control, modifies the ability of individuals to execute 
isometric jaw-closing tasks.  
 
2- To determine whether experimental noxious stimulation of the right masseter 
muscle results in significant (p<0.05) changes in the activity patterns (i.e. SMU 
recruitment patterns and thresholds) in the right temporalis muscle (a non-
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painful synergistic muscle) and right masseter muscle during isometric ramp jaw 
closing tasks at two different rates of force increase (slow and fast). 
 
 
3- To determine whether experimental noxious stimulation of the right masseter 
muscle results in significant (p<0.05) changes in the activity patterns (i.e. SMU 
recruitment patterns and firing rates of single motor units, and root mean square 
EMG activity) in the right temporalis muscle (a non-painful synergistic muscle) 
and right masseter muscle during isometric 2 step-levels jaw closing tasks. 
 
4- To determine whether experimental noxious stimulation of the right masseter 
muscle results in significant (p<0.05) changes in the activity patterns (i.e. 
recruitment patterns) in the right masseter (painful muscle) and in the right 
temporalis muscle (a non-painful synergistic muscle) that are not consistent with 
earlier theories of pain-motor interaction, namely, the Vicious Cycle Theory and 
The Pain Adaptation Model. 
 
 
5- To determine whether experimental noxious stimulation of the right masseter 
muscle results in significant (p<0.05) changes in the activity patterns in the right 
temporalis muscle and right masseter muscle that are associated with the 
scores from some psychological measures.  
 
 
2.2 Hypothesis: 
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According to the aims of the study, it is hypothesized that: 
1- Experimental noxious stimulation of the right masseter muscle, in comparison 
with control, does not modify the ability of individuals to execute isometric jaw-
closing tasks. 
2- Experimental noxious stimulation of the right masseter muscle results in 
significant (p<0.05) changes in the activity patterns (i.e. SMU recruitment 
patterns and thresholds) in the right temporalis muscle (a non-painful 
synergistic muscle) and right masseter muscle during isometric ramp jaw 
closing tasks at two different rates of force increase (slow and fast). 
3- Experimental noxious stimulation of the right masseter muscle results in 
significant (p<0.05) changes in the activity patterns (i.e. SMU recruitment 
patterns and firing rates of single motor units, and root mean square EMG 
activity) in the right temporalis muscle (a non-painful synergistic muscle) and 
right masseter muscle during isometric 2 step-levels jaw closing tasks. 
4- Experimental noxious stimulation of the right masseter muscle results in 
significant (p<0.05) changes in the activity patterns (i.e. recruitment patterns) 
in the right masseter (painful muscle) and in the right temporalis muscle (a non-
painful synergistic muscle) that are not consistent with earlier theories of pain-
motor interaction, namely, the Vicious Cycle Theory and The Pain Adaptation 
Model. 
5- Experimental noxious stimulation of the right masseter muscle results in 
significant (p<0.05) changes in the activity patterns in the right temporalis 
muscle and right masseter muscle that are associated with the scores from 
some psychological measures.  
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3 MATERIALS AND METHODS 
 
3.1 Recruitment  
 
Twenty participants (15 females, 5 males) between the ages of 22-40, with at least 24 
permanent teeth, no missing molars and no current orthodontic treatment were 
recruited for this study. Exclusion criteria were the presence of any orofacial pain at 
the time of the experiment, diagnosis of TMD, neurological disorders (e.g. cerebral 
palsy, Parkinson’s disease), bleeding disorders, cardiac problems, current pregnancy, 
high blood pressure, presence of systemic musculoskeletal pain disorders (e.g. 
fibromyalgia, inflammatory joint disease), serious systemic disease (e.g., current 
malignancies), medications for chronic diseases or medications that might influence 
muscle activity or a response to pain. 
 
Participants were recruited from the students of the University of Sydney, the general 
public, and family and friends of the research investigators. All potential participants 
were invited to take part in the study if they met the inclusion/exclusion criteria and 
were informed that participation was voluntary and that they were under no obligation 
to participate.  
 
Detailed information about the research and possible complications during and after 
the experiment were also explained to potential participants before they were invited 
to take part in the study. Participants were asked to sign a written informed consent 
form before being enrolled in the study and were also informed again about their right 
to withdrawn from the experiment at any point without the need to provide any 
explanation. The study was conducted in three sessions, all of which were located at 
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the Jaw Function and Orofacial Pain Research Unit based at Westmead Centre for 
Oral Health, Sydney, Australia. Sessions 1 and 3 involved the participant to be present, 
while session 2 involved customized construction of the bite force device. 
 
The study was approved by the Human Research Ethics Committee of the University 
of Sydney.  
 
3.2 First session 
 
For the first session, a clinical and psychological assessment for the investigation of 
the presence of TMD was made with the Research Diagnostic Criteria for 
Temporomandibular Disorders (RDC/TMD) (Dworkin and LeResche 1992) – see 
Appendix 8.1 - by a single calibrated examiner. When the absence of signs or 
symptoms of TMD was confirmed, alginate impressions of the upper and lower teeth 
were made in order to construct plaster cast models to facilitate the construction of the 
intraoral splints to house the bite force transducer. The impressions were poured in 
dental stone (Yellowstone, Lordell Trading Pty. Ltd.). 
 
3.3 Second session 
 
3.3.1 Splint 
 
With the participant’s plaster cast models, a thermoforming foil disc (Erkodent, 
Erkoplast-0, 1.5 mm thickness and 120 mm diameter) was used to produce a custom-
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made polyvinal splint that covered the upper teeth much like a very thin mouthguard 
(see Figure 3-1). Another polyvinal splint was made for the lower teeth using the same 
methods as above (see Figure 3-1).  
 
Figure 3-1 : Custom-made polyvinal splints before being trimmed. Upper teeth on the left of the panel 
and lower teeth on the right of the panel 
 
Because the material’s chemical characteristics allows it to bond to polymethyl 
methacrylate, the upper splint was modified with the use of acrylic resin to 
accommodate a metal housing for a small force transducer (LMA-A; Kyowa Dengyo, 
Tokyo, Japan) to measure vertical jaw closing force (see Figure 3-2). The lower splint 
was also modified by adding acrylic resin to house a small plate (lower plate, Figure 3-
2) that was oriented parallel to the occlusal plane. The force transducer and housing 
were embedded in acrylic which was secured to the upper splint (Figure 3-2). A hinged 
plate contacted the force transducer sensor and on the lower part of this hinged plate 
an acrylic ball was secured. The ball provided the contact with the lower plate secured 
to the lower acrylic splint. This arrangement was designed so that when the participant 
produces a vertical force, the force transducer would record the amount of force 
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applied (see Figure 3-2), and that non-vertical forces would result in slippage of the 
ball along the lower plate. 
 
Figure 3-2: Bite force transducer in a lateral view. The upper and lower splints accommodate the housing 
for the force transducer and the lower plate respectively (Reproduced with modifications from (Minami 
et al. 2013). 
 
The casts were initially articulated on a semi-adjustable articulator (Denar Mark II, whip 
mix, Louisville, KY 40217 USA) at the intercuspal position and at an average face-bow 
position (Figure 3-3). To enable set-up of the force transducer on the acrylic splints, 
the articulator was opened until its maximum, and the force transducer was secured in 
place via acrylic on the customised splints. 
Force transducer 
housing 
Lower plate 
Acrylic resin 
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Figure 3-3: Polyvinal splints after customization and adaptation of the force transducer holder and lower 
plate. Reproduced with modifications from (Malik 2016). A: Upper cast model with upper splint. B: Lower 
cast model with lower splint. C: Upper and lower cast models articulated. 
 
3.3.2 Electrode construction 
 
Two Teflon stainless-steel fine wires (Teflon®-coated stainless steel wire - diameter 
0.0045 mm) were threaded through a disposable spinal needle (24-26 gauge needles 
- 25mm long). The two fine wires were then bent at the end of the needle (~3-4mm out 
Lower 
plate 
Force 
transducer 
Ball 
Hinged 
plate 
A B 
C 
Wire for 
computer 
conexion 
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of the needle), and one of the wires were 2 mm shorter than the other to minimize the 
chances that the two wires would touch once inserted into the muscle. As Teflon 
surrounded the wires, the end of each wire was scraped to remove the Teflon at around 
0.5 mm from the end, in order to expose bare wire. The other end of the wire, were 
also scraped at a longer part (~10 mm) in order to connect with the recording apparatus 
on the day of the experiment. 
 
Figure 3-4 shows the needle with two separated fine wires. 
  
 
Figure 3-4: Needle with two stainless-steel fine wires. Blue circle indicates the separation of the wires 
which were bent at the end. Red lines show where the Teflon was removed to expose the bare wire. 
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3.4 Third session 
 
The third session of the experiment is summarized on the table 3-1 below: 
 
 
Table 3-1: Schematic sequence of the experiment. Circles: moment where some questionnaire was 
applied (DASS, PCS, MPQ). Triangles: events that happened between blocks; namely, introduction of 
catheter between the baseline and infusion 1, and 10 min rest between infusion 1 and infusion 2, and 
between infusion 2 and baseline 2). Lines: activities performed throughout the blocks.   
 
3.4.1 Health assessments and questionnaires: 
 
Firstly, details of the participant’s medical history and current health state were 
obtained with the use of a screening questionnaire on the day of the experiment to 
confirm their eligibility to be part of the study - see Appendix 8.2 
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Two additional questionnaires were completed to clarify possible associations between 
motor function and psychological status (Aim 5). Therefore, on the day of the 
experiment, but prior to starting the experiment, the participants were asked to 
complete the Depression, Anxiety and Stress Scales 21 (DASS21) (Lovibond and 
Lovibond 1995a) (Appendix 8.3) and the Pain Catastrophizing Scale (PCS) (Sullivan 
MJL 1995) (Appendix 8.4). 
 
The DASS21 questionnaire is a reliable and well validated self-report measure of the 
three negative emotional states of depression, anxiety and stress (Crawford and Henry 
2003; Lovibond and Lovibond 1995b). The instrument consists of 21 statements where 
the participant was required to mark on a 4-point Likert scale how much each statement 
applied in the past week. The scale ranges from “Did not apply to me at all” to “Applied 
to me very much, or most of the time”. The total scores for each scale were calculated 
by the summation of the 7 items that relate to the emotional states. The higher scores 
on each scale indicate higher risk of depression, anxiety or stress. The Depression 
scale assesses hopelessness, low self-esteem, and low positive affect. The Anxiety 
scale assesses autonomic arousal, physiological hyper-arousal, and the subjective 
feeling of fear. The Stress scale items assess, tension and agitation (Lovibond and 
Lovibond 1995b).  
 
Pain catastrophizing is the exaggerated negative belief about a painful experience 
which may influence the participant’s perception of pain intensity (Turner et al. 2002). 
The PCS is a 13 statement questionnaire which asks the participant to rate on a 5-
point scale ranging from “not at all” to “all the time”, the degree to which each statement 
applies to them (e.g., “I keep thinking of other painful events”; “I felt I was close to 
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panic”) in terms of the thoughts the participant have when they are in pain. The PCS 
total score was computed by summing responses to all 13 items that compose this 
questionnaire. The PCS total scores range from 0 – 52. The PCS subscales are 
computed by summing the responses to the following items: 
Rumination: Sum of questions 8, 9, 10, 11  
Magnification: Sum of questions 6, 7, 13  
Helplessness: Sum of questions 1, 2, 3, 4, 5, 12 
The total score (ranging from 0-52) indicates the level of pain catastrophizing (Sullivan 
MJL 1995). 
 
3.4.2 Electrode placement and EMG recording 
 
After the completion of the DASS-21 and PCS, each participant was seated in a dental 
chair in a quiet room. The skin overlying the right and left masseter and right and left 
temporalis muscles was cleaned with the use of alcohol pads (70% isopropyl alcohol, 
Alco wipe, Pro medica, Australia) and then disposable bipolar surface EMG electrodes 
(4 mm × 7 mm recording area, Duo-Trode, Myotronics, Washington, USA) were 
attached with non-allergenic adhesive tape (Transpore™ Surgical Tape, 3M™, St. 
Paul, MN, USA) to the skin overlying these muscles. 
 
A small amount (1-2 mL) of electrode conducting gel (Sigma Gel, Medtronic Denmark) 
was injected just under the conducting foam via hypodermic needle in order to facilitate 
the recording of the surface EMG signal. The area for the placement of the surface 
electrodes was chosen by palpating the muscles for identification of the most active 
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area during contraction and the electrodes were oriented parallel to the direction of the 
main fibres of the muscles. These surface electrodes were placed to help confirm that 
the tasks were being performed correctly by the participants, and also the surface EMG 
data were acquired for future analysis. The surface EMG data were not analysed in 
this thesis as the data were described as part of another parallel study (Sandoval, 
2017). 
 
The 2 splints were then inserted into the participant’s mouth. Subsequently, bipolar 
fine-wire electrodes were placed at 1 location in the right masseter and 1 location in 
the right temporalis muscle. Prior to the placement, the participant voluntarily 
contracted the masseter and temporalis muscles by repeated clenching activities. The 
masseter muscle contraction was palpated to identify the borders of the muscle in order 
to place the fine wire electrodes horizontally and vertically mid-muscle. The temporalis 
was palpated to identify the region 1cm posterior of the anterior border for placement 
of the fine wire electrodes.  
 
About 20 minutes before the insertion of the intramuscular electrodes, a topical 
anaesthetic gel (Emla, Astrazeneca, Australia) was applied on the skin over the right 
masseter and right temporalis areas that had previously been identified and this 
minimized the discomfort caused by the introduction of the needle.  
 
Intramuscular electrode placement was made via 24-26 gauge needles (25-mm-long) 
(Sae-Lee et al. 2006) containing 2 fine wires that were bent back over the tip of the 
needle 2-5 mm from the ends of the wires. The needle was inserted in a standardized 
inclination and was withdrawn leaving the fine-wire electrodes in the muscle. For each 
intramuscular electrode insertion, the needle was inserted ~20 mm beneath the skin 
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or until the needle contacted bone. For the masseter intramuscular insertion, the 
needle was angled downwards at ~30 degrees in relation to the ramus. For the 
temporalis muscle insertion, the needle was angled downwards at ~45 degrees relative 
to the horizontal. After insertion, the needle was withdrawn, leaving the fine wires within 
each muscle. The electrodes were sterilised prior to placement in each muscle. 
 
The EMG activities from the intramuscular and surface electrodes were confirmed prior 
to the experiment by asking participants to clench their teeth in order to confirm 
placement and that all the acquisition equipment was working satisfactorily. A ground 
electrode was attached to the left wrist. 
 
The EMG activity was amplified with a bioelectric 1902 isolated pre-amplifier 
(Cambridge Electronic Design Limited, Cambridge, UK), with an amplification ranging 
from 3,000 to 10,000x for the intramuscular electrodes according to the intensity of the 
EMG signal displayed on each muscle channel on the computer screen.  
 
The EMG signal was digitized by CED Micro 1401-3 processor (equipment for data 
acquisition from Cambridge Electronic Design, Cambridge, UK) for subsequent offline 
analysis (Figure 3-5). Muscle activity from the intramuscular electrodes was sampled 
at a bandwidth of 20 Hz to 2.5 kHz in the first 5 participants at a sampling rate of 5,000 
samples/s. For the remaining 15 participants, the muscle activity from the 
intramuscular electrodes was sampled at a bandwidth of 20 Hz to 10 kHz at a sampling 
rate of 20,000 samples/s. As the force data were only used to choose a maximum and 
a minimum force and the average rate of change of force between these forces, as 
well as establishing a stable force level, then a lower sampling rate for the remaining 
participants was considered to be adequate. The EMG muscle activity was recorded 
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synchronously with the force output from the force transducer. 
 
During every experiment, Spike2 software (Cambridge Electronic Design Limited, 
Cambridge, UK) was used to provide visual feedback, on a computer screen placed in 
front of the participant, of the level of the force in volts that was being exerted. The 
force output was displayed on the computer screen as a horizontal line.  
 
The horizontal line displaced in the positive direction on the y-axis with increases in 
closing force. Scripts written with Spike2 software were used to generate a target line 
that was superimposed over the force transducer output (see below for detailed 
description of the tasks). Participants were instructed to match the force line with the 
target levels as closely as possible. The scripts controlled the rate at which the force 
changed for all the tasks. 
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Figure 3-5: The EMG signals from the temporalis and masseter muscles were amplified by the 1902 
Isolated pre-amplifier and the Micro 1401-3 for acquisition and digitization of the EMG muscle activity. 
The Spike2 was the software used for data acquisition, visualization and analysis. Reproduced from: 
(Sandoval 2017). 
 
3.4.3   Tasks 
 
The participant was asked to perform 3 different isometric jaw-closing tasks (clenching 
tasks) using the bite force transducer constructed in the second session. Each 
performance of a task was termed a ‘trial’. Every trial commenced with a rest period of 
2-3 s prior to the initiation of the increase in closing force associated with the tasks – 
See figure 3-7. 
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1. A slow ramp jaw closing task that involved increasing jaw closing force at a 
low force rate (of 5 N/s). This task took 18.5 s for completion of the task, 
excluding the initial 2-3 s rest period prior to the initiation of the increase in force.  
 
2. A fast ramp jaw closing task that involves increasing jaw closing force at a 
higher force rate (of 17 N/s) than for the slow ramp jaw closing task. This task 
took 7 s for completion of the task, excluding the initial 2-3 s rest period prior to 
the initiation of force increase.  
 
3. A 2 step-levels jaw closing task where the participant increased jaw closing 
force up to a first level (step 1), held for 3 s and then, increased the force up to 
a second level (step 2) and held again for another 3 s before relaxing. Both 
levels were customised for each participant based on the visual confirmation on 
the computer screen of the recruitment of the first single motor units as the 
determination of the force level that will constitute step 1 for that participant. 
Then, for step 2, the participant increased closing force so that there was a clear 
increase in the firing rates of the existing single motor units and/or there was 
recruitment of additional single motor units (See figure 3-6). Both of the closing 
forces levels considered were readily achievable closing forces. The step task 
took ~8 s for completion of the task excluding the initial 2-3 s period prior to the 
initiation of force increase; there was a duration of 0.5-1 s for the increase in 
force from rest to step 1, and from step 1 to step 2. 
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Figure 3-6: Increased force showing the difference between step 1 and step 2. X-axis: time in seconds 
(Sec). Y-axis: force transducer output in volts (V). 
 
For the 2 step-levels jaw closing task, once established, the same customised force 
levels were used until the end of the experiment for that specific participant in order to 
standardize the step levels during the whole experiment.  
 
 
 
Figure 3-7: Schematic figure of target forces on the computer screen placed in front of the participant 
and which each participant was instructed to match to achieve the same force rates and levels in every 
trial. 
 
Each of the three isometric jaw closing tasks was repeated 3 times, that is 3 trials were 
performed for each task. These 9 trials were then repeated over 4 blocks, which were: 
 
Step 1 Step 2 
0.5 s 
1000 mv  
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1- Block 1: baseline, before any infusion  
2- Block 2: infusion of hypertonic saline or isotonic saline infusion (the order was 
alternated between participants) 
3- Block 3: infusion 2, after isotonic saline or hypertonic saline infusion (the order 
was alternated between participants) 
4- Block 4: baseline 2, after the two infusions were completed. 
 
If technical difficulties were encountered, extra repetitions were needed due to 
technical issues (e. g. when the EMG signal was capturing lots of noise). In all trials, 
participants were instructed and motivated to match bite force as closely as possible 
to the target force levels marked for that participant. The electrodes were left in situ for 
approximately 3 hours. 
 
3.4.4 Induction and assessment of jaw-muscle pain 
 
The induction and assessment of jaw-muscle pain followed closely our previously 
published protocol (Sae-Lee et al. 2006). Firstly, a disposable 22 or 24 gauge needle 
integrated IV catheter (Smiths Medical, Lancashire, UK) was placed into the mid-
portion of the right masseter muscle until bone was reached (Sae-Lee et al. 2006; 
Stohler et al. 1992). A 1 ml syringe (Becton Dickinson, Singapore) was then attached 
to the catheter before the injection of any saline in order to demonstrate a negative 
aspiration to avoid injecting into blood vessels.  
 
Then, the catheter was connected via an extension set (75 cm length, TUTA, Australia) 
to an infusion pump (IVAC Model P2000, UK) –See figure 3-8 containing one of the 
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following solutions in a 10 ml syringe (Becton Dickinson, Singapore): 5% sterile saline 
(hypertonic saline) or 0.9% sterile saline (isotonic saline). 
 
Figure 3-8: Infusion pump for the continuous infusion of the saline. 
 
Participants were not aware of which solution would be infused first, although they 
could perceive which block was the painful one as soon as the infusion of hypertonic 
solution had started. The infusion of isotonic saline was used as a control for possible 
changes in jaw muscle activity and/or jaw forces due to volumetric changes within the 
muscle from the infusion of a solution and also was used alternately with the hypertonic 
saline infusion to minimize time-related effects. 
 
This study aimed to induce moderate pain and therefore during the hypertonic saline 
infusion, pain intensity was maintained between 30-60 on a 100 mm visual analogue 
scale (VAS) (see figure 3-9 below) for approximately 10 minutes and this was achieved 
by continuous pump infusion.  
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Figure 3-9: Pain intensity visual analogue scale (VAS). Each participant was instructed to mark on the 
line how intense the pain was at that time. The pain intensity was maintained at a moderate level by 
adjusting the infusion rate so that the participant made a mark somewhere between 30-60 mm on the 
100 mm scale as shown on the figure. 
 
The VAS is one of most popular methods used to assess pain intensity as it is reliable, 
and is validated with adequate sensitivity (Carlsson 1983). The VAS had anchors of 
“no pain” and “the worst pain possible”. A moderate level of pain (one mark around the 
middle of the 100 mm line) was maintained by noting the VAS score that was obtained 
after each task trial during blocks 2 and 3.  
 
The VAS score is determined by measuring in millimetres from the left hand end of the 
line to the point that the patient marks. If the participant marked a score on a position 
that was visually equivalent to a value lower than 30/100 mm, the infusion rate of 
hypertonic saline was increased by 1-4 ml/hr. Similarly, after a VAS score was marked 
on a position equivalent to a value higher than 60/100 mm, the infusion rate was 
decreased or stopped temporarily until the VAS score marked after a subsequent trial 
returned to the 30-60 mm range. One of the operator’s sole task was to monitor and 
adjust the infusion rates. 
 
The rates of infusion varied considerably between participants. For those participants 
who had hypertonic infusion as the first infusion block (i.e. block 2), the infusion rates 
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were determined according to their VAS scores as explained above, and the isotonic 
infusion rates used in block 3 followed the hypertonic parameters. For those 
participants who had isotonic saline as the first solution applied (block 2), the rate of 
isotonic saline infusion was set at 4 ml/h for the first 3 minutes and then increased to 
6 ml/h for the remainder of the isotonic infusion block. The hypertonic rates of infusion 
for the subsequent block 3 were then adjusted according to the VAS scores as 
described above. 
 
After the completion of each task trial (a single recording of a task) during both 
infusions (i.e. blocks 2 and 3), during both infusions (i.e. blocks 2 and 3), a recording 
was made of the pain intensity VAS on a paper version of the scale. In addition, each 
participant was asked to make a drawing of the maximum distribution of their pain on 
the front, back, right and left lateral-profile outline pictures of the head and neck. (see 
Figure 3-10 below).   
 
 
98 
 
 
Figure 3-10 Visual analogue scale (VAS) and pain maps. This sheet was given to the participant to 
complete after each task trial throughout Blocks 2 and 3. 
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After each block of trials involving an infusion, each participant was asked to complete 
the McGill Pain Questionnaire (MPQ) (Melzack 1975) – see appendix 8.5. 
 
The MPQ is a scale of pain rating that was developed at McGill University by Melzack 
and Torgerson (1971). It is a self-report questionnaire that helps individuals to give a 
description of the quality and intensity of the pain that they are experiencing. The MPQ 
is composed of 78 pain descriptors which fall into four categories, that is, sensory, 
affective, evaluative, and miscellaneous characteristics of a painful experience, and 
from which participants choose those that best describe their pain.  
 
Three main types of data can be obtained from this questionnaire: 
 
1- Pain rating index (PRI) – This consist of the total sum of the scale values of all 
the words chosen in a given category. In other words, the rank values of the 
words chosen by a patient are summed to obtain a separate score for each 
dimension. The maximum possible scores are: PRI sensory (42), PRI affective 
(14), PRI evaluative (5) and PRI miscellaneous (17). Higher scores indicate 
more severe pain.  
2- The number of words chosen - (NWC) - is the sum score of the total number of 
descriptors that the participant chooses. 
3- The present pain intensity - (PPI) – the number and word combination chosen 
indicates the overall intensity of pain (Melzack 1975).  
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The most frequent data to explain the results obtained from this questionnaire is the 
Pain Rating Index – PRI. 
 
Figure 3-11 shows the front and lateral view of one participant after the placement of 
surface and intramuscular electrodes.  
 
Figure 3-11: participant in front and lateral view. Panel A: right side of participant showing surface EMG 
for temporalis and masseter muscles, as well as the region of face where intramuscular electrodes were 
placed (circled in red). Panel B: front view of the participant with customised splints on the mouth and 
electrodes in place. Panel C: left side of participant showing surface EMG for temporalis and masseter 
muscle.   
   
3.5 Data analysis  
 
3.5.1 Participant demographic data/questionnaires  
 
A C B 
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3.5.1.1 Participant demographic data 
 
Participant demographic data was qualitatively described and tabulated with means 
and standard deviations. 
 
3.5.1.2 RDC/TMD 
 
The results of the RDC/TMD were reported qualitatively to confirm that the participant 
did not have TMD.  
 
3.5.1.3 DASS 21 and PCS 
 
Means and standard deviation scores were calculated for each scale of the DASS, and 
subscales of the PCS.  
 
3.5.1.4 Infusions 
 
The means and standard deviations of the total infused volume across the 20 
participants during hypertonic saline and isotonic saline infusion were documented. A 
paired samples t-test was used to determine whether there was a significant difference 
in the volume of saline infused between the hypertonic and isotonic saline sessions 
across all participants. 
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3.5.1.5 VAS scores 
 
The values for each repetition, means and standard deviations of the VAS scores 
across the 20 participants during hypertonic saline and isotonic saline infusion were 
documented. 
 
Repeated measures Analysis of Variance (ANOVA) was done for the VAS scores of 
pain intensity to analyse possible effects of repeating the trial within an infusion block 
and, therefore to enable means of the repeated tasks within one block to be used in 
further analyses. 
 
Paired sample t-tests were done to compare the following VAS pain intensity scores:  
 Hypertonic block x isotonic block during slow ramp jaw closing task,  
 Hypertonic block x isotonic block during fast ramp jaw closing task and, 
 Hypertonic block x isotonic block during 2 step-levels jaw closing task. 
 
3.5.1.6 Distribution of perceived pain 
 
The distribution of perceived pain (location of pain during the hypertonic and isotonic 
saline infusion blocks) was also reported in tables. 
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3.5.1.7  McGill Pain questionnaire scores 
 
The most cited word was calculated and described in terms of how often they appeared 
for the hypertonic saline and the isotonic saline infusion block.  
 
Each pain rating index (PRI) was calculated for both infusion blocks (i.e. hypertonic 
saline infusion block and isotonic saline infusion block). For this analysis, the words 
that were not cited by any participant were excluded and the mean scales and mean 
scores were calculated for each of the pain descriptors from the MPQ based on how 
many times the word was cited and the scale and score given to that specific word 
(see Appendix 8.6).  
 
Besides the score, each word was given a weight. To find the weight it was necessary 
to multiply the word score by a constant value established for each of the 20 different 
groups of words (Melzack 1975). After excluding the words that were not cited by any 
participant, a scale value and a weight value is established based on the remaining 
words and how many times each word is cited – See table 3-3. 
 
This data were presented quantitatively to describe the computed value of the pain 
experience. 
Scale 
value 
(scale x 
number 
of times 
cited) 
Weighted 
value 
(weight x 
number 
of times 
cited) 
Table 3-2: shows how the scale and weighted values were calculated 
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Paired T-tests were done to compare the scores of the mean scale and mean weight 
between the hypertonic saline infusion block and isotonic saline infusion block 
 
3.5.2 Analysis of force 
 
The force values of the script at which the participants performed the different tasks 
(slow ramp jaw closing task, fast ramp jaw closing task and 2 step-levels jaw closing 
tasks) were obtained. The force was recorded in volts and was then converted into 
Newtons (N), using the following mathematic formula: 
 
Load (N) = (Bridge output/gain) x rated capacity of the transducer/rated output (mV/V) 
 
Where the constant values are the gain of the force transducer channel (3 mV) and the 
rated capacity of the transducer (1142.857 mV/s). 
 
The mean and standard deviation of the force values in Newtons (after being converted 
from volts) were calculated for each of the 3 trials of the jaw closing force tasks and 
graphs were generated of the force outputs. The graphs were used to identify the start 
and end points of the slow ramp jaw closing task, fast ramp jaw closing task and the 
most stable period of each step level for the 2 step-levels jaw closing task. For the 
ramp jaw closing tasks (fast and slow), the beginning of the increase in force was 
determined as the first deviation after a plateau or the initial rest period and the end 
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point was determined as the highest force level reached for each participant for that 
ramp task. 
 
For the 2 step-levels jaw closing tasks, the most stable ~2 s period of force was chosen 
during each holding force level (Step 1 and Step 2). This was determined from the 
graph where the data indicated a consistently low standard deviation across the 
holding force period. Therefore, the most stable period with the lowest standard 
deviation was chosen for the analysis of the root mean square RMS of the EMG activity 
and single motor unit discrimination. Then, using the Spike2 program, two vertical 
cursors were created to define the boundary of the most stable period with the lowest 
standard deviation– See figure 3-12. 
 
 
Figure 3-12: Screen shot taken from the EMG activity and the force output of one of the participants. 
Two vertical courses determining each of the stable periods for step 1 and step 2. X-axis: time in 
seconds (Sec). Y-axis: force transducer output in volts (V). 
Step1 
Step2 
0.5 s 
1000 mv  
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A repeated measures analysis of variance (ANOVA) was carried out to determine 
possible differences in the force values reached throughout the baseline block, 
hypertonic saline infusion block and isotonic saline infusion block namely: 
 Force amplitude – the highest force achieved for each participant (N) – during 
each task repetition of the ramps tasks (3 slow ramp jaw closing tasks and 3 
fast ramp jaw closing tasks); 
 Force  levels at step level 1 (N) during the first chosen time period of the 2 step-
levels, during each task repetition of the 2 step-levels jaw closing task; 
 Force levels step level 2 (N), during the second chosen time periods of the 2 
step-levels, during each task repetition of the 2 step-levels jaw closing task. 
 
Pairwise comparisons with Bonferroni corrections were done to investigate possible 
differences between the blocks, baseline, hypertonic saline infusion and isotonic saline 
infusion.  
 
The force rates of the ramps jaw closing tasks were calculated by dividing the highest 
force the participant achieved by the number of seconds the participant took to achieve 
it. Those values were presented in tables. Paired t-tests calculated some possible 
significant difference between the following: 
 Baseline slow ramp x hypertonic slow ramp 
 Baseline slow ramp x isotonic slow ramp 
 Hypertonic slow ramp x isotonic slow ramp 
 Baseline fast ramp x hypertonic fast ramp 
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 Baseline fast ramp x isotonic fast ramp 
 Hypertonic fast ramp x isotonic fast ramp 
The rates between baselines (slow ramp x fast ramp), hypertonic infusions (slow ramp 
x fast ramp) and isotonic infusions (slow ramp x fast ramp) were also compared. 
 
3.5.3 Root mean square (RMS) activity 
 
In order to capture possible differences in the overall EMG activity for all of the 
participants, the data were analysed using the RMS of the EMG signal at each 
intramuscular electrode EMG site (right masseter and right temporalis muscle) for the 
2 step-levels task. 
 
The most stable period at each level of the 2 step-levels task was chosen as described 
above. The Spike 2 then limited the calculation of the RMS values to within the range 
between these 2 cursors (see Figure 3-12) and then, excel files were generated with 
RMS values for every trial and at each level of the 2 step-levels jaw closing task during 
the 4 blocks applied in this study.  
 
A repeated-measures ANOVA was used for the 3 repetitions of each task for all the 
participants to determine whether there was a variance on the EMG activity between 
the repeated trials. If no significant effect for repeating was found, then the mean of 
the repetitions were calculated and used for further analysis of difference between the 
blocks.   
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3.5.4 Single motor unit (SMU) activity 
 
From each trial of tasks from the baseline (block 1), hypertonic saline infusion, isotonic 
saline infusion and baseline 2 (block 2) blocks, SMU activity was discriminated in the 
right temporalis muscle.The present data analysis , did not include baseline 2 for the 
masseter EMG analysis only from the baseline, hypertonic saline infusion and isotonic 
saline infusion blocks, as the main aim of this study was to analyse the effects of pain 
on the non-painful muscle, in this case the temporalis.  
 
For the slow ramp jaw closing task and the fast ramp jaw closing task, SMUs were 
discriminated through the whole force period until the point where a higher force would 
make it difficult to distinguish clearly the recruitment of additional SMUs. For each trial 
of the 2 step-levels jaw closing task, on the other hand, the 2 s of data with the lowest 
variability of force at each force level (as defined above, see Figure 3-12) were selected 
to be analysed.  
 
Single motor units were discriminated based on SMU waveform using specialized 
software (Spike2, Cambridge Electronic Design, Cambridge, UK). This template 
matching software was used to identify initially SMUs within a recording. This software 
does allow some variation in the shape of the identified SMU and still will classify the 
unit as the same SMU. All SMUs that were classified by the algorithm as being the 
same SMU, were also manually confirmed that they were similar in amplitude and 
shape. For each trial of the tasks, an assessment was made of the occurrence or not 
of a SMU –See figure 3-13 and 3-14. The criteria for discriminating single motor units 
were: 
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1- Similarities in waveform; 
2- A regular time of occurrence;  
3- Firing within a continuous 2-s period.  
 
As each kind of task had a minimum of 3 trials, in order to be considered present during 
one task, the SMU should fit all the mentioned criteria for at least 2 out of the 3 repeated 
trials. 
 
 
Figure 3-13: Spike2 screen showing three different waveforms (shapes) characterizing the 
discrimination of three different SMUs. On the bottom line it is possible to see the EMG signal and on 
the top line it is possible to see the discrimination of SMUs as identified by the waveform discrimination 
software (Spike2 Cambridge Electronic Design, Cambridge, UK); the software allocates different colours 
for each SMU. The 3 SMUs in the blue circle are enlarged in Figure 3-14. 
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Figure 3-14: The three different SMUs discriminated according to the shape of the waveform and 
displayed on a zoom image. 
 
Every SMU determined as present or not present during each jaw closing task in each 
block were tabulated for each muscle analysed (right temporalis and right masseter). 
This allowed an assessment of whether the particular SMU was active in each task 
and block or only in some tasks or blocks. For example, it was possible to determine 
whether an SMU was recruited (i.e. it was present) during a task in one or more blocks 
or whether an SMU was de-recruited (i.e. it was not present) during a task in one or 
more blocks.  
 
An analysis was performed to compare the occurrence (if SMUs were recruited, de-
recruited or presented no change) of SMUs during the hypertonic saline infusion block 
with their occurrences during the baseline, isotonic saline infusion and baseline 2 for 
the temporalis muscle, and with baseline and isotonic block for the masseter muscle.  
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One of the functions of the baseline was to allow the participant to become accustomed 
to the experimental tasks, as well as a comparator for the infusion blocks. However, 
the comparison between the isotonic saline and hypertonic saline blocks was the 
principal comparison used in this study for defining whether there was recruitment, de-
recruitment or no change in SMU EMG activity. This is because the only differences 
between the isotonic saline and the hypertonic saline infusion blocks was the presence 
of pain and that one was done after the other, that is, there was an order-related factor 
to consider. The order factor was however, addressed by alternating the sequence of 
type of infusion between participants. 
 
An analysis was also performed to determine whether the changes in the pattern of 
occurrence of SMUs at the temporalis and masseter muscle sites were consistent with 
the proposals of the Vicious Cycle Theory or the Pain Adaptation Model. If the SMU 
was recruited during the hypertonic saline infusion session but was inactive (i.e. not 
present) in the isotonic session, then the pattern of occurrence of the SMU was 
considered to be consistent the Vicious Cycle Theory as the pain, according to this 
theory, would cause “muscle hyperactivity” and one manifestation of this “hyperactivity” 
would be SMU recruitment. On the other hand, if the SMU becomes inactive (i.e. not 
present) during the hypertonic infusion session in comparison with the isotonic session, 
this pattern of occurrence was considered to be consistent with the Pain Adaptation 
Model where pain is associated with decreased agonist muscle activity and one 
manifestation of this would be de-recruitment of one or more SMUs. The net result of 
this pain effect as proposed by the Pain Adaptation Model would be slower and smaller 
movements to prevent further injury and help healing.  
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For each trial of the 2 step-levels jaw closing task, the firing rates of each identified 
SMU at each level of force were calculated as the number of times the SMU fired 
divided by the time. The firing frequencies of each of the SMUs were qualitatively 
compared between the hypertonic and isotonic block of recording sessions. A repeated 
measures analysis of variance (ANOVA) was carried out to determine a significant 
effect of pain on the muscle activity and multiple comparisons with Bonferroni 
corrections investigated if the hypertonic saline infusion block (pain) had significantly 
different firing rates to that of the baseline and isotonic saline block recordings. 
 
For each trial of each of the slow and fast ramp jaw closing tasks, calculation of the 
threshold for onset of firing in relation to force (N) for each SMU was done. The time 
point that in each trial the SMU commenced firing continuously for at least one second 
was defined as the threshold value. A repeated measures analysis of variance 
(ANOVA) was carried out to determine a significant effect of pain on the SMU threshold 
values and multiple comparisons with Bonferroni corrections investigated if the 
hypertonic saline infusion block (pain) threshold values were significantly different to 
the SMU thresholds for the baseline and isotonic saline block recordings. 
 
The sequence of recruitment of SMUs from the right temporalis muscle was further 
analysed to check whether the sequence of recruitment would be altered according to 
the infusion or not. For this purpose, only units that were present in the baseline, 
hypertonic and isotonic blocks were considered and participants that only had one unit 
that was present in the three blocks were also not considered in this analysis as it is 
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not possible to provide a recruitment sequence. The sequence of recruitment on which 
each motor unit appeared within a task in one block, was tabulated and compared with 
other blocks. 
 
3.5.5 Psychological values 
 
A quantitative analysis was done to determine a possible correlation between a change 
in SMU characteristics (occurrences) and psychological variables. The PCS and 
DASS-21 scores of the individuals where the occurrence of SMU activity did not alter 
during any of the infusions for the temporalis muscle was compared with the same 
scores of those participants where the occurrence of SMU activity did change in at 
least one block of infusion and those values were presented in tables.  
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4  RESULTS: 
 
The Results chapter is divided into 6 sections: 4.1. demographics, questionnaires and 
infusion data, 4.2 force amplitude, rates, levels, 4.3 root mean square (RMS) analysis, 
4.4. Single motor unit (SMU) analysis, 4.5. Masseter and temporalis occurrence and 
consistency with VCT and PAM – comparison and 4.6. Psychological variable 
influence on jaw muscle pain. 
 
4.1 Demographics, questionnaires and infusion data: 
 
4.1.1 Age, gender and solution injected first: 
 
20 participants were recruited - 15 females (75%) and 5 males (25%) - aged between 
22-40 yrs (mean (SD) 29.5 (4.3) yrs). Table 4-1 lists sex and age and the sequence of 
infusion. All the participants were able to perform all the different tasks (slow ramp jaw 
closing task, fast ramp jaw closing task, 2 step-levels jaw closing task) under the 4 
different blocks (baseline, hypertonic saline infusion, isotonic saline infusion, baseline 
2).   
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Participant 
ID 
Sex Age 
(yrs) 
Solution applied 
first 
1 F 26 Hypertonic 
2 F 30 Isotonic 
3 M 33 Hypertonic 
4 F 29 Isotonic 
5 F 29 Hypertonic 
6 F 40 Isotonic 
7 M 25 Hypertonic 
8 F 28 Isotonic 
9 M 29 Hypertonic 
10 F 39 Isotonic 
11 F 28 Hypertonic 
12 F 31 Isotonic 
13 M 27 Hypertonic 
14 M 31 Isotonic 
15 F 22 Hypertonic 
16 F 24 Hypertonic 
17 F 30 Isotonic 
18 F 31 Hypertonic 
19 F 29 Isotonic 
20 F 28 Hypertonic 
Mean  29.5  
SD  4.3  
Table 4-1: Participants’ ID, sex, age, and solution injected first. SD: Standard deviation 
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4.1.2 Scores from the RDC/TMD history and clinical examination 
 
Of the 20 participants, only one reported to have felt pain in the past month, although 
the pain was described as a one-time occurrence, and none of the participants reported 
pain in any part of their body prior to starting on the day of the experiment. 
 
Five participants reported to have heard a pop or a clicking while chewing, and 11 
participants reported grinding or clenching their teeth while sleeping at night, while only 
3 reported grinding or clenching their teeth during the day.  
 
Among all the participants, none reported any jaw problem that would interfere with 
any of the following activities: chewing, drinking, exercising, eating hard foods, eating 
soft foods, smiling/laughing, sexual activity, cleaning teeth or face, yawning, 
swallowing, talking, and having their usual facial appearance. 
 
During the clinical examination, 7 participants presented with joint sounds during jaw 
opening or closing or both. And finally, when the examiner palpated different areas of 
the participants’ muscles on the face, head and neck, only 1 participant indicated mild 
pain on intraoral palpation of the lateral pterygoid area.   
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4.1.3 Scores from the DASS-21 questionnaire 
 
The scores for depression, anxiety and stress, and means and standard deviations 
(SD) for each participant are shown in Table 4-2 below. The table also shows that 
within the 3 scales scores, stress had the highest mean (1.5) followed by anxiety (0.5) 
and depression (0.2). 
 
Participant Stress Depression  Anxiety 
1 0 0 0 
2 0 3 1 
3 3 0 2 
4 0 0 0 
5 0 0 0 
6 2 1 0 
7 0 0 0 
8 0 0 0 
9 1 0 0 
10 1 0 0 
11 0 0 0 
12 1 0 0 
13 2 0 1 
14 3 0 1 
15 3 0 1 
16 0 0 0 
17 2 0 0 
18 7 1 3 
19 5 0 1 
20 0 0 0 
Mean 1.5 0.2 0.5 
SD 1.9 0.7 0.8 
Table 4-2: DASS-21 scores (sum of the relevant statements) for depression, anxiety and stress for each 
participant along with mean and standard deviation (SD) for each of the scale scores. 
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4.1.4 Scores from the PCS questionnaire:  
 
Pain catastrophising scores for each participant are shown in Table 4-3. This table 
shows the total score and the scores for each of the 3 sub-scales as well as means 
and standard deviations of all of the participants’ scores. The table shows that pain-
related catastrophizing varied considerably between the participants with a total score 
range of 0 to 23 out of a possible score of 52. The table also shows that the mean total 
score was 8.35 and that within the 3 subscales, rumination and helplessness had the 
highest group mean (3.25) for both followed by magnification (1.85).  
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Participant Rumination Magnification Helplessness Total 
Score 
score 1 2 2 0 4 
2 1 0 1 2 
3 3 0 0 3 
4 11 3 9 23 
5 1 1 0 2 
6 2 2 2 6 
7 3 4 6 13 
8 0 1 1 2 
9 0 0 0 0 
10 4 3 6 13 
11 8 2 4 14 
12 0 0 0 0 
13 1 0 1 2 
14 0 0 1 1 
15 2 0 2 4 
16 10 5 7 22 
17 2 2 3 7 
18 6 5 10 21 
19 4 3 7 14 
20 5 4 5 14 
Mean 3.2 1.8 3.2 8.3 
SD 3.3 1.7 3.2 7.7 
Table 4-3: PCS scores for rumination, magnification and helplessness subscales and total PCS scores 
along with their respective means and standard deviations (SD). 
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4.1.5 Infusions 
 
A standardized infusion paradigm with a bolus of 0.1-0.3 ml of 5% hypertonic saline 
was infused for all the 20 participants. The infusion rate during continuous infusion was 
controlled between 0.6-17 ml/h, with differences in rates between participants being 
adjusted in order to maintain pain intensity ideally at a constant level of a 30-60 mm 
on a 100-mm VAS.  
 
The total amount of infused solution (i.e., initial bolus volume plus continuous infusion 
volume) for each participant is shown in Tables 4-4 and 4-5. There was a high 
variability in the VAS scores between individuals (see next section) and there was a 
very high infusion volume required for some participants (e.g. 1.9 ml, participant 9), 
and a very low volume (e.g. 0.1 ml, participant 6) was required for others. 
 
The means and standard deviations of the total infused volume across the 20 
participants during the hypertonic saline and isotonic saline infusions were 0.8 ml (SD: 
0.5 ml) and 0.7 ml (SD: 0.4 ml), respectively. A paired samples t-test found no 
significant difference (p=0.74) between the total volume infused for hypertonic (0.8 ml) 
and isotonic saline solutions (0.7 ml). 
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 Volume of hypertonic saline infused and infusion rate 
Participant  Bolus infusion (ml) Total volume (ml) Rate (ml/h) 
1  0.1 0.2 2 
2  0.1 0.4 No data 
3  0.2 0.3 2-4 
4  0.2 0.5 2-4 
5  0.2 0.9 4-10 
6  0.1 0.1 1 
7  0.2 1.3 4-10 
8  0.3 1.5 4-12 
9  0.2 1.9 9-14 
10  0.2 0.9 9 
11  0.2 0.7 0.6 
12   0.2 0.6 3 
13  0.2 1.9 10 -17 
14  0.1 0.6 4 
15  0.2 1.4 4-15 
16  0.3 0.8 5-13 
17  0.2 1 4-9 
18   0.3 1 4-8 
19  0.2 0.4 4-1 
20  0.2 0.2 1-2 
MEAN  0.2 0.8  
SD  0.06 0.5  
Table 4-4: Initial bolus infusion volume (ml), and total volume of infused hypertonic saline (5%) (ml) and 
rate of infusion (ml/h) obtained from each participant. No data: data was not recorded. 
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 Volume of isotonic saline infused and infusion rate 
Participant  Bolus infusion (ml) Total volume (ml) Rate (ml/h) 
1 
0.1 0.4 2 
2 
0.2 0.3 No data 
3 
0.2 0.3 2-4 
4 
0.2 0.2 1-2 
5 
0.2 1 4-9 
6 
0.2 0.4 4 
7 
0.2 1.3 4-11 
8 
0.2 0.7 4 
9 
0.2 1.3 5-9 
10 
0.2 0.6 4 
11 
0.2 0.6 4 
12  
0.2 0.7 4 
13 
0.2 1.5 10-14 
14 
0.2 0.6 4 
15 
0.2 1.4 4-14 
16 
0.3 0.8 5-13 
17 
0.2 0.6 3-4 
18  
0.3 1 4-8 
19 
0.2 0.4 4-1 
20 
0.2 0.2 1-2 
MEAN 
0.2 0.7  
SD 
0.03 0.4  
Table 4-5: Initial bolus infusion volume (ml), and total volume of infused isotonic saline (0.9%) (ml) and 
rate of infusion (ml/h) obtained from each participant. No data: data was not recorded 
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4.1.6 Scores from the VAS: 
The VAS scores are illustrated in Tables 4-6, 4-7, 4-8, 4-9, 4-10, and 4-11 below. Most 
of the participants reported moderate pain for the hypertonic saline block and minimal 
pain intensity or no pain at all for all the tasks under isotonic block of infusion. However, 
5 participants reported to have felt pain during the isotonic saline block of infusion and 
their scores varied from 3.3/100 to 34.7/100 during the slow ramp jaw closing task 
(Table 4-7), 4 participants felt pain with their scores varying from 10/100 to 35/100 
during the fast ramp jaw closing task (Table 4-9), and 4 participants scored from 10/100 
to 32.7/100 on the VAS of the 2 step-levels jaw closing task (Table 4-11) during the 
isotonic saline block of infusion. For the hypertonic block, the highest mean VAS score 
was recorded from Participant 20 during the slow ramp jaw closing task at 
approximately 71/100 whereas the lowest mean score was noted by Participant 9 also 
during the slow ramp jaw closing tasks at 20/100.  
 
Repeated measures Analysis of Variance (ANOVA) of the VAS pain intensity scores 
after each trial of a jaw closing task during the hypertonic saline infusion showed no 
significant effect of repeating the trial (3 trials of slow ramp jaw closing task, 3 trials of 
fast ramp jaw closing task, 3 trials of 2 step-levels jaw closing task) with p=0.308 for 
the slow ramp jaw closing task, p=0.107 for the fast ramp jaw closing task, and p=0.379 
for the 2 step-levels jaw closing task. During the isotonic saline infusion there were 
also no significant effects for repetitions with p=0.45 for the slow ramp jaw closing task, 
p=0.362 for the fast ramp jaw closing task, p=0.248 for the 2 step-levels jaw closing 
task.  
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Because there was no significant difference found in the repetitions, the means of each 
block were used in a paired samples t-test of within participants and revealed that the 
VAS scores obtained during hypertonic saline infusion were significantly greater 
(p<0.001) than the VAS scores obtained during the isotonic saline infusion for each of 
the three different tasks (slow ramp jaw closing task, fast ramp jaw closing task, 2 step-
levels jaw closing tasks) – See figures 4-1, 4-2, 4-3. 
 
 SLOW RAMP JAW CLOSING TASK:   
 Hypertonic saline infusion 
Participant SR1 SR2 SR3 Mean SD 
1 50 50 60 53.3 5.7 
2 50 40 42 44 5.3 
3 47 55 55 52.3 4.6 
4 23 43 24 30 11.3 
5 30 46 56 44 13.1 
6 57 60 54 57 3 
7 50 30 30 36.7 11.5 
8 40 40 40 40 0 
9 20 20 20 20 0 
10 23 15 20 19.3 4 
11 50 40 40 43.3 5.8 
12 43 37 47 42.3 5 
13 53 25 20 32.7 17.8 
14 50 50 50 50 0 
15 45 47 43 45 2 
16 39 24 20 27.7 10 
17 54 39 40 44.3 8.4 
18 41 57 49 49 8 
19 60 60 50 56.7 5.7 
20 75 75 65 71.7 5.7 
Mean  45 42.6 41.2 43 1.9 
SD  13.5 15.1 14.4 12.8 0.8 
Table 4-6: VAS (visual analogue scale) scores (mean and SD in millimetres) for all participants, during 
slow ramp jaw closing task across hypertonic saline infusion block. SD: standard deviation. SR 1: Slow 
ramp jaw closing task first repetition. SR 2:  Slow ramp jaw closing task second repetition. SR 3: Slow 
ramp jaw closing task third repetition. 
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 Isotonic saline infusion  
Participant SR1 SR2 SR3 Mean SD 
1 0 0 0 0 0 
2 35 34 35 34.7 0.6 
3 0 0 0 0 0 
4 21 14 25 20 5.6 
5 0 0 0 0 0 
6 8 11 7 8.7 2.1 
7 0 0 0 0 0 
8 0 0 0 0 0 
9 0 0 0 0 0 
10 0 0 0 0 0 
11 0 0 0 0 0 
12 10 0 0 3.3 5.8 
13 0 0 0 0 0 
14 0 0 0 0 0 
15 0 0 0 0 0 
16 0 0 0 0 0 
17 0 0 0 0 0 
18 0 0 0 0 0 
19 10 10 10 10 0 
20 0 0 0 0 0 
Mean  4.2 3.4 3.8 3.9 0.4 
SD  9.1 8.4 9.5 8.9 0.5 
Table 4-7: VAS (visual analogue scale) scores (mean and SD in millimetres) for all participants, during 
slow ramp jaw closing task across isotonic saline infusion block. SD: standard deviation. SR 1: Slow 
ramp jaw closing task first repetition. SR 2:  Slow ramp jaw closing task second repetition. SR 3: Slow 
ramp jaw closing task third repetition. 
 
Figure 4-1: Mean VAS scores (y axis) from each participant (x axis) during slow ramp jaw closing task 
during hypertonic saline infusion block (blue) and during isotonic saline infusion block (orange). H SR: 
Slow ramp jaw closing task during hypertonic saline infusion. I SR: Slow ramp jaw closing task during 
isotonic saline infusion. 
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 FAST RAMP JAW CLOSING TASK: 
 
 Hypertonic saline infusion 
Participant FR1 FR2 FR3 Mean SD 
1 50 51 52 51 1 
2 42 45 43 43.3 1.5 
3 51 54 49 51.3 2.5 
4 35 41 32 36 4.6 
5 40 23 37 33.3 9.1 
6 31 29 16 25.3 8.1 
7 40 40 50 43.3 5.8 
8 40 30 30 33.3 5.8 
9 40 50 50 46.7 5.8 
10 11 30 30 23.7 11 
11 50 60 60 56.7 5.8 
12 49 50 53 50.7 2.1 
13 31 35 40 35.3 4.5 
14 50 50 50 50 0 
15 43 47 49 46.3 3.1 
16 18 50 65 44.3 24 
17 40 40 37 39 1.7 
18 35 35 45 38.3 5.8 
19 50 50 60 60.7 5.8 
20 60 62 60 60.7 1.1 
Mean  40.3 43.6 45.4 43.5 2.6 
SD 11.6 10.7 12.4 10.5 0.8 
Table 4-8: VAS (visual analogue scale) scores (mean and SD in millimetres) for all participants, during 
fast ramp jaw closing task across hypertonic saline infusion block. SD: standard deviation. FR 1: Fast 
ramp jaw closing task first repetition. FR 2:  Fast ramp jaw closing task second repetition. FR 3: Fast 
ramp jaw closing task third repetition.  
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 Isotonic saline infusion 
Participant FR1 FR2 FR3 Mean SD 
1 0 0 0 0 0 
2 35 33 37 35 2 
3 0 0 0 0 0 
4 30 40 20 30 10 
5 0 0 0 0 0 
6 20 12 7 13 6.7 
7 0 0 0 0 0 
8 0 0 0 0 0 
9 0 0 0 0 0 
10 0 0 0 0 0 
11 0 0 0 0 0 
12 0 0 0 0 0 
13 0 0 0 0 0 
14 0 0 0 0 0 
15 0 0 0 0 0 
16 0 0 0 0 0 
17 0 0 0 0 0 
18 0 0 0 0 0 
19 10 10 10 10 0 
20 0 0 0 0 0 
Mean  4.7 4.7 3.7 4.4 0.6 
SD  10.7 11.4 9.3 10.3 1.1 
Table 4-9: VAS (visual analogue scale) scores (mean and SD in millimetres) for all participants, during 
fast ramp jaw closing task across isotonic saline infusion block. SD: standard deviation. FR 1: Fast ramp 
jaw closing task first repetition. FR 2:  Fast ramp jaw closing task second repetition. FR 3: Fast ramp 
jaw closing task third repetition. 
 
Figure 4-2: Mean VAS scores (y axis) from each participant (x axis) during fast ramp jaw closing task 
during hypertonic saline infusion block (blue) and isotonic saline infusion block (orange). H FR: Fast 
ramp jaw closing task during hypertonic saline infusion. I FR: Fast ramp jaw closing task during isotonic 
saline infusion. 
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 2 STEP-LEVELS JAW CLOSING TASK: 
 
 Hypertonic saline infusion 
Participant ST 1 ST 2 ST 3 Mean SD 
1 53 49 49 50.3 2.3 
2 45 40 44 43 2.6 
3 45 45 44 44.7 0.6 
4 43 36 33 37.3 5.1 
5 34 44 49 42.3 7.6 
6 52 50 50 50.7 1.1 
7 40 50 50 46.7 5.8 
8 30 40 40 36.7 5.8 
9 60 60 50 56.7 5.8 
10 40 50 50 46.7 5.8 
11 50 50 40 46.7 5.8 
12 51 56 53 53.3 2.5 
13 45 43 46 44.7 1.5 
14 50 50 50 50 0 
15 25 35 37 32.3 6.4 
16 47 56 50 51 4.6 
17 49 50 56 51.7 3.8 
18 45 40 50 45 5 
19 60 60 60 60 0 
20 61 60 50 57 6.1 
Mean  46.2 48.2 47.5 47.3 1 
SD  9.4 7.7 6.4 7 1.5 
Table 4-10: VAS (visual analogue scale) scores (mean and SD in millimetres) for all participants, during 
2 step-levels jaw closing task across hypertonic saline infusion block. SD: standard deviation. ST 1: 2 
step-levels jaw closing task first repetition. ST 2:  2 step-levels jaw closing task second repetition. ST 3: 
2 step-levels jaw closing task third repetition. 
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 Isotonic saline infusion 
Participant ST 1 ST 2 ST 3 Mean SD 
1 0 0 0 0 0 
2 35 33 30 32.7 2.5 
3 0 0 0 0 0 
4 24 11 16 17 6.6 
5 0 0 0 0 0 
6 21 21 20 20.7 0.6 
7 0 0 0 0 0 
8 0 0 0 0 0 
9 0 0 0 0 0 
10 0 0 0 0 0 
11 0 0 0 0 0 
12 0 0 0 0 0 
13 0 0 0 0 0 
14 0 0 0 0 0 
15 0 0 0 0 0 
16 0 0 0 0 0 
17 0 0 0 0 0 
18 0 0 0 0 0 
19 10 10 10 10 0 
20 0 0 0 0 0 
Mean 4.5 3.7 3.8 4 0.4 
SD  10.1 8.8 8.5 9 0.9 
Table 4-11: VAS (visual analogue scale) scores (mean and SD in millimetres) for all participants, during 
2 step-levels jaw closing task across isotonic saline infusion block. SD: standard deviation. ST 1: 2 step-
levels jaw closing task first repetition. ST 2:  2 step-levels jaw closing task second repetition. ST 3: 2 
step-levels jaw closing task third repetition. 
 
Figure 4-3: Mean VAS scores (y axis) from each participant (x axis) during 2 step-levels jaw closing task 
during hypertonic saline infusion block (blue) and isotonic saline infusion block (orange). H SR: 2 step-
levels jaw closing task during hypertonic saline infusion. I SR: 2 step-levels jaw closing task during 
isotonic saline infusion. 
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4.1.7 Distribution of perceived pain 
 
The evoked pain was visually mapped after the performance of every trial of each task 
during both saline infusion blocks. A summary of the pain maps from all participants is 
shown in Table 4-12.  
 
This table indicates that for the hypertonic block of infusion, all participants (n=20) 
described localised pain in the area of the right masseter that was infused with the 
hypertonic saline solution. Participants 2 and 17 also reported referred pain in the right 
anterior temporalis muscle. For the isotonic block of infusion, on the other hand, 
participants 2, 4, 6 and 19 reported localised pain in the area of the right masseter that 
was infused with isotonic saline solution and participant 2 also reported referred pain 
in the right anterior temporalis. – See figure 4-4. 
 
  
131 
 
Hypertonic   Isotonic saline infusion 
Participant 
Right 
Masseter 
Right 
Temporalis Other 
Pain free 
after Participant 
Right 
Masseter 
Right 
Temporalis Other 
1 Yes No No 5 min 1 No No No 
2 Yes Yes No 7 min  2 Yes Yes No 
3 Yes No No 3 min  3 No No No 
4 Yes No No 5 min 4 Yes No No 
5 Yes No No 4 min 5 No No No 
6 Yes No No 8 min 6 Yes No No 
7 Yes No No 9 min 7 No No No 
8 Yes No No 1 min 8 No No No 
9 Yes No No 3 min  9 No No No 
10 Yes No No 5 min 10 No No No 
11 Yes No No 2 min 11 No No No 
12 Yes No No 5 min 12 No No No 
13 Yes No No 2 min 13 No No No 
14 Yes No No 6 min  14 No No No 
15 Yes No No 4 min  15 No No No 
16 Yes No No 1 min 16 No No No 
17 Yes Yes No  2 min  17 No No No 
18 Yes No No 5 min  18 No No No 
19 Yes No No 6 min  19 Yes No No 
20 Yes No No 6 min  20 No No No 
Table 4-12: Location of pain during the hypertonic and isotonic saline infusion blocks. For hypertonic 
and isotonic saline infusion blocks, Yes: pain map located over the muscle (right masseter or right 
temporalis). No: pain map not located over the muscle (right masseter, right temporalis or other muscle). 
Highlighted Participant 2 and 17 who reported referred pain on the right temporalis muscle during the 
hypertonic saline infusion block, and Participant 2, who have reported pain on the right masseter and 
right temporalis muscle during the isotonic saline infusion block and Participant 4, 6 and 19 who have 
reported pain in the right masseter during the isotonic saline infusion block. 
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Figure 4-4: Example of one participant where pain was felt not only at the site of the saline infusion 
(masseter muscle, local pain) but also in the region of the temporalis muscle (referred pain). 
 
In summary, during the hypertonic saline infusion block all 20 participants (100%) felt 
pain in the masseter muscle and of these, 2 participants also felt pain in the region of 
the temporalis muscle. 
 
In the isotonic saline infusion block, some participants marked a pain area for the right 
masseter only or right masseter and right temporalis. Of the 20 participants, 4 
participants (Participant 2, 4, 6, 19) felt pain in the masseter muscle and only 1 
(Participant 2) felt pain in the region of the temporalis muscle. There was no report of 
pain felt elsewhere on the face. 
 
  
Local pain 
Referred 
pain 
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4.1.8 Scores from the McGill questionnaire 
 
The most cited word in this study for the hypertonic block of infusion was “annoying” 
(14/20), followed by “aching” (13/20), “pressing” (12/20) and “jumping” (8/20). For the 
most cited words during the isotonic block of infusion, “boring” was cited by 3 people 
and “annoying” by 2.  
 
The following tables (Table 4-13 and 4-14) detail the words chosen for both hypertonic 
and isotonic blocks of infusion: 
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Descriptors Group Words Number of times the word was 
cited in Hypertonic saline  
scale weight scale value 
(scale x number of times cited) 
weighted value 
(weight x number of times cited) 
Sensory 
 
 
 
1 
Pulsing 1 3 2.07 3 2.07 
Beating 2 5 3.45 10 6.9 
2 
Jumping 8 1 1.38 8 11.04 
Shooting 5 3 4.14 15 20.7 
3 
Pricking 3 1 0.93 3 2.79 
Boring 6 2 1.86 12 11.16 
Drilling 3 3 2.79 9 8.37 
Stabbing 2 4 3.72 8 7.44 
4 
Sharp 5 1 1.59 5 7.95 
Cutting 2 2 3.18 4 6.36 
5 
Pinching 4 1 0.81 4 3.24 
Pressing 12 2 1.62 24 19.44 
Gnawing 1 3 2.43 3 2.43 
Cramping 1 4 3.24 4 3.24 
Crushing 1 5 4.05 5 4.05 
6 Pulling 1 2 2.38 2 2.38 
7 
Hot 2 1 1.28 2 2.56 
Burning 1 2 2.56 2 2.56 
Searing 1 4 5.12 4 5.12 
8 
Smarting 1 3 2.1 3 2.1 
Stinging 3 4 2.8 12 8.4 
9 
Dull 1 1 0.72 1 0.72 
Sore 5 2 1.44 10 7.2 
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Table 4-13: Table with words from the McGill questionnaire endorsed during the hypertonic saline infusion block. The table lists the number of times the word 
was cited, the scale, and weight, and the scale value and weighted values that were calculated.  
 
Descriptors Group Words Number of times the word was 
cited in Hypertonic saline  
scale weight scale value 
(scale x number of times cited) 
weighted value 
(weight x number of times cited) 
Sensory 
9 
Hurting 4 3 2.16 12 8.64 
Aching 13 4 2.88 52 37.44 
Heavy 1 5 3.6 5 3.6 
10 
Taut 6 2 1.88 12 11.28 
Splitting 1 4 3.76 4 3.76 
Affective 
11 
Tiring 3 1 1.74 3 5.22 
Exhausting 3 2 3.48 6 10.44 
12 Sickening 2 1 2.22 2 4.44 
13 Terrifying 1 3 5.61 3 5.61 
14 
Punishing 1 1 1.32 1 1.32 
Grueling 1 2 2.64 2 2.64 
Evaluative 16 
Annoying 14 1 1.01 14 14.14 
Miserable 3 3 3.03 9 9.09 
Intense 3 4 4.04 12 12.12 
Miscellaneous 
17 
Radiating 2 2 2.44 4 4.88 
Penetrating 6 3 3.66 18 21.96 
18 
Tight 2 1 0.81 2 1.62 
Numb 1 2 1.32 2 1.32 
19 
Cool 1 1 1 1 1 
Freezing 1 3 3 3 3 
20 
Nagging 1 1 1.15 1 1.15 
Dreadful 5 4 4.6 20 23 
  
Total 
chosen 146 
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Descriptors Group Words Number of times the word was 
cited in Isotonic saline 
scale Weight scale value 
(scale x number of times cited) 
weighted value 
(weight x number of times 
cited) 
Sensory 
1 Beating 1 5 3.45 5 3.45 
2 Shooting 1 3 4.14 3 4.14 
3 
Boring 3 2 1.86 6 5.58 
Drilling 1 3 2.79 3 2.79 
4 Sharp 1 1 1.59 1 1.59 
5 
Pressing 1 2 1.62 2 1.62 
Gnawing 1 3 2.43 3 2.43 
6 Pulling 1 2 2.38 2 2.38 
7 Burning 1 2 2.56 2 2.56 
8 Stinging 1 4 2.8 4 2.8 
9 
Sore 1 2 1.44 2 1.44 
Hurting 1 3 2.16 3 2.16 
Aching 1 4 2.88 4 2.88 
Heavy 1 5 3.6 5 3.6 
10 Tender 1 1 0.94 1 0.94 
Affective 
11 Tiring 1 1 1.74 1 1.74 
13 Fearful 1 1 1.87 1 1.87 
Evaluative 16 
Annoying 2 1 1.01 2 2.02 
Troublesome 1 2 2.02 2 2.02 
Miscellaneous   Penetrating 1 3 3.66 3 3.66 
  Total chosen 23 
Table 4-14: Table with words from the McGill questionnaire endorsed during isotonic saline infusion block. The table lists the number of times the word was 
cited, the scale, and weight, and the scale value and weighted values that were calculated. 
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For each descriptor, a pain rating index (PRI) was calculated for the 2 different blocks 
of infusions and each is shown in the following tables (Tables 4-15, 4-16). 
 
Hypertonic saline infusion: 
Pain rating 
index 
Sum scale Sum weight Mean scale Mean weight 
Sensory 238 
 
212.9 
 
8.5 
 
7.6 
 Affective 17 
 
29.7 
 
2.8 
 
4.9 
 Evaluative 35 
 
35.3 
 
11.8 
 
11.8 
 Miscellaneous 51 
 
57.9 
 
6.4 
 
7.2 
 Total (mean) 85.2 
 
84 
 
7.4 
 
7.9 
 
Table 4-15: Total sum scale, total sum weight  and pain rating index (PRI) descriptor class scores to 
describe the pain according to the obtained scale and weighted scores after the hypertonic saline 
infusion block.  
 
Isotonic saline infusion block: 
Pain rating 
index 
Sum scale Sum weight Mean scale Mean weight 
Sensory 46 
 
40.4 
 
3.1 
 
2.7 
Affective 2 
 
3.6 
 
1 1.8 
 Evaluative 4 
 
4 
 
2 
 
2 
 Miscellaneous 3 
 
3.7 
 
3 
 
3.7 
 Total (mean) 13.7 
 
12.9 
 
2.3 
 
2.5 
 
Table 4-16: Total sum scale, total sum weight  and pain rating index (PRI) descriptor class scores to 
describe the pain according to the obtained scale and weighted scores after the isotonic saline infusion 
block. 
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Paired T-tests were done to compare the scores of the mean scale and mean weight 
between the hypertonic saline infusion block and isotonic saline infusion block and 
found a significant (p<0.005) difference in the each of the PRIs analysed.   
 
4.2 Force amplitude, rates, levels 
 
Force values, captured in volts were mathematically converted to Newtons with the aid 
of the Excel program. As stated in the Methods, the highest force achieved for each of 
the slow and fast ramp jaw closing tasks were compared between each repetition 
within each participant. A similar calculation was done for the most stable 2-second 
period for each of step 1 and step 2, in the 2 step-levels jaw closing task. The value 
found on the excel sheet was confirmed visually on the force output from the spike2 
program (See figures 4-5, 4-6 and 4-7 below). 
 
 
Figure 4-5: Example of force output for a slow ramp jaw closing task. An arrow is placed indicating the 
exact moment where this particular participant achieved the highest force. It can be seen that the time 
from the lowest to the highest level of force took about 7.5 s (from 7.0 s to 14.5 s). X-axis: time in 
seconds (Sec). Y-axis: force transducer output in volts (V). 
7s 14.5s 
0.5 s 
500 mv  
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Figure 4-6: Example of force output for a fast ramp jaw closing task. An arrow is placed indicating the 
exact moment where this particular participant achieved the highest force. The time from the lowest 
force level to the highest one took about 3.5 s approximately (from 4.8 s to 8.3 s). X-axis: time in seconds 
(Sec). Y-axis: force transducer output in volts (V).  
 
 
Figure 4-7: Example of force output for a 2 step-levels jaw closing task with the most stable period of 
approximately 2 seconds for each step level defined. See Methods for criterion used to define the most 
stable 2-s period. X-axis: time in seconds (Sec). Y-axis: force transducer output in volts (V). 
 
4.8s 8.3s 
5.5s 7.5s 11.5s 9.5s 
0.5 s 
500 mv  
0.5 s 
500 mv  
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Force rates were also analysed based on the same Excel program, by dividing the 
value in newtons of the highest point of the exerted force for the number of seconds 
that the participant took to exert that force. 
 
4.2.1 Force amplitude 
 
Tables 4-17 and 4-18 show the mean of the highest force values in newtons across 
the 3 repetitions of each task of the jaw closing ramp tasks (slow ramp jaw closing task 
and fast ramp jaw closing task).  
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 SLOW RAMP JAW CLOSING TASK: 
ID Baseline Hypertonic Saline Isotonic Saline 
 Mean  SD Mean  SD Mean  SD 
1 95.0 1.9 83.5 2.5 83.9 4.4 
2 33.4 5.0 41.5 4.3 36.7 1.0 
3 51.2 9.7 37.1 5.1 38.5 6.4 
4 56.3 9.0 50.6 4.3 53.9 9.5 
5 59.5 5.3 58.1 2.0 57.0 1.3 
6 52.9 4.6 51.2 4.7 54.8 1.6 
7 37.0 3.8 40.6 2.8 43.1 2.5 
8 51.3 5.4 55.3 3.3 56.0 1.7 
9 47.5 3.8 52.7 12.0 62.9 7.5 
10 62.1 1.4 56.0 2.2 62.6 3.8 
11 51.1 1.9 59.3 6.7 58.7 3.1 
12 55.6 2.3 50.7 12.2 54.6 0.8 
13 59.9 3.3 61.2 2.2 61.8 2.7 
14 65.3 2.6 62.2 3.2 48.3 5.0 
15 58.5 6.0 59.7 2.2 56.8 3.4 
16 55.9 0.6 52.2 1.7 46.3 0.2 
17 66.3 4.5 60.2 2.5 54.3 7.9 
18 49.0 6.0 33.8 15.3 53.7 1.9 
19 39.9 19.4 42.2 8.5 55.6 4.4 
20 49.0 5.9 42.5 9.7 57.6 2.5 
Table 4-17: Mean of the highest force in N for the slow ramp jaw closing tasks during baseline, 
hypertonic saline infusion block and isotonic saline infusion block. ID: participant number. SD: standard 
deviation. For comparisons between the hypertonic saline infusion block and the isotonic saline infusion 
block, the highlighted values show the block where the force was smaller than the other block. . 
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 FAST RAMP JAW CLOSING TASK: 
ID Baseline Hypertonic Saline Isotonic Saline 
 Mean  SD Mean  SD Mean  SD 
1 89.6 4.1 89.8 10.2 69.8 12.9 
2 126.9 5.3 128.2 5.1 107.2 6.7 
3 49.1 10.8 53.8 2.2 46.5 1.9 
4 67.1 1.8 66.1 1.4 60.2 8.4 
5 59.3 2.2 61.3 2.2 65.9 2.0 
6 51.9 1.6 54.5 6.0 53.8 5.7 
7 43.8 1.8 50.0 6.5 44.0 1.8 
8 52.5 3.4 66.5 13.8 62.1 2.5 
9 51.9 1.3 62.4 12.1 69.1 4.7 
10 64.3 5.2 65.9 8.0 75.1 3.0 
11 43.5 4.8 55.0 2.6 46.6 4.1 
12 36.0 0.3 36.1 5.3 34.9 0.8 
13 56.5 4.4 51.9 3.1 60.1 5.6 
14 49.9 4.5 64.8 4.7 70.9 7.0 
15 58.4 5.3 61.0 0.9 60.1 2.4 
16 54.7 4.4 60.8 3.6 53.0 2.2 
17 67.5 2.9 61.2 2.3 58.8 7.7 
18 51.8 4.8 47.0 4.2 55.4 3.9 
19 64.3 1.2 64.4 1.7 63.7 2.5 
20 55.1 3.8 51.2 1.1 61.3 2.8 
Table 4-18: Mean of the highest force in N for the fast ramp jaw closing tasks during baseline, hypertonic 
saline infusion block and isotonic saline infusion block. ID: participant number. SD: standard deviation. 
For comparisons between the hypertonic saline infusion block and the isotonic saline infusion block, the 
highlighted values show the block where the force was smaller than the other block. . 
 
Qualitatively, it was possible to notice that, for the slow ramp jaw closing task and for 
comparison among the 3 blocks, 7 participants (participant 2, 7, 8, 9, 11, 13, 19) 
exerted the lowest force during the baseline block, 8 participants (participant 1, 3, 4, 6, 
10, 12, 18, 20) exerted the lowest force during the hypertonic saline infusion block and 
lastly, 5 participants (participant 5, 14, 15, 16, 17) exerted the lowest force during the 
isotonic saline infusion block.  
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For the fast ramp jaw closing task and for comparison among the 3 blocks, it was 
possible to notice that 9 participants (participant 5, 6, 7, 8, 9, 10, 11, 14, 15) exerted 
the lowest during the baseline block, only 3 participants (participant 13, 18, 20) exerted 
the lowest force during the hypertonic saline infusion block and lastly, 8 participants 
(participant 1, 2, 3, 4, 12, 17, 18, 19) exerted the lowest force during the isotonic saline 
infusion block.  
 
A repeated measures analysis of variance (ANOVA) determined that there were no 
significant effects (p>0.05) of the repetitions on the force values for each participant 
during each task trial of the jaw closing ramp tasks (slow ramp jaw closing task and 
fast ramp jaw closing task). 
 
 For the repetitions during the slow ramp jaw closing tasks:  
o p=0.41 for the baseline block; 
o p=0.06 for the hypertonic saline infusion block; 
o p=0.63 for the isotonic saline infusion block.  
 
Because no effect of repetition during the slow ramp jaw closing tasks was found, 
further analysis (pairwise comparisons with Bonferroni corrections) were done using 
the mean of the repetitions and found that there was no significant effect of the block 
(p=0.33) on the force values during the slow ramp jaw closing task. 
 
 For the repetitions during the fast ramp jaw closing tasks:  
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o p=0.44 for the baseline block; 
o p=0.22 for the hypertonic saline infusion block; 
o p=0.94 for the isotonic saline infusion block. 
 
Because no effect of repetition during the fast ramp jaw closing tasks was found, further 
analysis (pairwise comparisons with Bonferroni corrections) were done using the mean 
of repetitions and found that there was no significant effect of the block (p=0.32) on the 
force values during the fast ramp jaw closing task. 
 
Therefore, force values were not affected by the pain induction and all the participants 
were able to perform all the trials of the jaw closing ramp tasks (slow ramp jaw closing 
task and fast ramp jaw closing task) for the three blocks analysed in this study. 
 
4.2.2 Force rates 
 
Tables 4-19 and 4-20 show the force rate values (N/s) for the slow ramp jaw closing 
task and fast ramp jaw closing task.  
 
 
 
 SLOW RAMP JAW CLOSING TASK: 
 
Baseline Hypertonic Isotonic 
145 
 
8.9 8.2 8.4 
5.2 7.0 6.7 
8.0 3.2 2.7 
3.3 3.0 3.0 
3.1 3.3 3.2 
3.3 3.2 3.1 
2.9 2.7 2.7 
3.0 3.4 3.5 
3.3 3.6 3.5 
3.7 3.4 4.2 
2.8 3.5 3.3 
3.5 3.3 3.5 
3.1 3.8 3.5 
3.7 3.4 2.7 
3.2 3.3 3.4 
3.2 3.0 2.7 
3.5 3.0 2.8 
2.9 2.3 2.8 
3.7 3.2 3.4 
3.1 2.6 3.2 
Table 4-19: Force rate values for slow ramp jaw closing task 
 
 
Paired t-tests showed no significant difference between baseline and hypertonic 
(p=0.4), baseline and isotonic (p=0.4) or hypertonic and isotonic (p=0.9) for the slow 
ramp jaw closing task. 
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 FAST RAMP JAW CLOSING TASK: 
Baseline Hypertonic Isotonic 
18.8 18.7 18.2 
21.1 22.6 12.3 
16.4 8.5 7.0 
8.0 8.7 6.9 
6.9 8.0 7.6 
6.0 7.2 5.9 
7.1 7.9 7.0 
7.6 9.1 9.6 
7.6 8.5 9.2 
9.0 9.4 10.1 
5.4 6.7 6.2 
5.3 5.8 5.4 
8.1 6.4 8.3 
5.8 7.0 8.3 
7.5 8.4 7.0 
9.4 9.4 7.9 
7.8 7.7 7.2 
6.5 6.2 6.6 
8.8 8.4 7.5 
7.2 7.0 8.2 
Table 4-20: Force rate values for fast ramp jaw closing task 
 
Paired t-tests showed no significant difference between baseline and hypertonic 
(p=0.9), baseline and isotonic (p=0.3) or hypertonic and isotonic (p=0.2) for the fast 
ramp jaw closing task. However, comparing the rates between slow ramp and fast 
ramp, paired t tests showed a significant difference between baseline slow ramp and 
baseline fast ramp, hypertonic slow ramp and isotonic fast ramp, isotonic slow ramp 
and isotonic fast ramp (p<0.005) for the three conditions. 
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4.2.3 Force levels 
  
Tables 4-21 and 4-22 show the mean of the force values in newtons across the 3 
repetitions at each level of the 2 step-levels jaw closing task (step 1 and step 2).  
 
 STEP 1 OF THE 2 STEP-LEVELS JAW CLOSING TASK:  
ID Baseline Hypertonic Isotonic 
 Mean  SD Mean  SD Mean  SD 
1 18.0 3.4 16.7 2.4 18.8 2.7 
2 68.5 2.3 65.7 1.6 62.2 5.8 
3 50.3 2.7 49.7 2.5 47.3 3.1 
4 49.8 2.0 52.4 1.6 47.0 3.0 
5 27.3 2.0 29.9 2.5 27.8 1.6 
6 45.8 5.3 52.3 0.7 52.4 5.4 
7 48.2 4.3 44.8 2.9 45.0 6.6 
8 27.0 4.4 25.0 0.9 29.0 1.8 
9 23.8 1.1 18.6 1.3 15.2 4.1 
10 12.0 2.8 8.5 1.1 12.0 1.5 
11 23.2 5.7 19.8 6.8 18.1 2.2 
12 33.1 0.9 32.0 2.3 31.8 0.8 
13 29.7 1.2 29.6 4.1 27.0 1.2 
14 40.7 4.4 34.2 3.5 44.4 3.4 
15 26.3 6.5 30.7 0.5 28.5 1.8 
16 23.0 3.8 18.5 1.6 14.3 0.9 
17 34.8 1.2 32.5 5.3 36.1 2.6 
18 33.4 2.0 33.1 0.3 34.9 2.0 
19 11.2 0.7 10.4 1.9 10.9 0.3 
20 39.7 3.5 41.0 0.5 39.8 3.0 
Table 4-21: Mean of the highest force in N for the step 1 of the 2 step-levels jaw closing tasks during 
baseline, hypertonic saline infusion block and isotonic saline infusion block. ID: participant number. SD: 
standard deviation. For comparisons between the hypertonic saline infusion block and the isotonic saline 
infusion block, the highlighted values show the block where the force was smaller than the other block.  
 
 
 STEP 2 OF THE 2 STEP-LEVELS JAW CLOSING TASK:  
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ID Baseline Hypertonic Isotonic 
 Mean  SD Mean  SD Mean  SD 
1 36.2 0.1 41.2 1.4 40.3 1.8 
2 113.7 3.3 118.5 0.6 115.8 5.9 
3 66.3 0.8 65.1 1.4 64.0 0.6 
4 67.2 2.7 70.6 1.1 68.5 1.3 
5 61.3 4.3 61.8 3.2 62.9 2.0 
6 88.9 6.0 95.9 3.7 99.1 5.0 
7 74.0 0.4 67.1 4.0 67.4 4.0 
8 60.1 0.0 63.3 2.7 59.9 2.0 
9 47.8 2.7 42.2 1.9 37.9 3.9 
10 51.0 0.3 51.7 4.1 48.2 1.4 
11 67.6 0.7 59.5 7.2 61.5 3.1 
12 47.1 1.1 47.1 0.6 47.0 2.8 
13 65.2 3.0 62.4 1.5 61.9 0.5 
14 148.2 3.6 141.8 3.3 153.0 3.6 
15 50.5 7.0 54.9 0.7 51.4 1.7 
16 56.6 3.5 51.9 0.9 50.9 1.9 
17 66.1 2.2 59.5 2.7 64.7 1.5 
18 51.6 2.1 51.9 1.1 52.5 0.6 
19 31.2 4.5 30.7 3.7 30.2 2.1 
20 72.2 4.4 75.2 4.0 72.2 1.8 
Table 4-22: Mean of the highest force in N for the step 2 of the 2 step-levels jaw closing tasks during 
baseline, hypertonic saline infusion block and isotonic saline infusion block. ID: participant number. SD: 
standard deviation. For comparisons between the hypertonic saline infusion block and the isotonic saline 
infusion block, the highlighted values show the block where the force was smaller than the other block. 
 
For the step 1 of the 2 step-levels jaw closing task and for comparison among the 3 
blocks, it was possible to notice that 4 participants (participant 5, 6, 15, 20) exerted the 
lowest force during the baseline block, 8 participants (participant 1, 7, 8, 10, 14, 17, 
18, 19) exerted the lowest force during the hypertonic saline infusion block and lastly, 
8 participants (participant 2, 3, 4, 9, 11, 12, 13, 16) exerted the lowest force during the 
isotonic saline infusion block.  
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And lastly, for the step 2 of the 2 step-levels jaw closing task and for comparison among 
the 3 blocks, it was possible to notice that 7 participants (participant 1, 2, 4, 5, 6, 15, 
18) exerted the lowest force during the baseline block, 4 participants (participant 7, 11, 
14, 17) exerted the lowest force during the hypertonic saline infusion block and lastly, 
9 participants (participant 3, 8, 9, 10, 12, 13, 16, 19, 20) exerted the lowest force during 
the isotonic saline infusion block.  
 
A repeated measures analysis of variance (ANOVA) determined that there was no 
significant effect (p> 0.05) of the repetitions on the force values for each participant 
during each task trial of the 2 step-levels jaw closing task. 
 
 For the repetitions during the step 1 of the 2 step-levels jaw closing tasks:  
o p=0.45 for the baseline block; 
o p=0.58 for the hypertonic saline infusion block; 
o p=0.69 for the isotonic saline infusion block. 
 
Because no effect of repetition during the step 1 of the 2 step-levels jaw closing tasks 
was found, further analysis were done using the mean of the repetitions and found no 
significant effect of the block (p=0.3) on the force level during the step 1 of the 2 step-
levels jaw closing task. 
 
 For the repetitions during the step 2 of the 2 step-levels jaw closing tasks:  
o p=0.94 for the baseline block; 
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o p=0.48 for the hypertonic saline infusion block; 
o p=0.27 for the isotonic saline infusion block. 
 
Because no effect of repetition during the step 2 of the 2 step-levels jaw closing tasks 
was found, further analysis were done using the mean of repetitions and found no 
significant effect of the block (p=0.76) on the force level during the step 2 of the 2 step-
levels jaw closing task. 
 
Therefore, force values were not affected by the pain induction and all the participants 
were able to perform all the trials of the 2 step-levels jaw closing tasks for the three 
blocks analysed in this study. Paired T-tests was also done to calculate if step 2 was 
significantly greater than step 1 under the three conditions analysed and it was found 
a significant difference for the three comparisons:   
o p=0.002 for baseline step 1 x baseline step 2; 
o p=0.003 for hypertonic step 1 x hypertonic step 2;  
o p=0.000 for isotonic step 1 x isotonic step 2. 
 
4.3 Root mean square (RMS) 
 
In order to capture possible differences in the EMG activity of the temporalis and 
masseter muscles between the hypertonic and isotonic saline blocks of infusion, two 
measures were utilized: Root Mean Square (RMS) activity from the intramuscular EMG 
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recordings for the 2 steps-levels jaw closing tasks and a single motor unit analysis for 
slow and fast ramps jaw closing tasks and the 2 step-levels jaw closing tasks. 
 
Among the 3 trials done for each task in each block of infusion, a repeated-measures 
ANOVA was done to determine the existence of any effect of repeating the jaw tasks 
on the RMS values of the EMG activity in each trial. 
 
Tables 4-23 and 4-24 show the results of the repetition analysis for the masseter and 
temporalis muscle EMG activities, respectively.  
 Masseter step 1 Masseter step 2 
Baseline P= 0.6 P= 0.39 
Hypertonic saline P= 0.36 P= 0.91 
Isotonic saline P= 0.67 P= 0.42 
Baseline 2 P= 0.53 P= 0.27 
Table 4-23: For the intramuscular activity of the right masseter muscle, no significant effect of repetitions 
was found for step 1 during baseline (p=0.6), hypertonic saline infusion (p=0.36), isotonic saline infusion 
(p=0.67), and baseline 2 (p=0.53); and for step 2 during baseline (p=0.39), hypertonic saline infusion 
(p=0.91), isotonic saline infusion (p=0.42), and baseline 2 (p=0.27). 
 
 Temporalis step 1 Temporalis step 2 
Baseline P= 0.45 P= 0.11 
Hypertonic P= 0.33 P= 0.42 
Isotonic P= 0.71 P= 0.3 
Baseline 2 P= 0.37 P= 0.42 
Table 4-24: For the intramuscular activity of right temporalis, no significant effect of repetitions was found 
for step 1 during baseline (p=0.45), hypertonic saline infusion (p=0.33), isotonic saline infusion (p=0.71), 
and baseline 2 (p=0.37); and for step 2 during baseline (p= 0.11), hypertonic saline infusion (p=0.42), 
isotonic saline infusion (p=0.3), and baseline 2 (p=0.42). 
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Because there was no significant effect (p > 0.05) of repeating the tasks on the activity 
of the right masseter or the activity of the right temporalis muscles from the 
intramuscular electrodes, it was possible to use the mean EMG activity of the 
repetitions for further analysis. Pairwise comparisons were used to determine the 
presence of an overall significant effect of the pain block (hypertonic saline infusion) 
compared to the other blocks. This was done for each muscle, at each of the step 
levels from the 2 step-levels jaw closing task. There was no significant (p>0.05) effect 
of the pain (hypertonic saline infusion block) found for the right masseter step 1 (p=0.4), 
right masseter step 2 (p=0.36), right temporalis step 1 (p= 0.21), or right temporalis 
step 2 (p= 0.16).  
 
Tables 4-25 and 4-26 show the RMS values of each muscle for each step level. Note 
that, although no effect of pain was significantly different, variability was found between 
participants. 
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Right masseter intramuscular electrode:  
ID 
right masseter intra step 1   right masseter intra step 2   
Base Hyper Iso Base 2 Base Hyper Iso Base 2 
1 0.17 0.34 0.26 0.16 0.21 0.19 0.20 0.20 
2 0.08 0.28 0.19 8.69 4.44 6.57 5.50 5.50 
3 0.80 0.89 1.34 1.15 1.25 1.20 1.22 1.22 
4 1.35 0.97 1.24 1.04 1.14 1.09 1.12 1.12 
5 0.36 0.80 0.74 0.62 0.68 0.65 0.67 0.67 
6 0.90 1.00 0.92 0.65 0.79 0.72 0.75 0.75 
7 1.52 1.38 2.00 1.93 1.97 1.95 1.96 1.96 
8 2.07 0.83 1.48 1.06 1.27 1.16 1.22 1.22 
9 0.32 0.69 0.66 1.12 0.89 1.01 0.95 0.95 
10 3.40 3.80 3.95 3.04 3.50 3.27 3.38 3.38 
11 0.48 0.57 0.59 0.24 0.41 0.33 0.37 0.37 
12 0.60 0.58 0.70 1.06 0.88 0.97 0.93 0.93 
13 0.84 0.13 0.25 0.31 0.28 0.30 0.29 0.29 
14 0.53 0.29 0.65 0.40 0.53 0.46 0.50 0.50 
15 0.30 0.32 0.32 0.27 0.29 0.28 0.29 0.29 
16 0.66 0.23 0.16 0.31 0.23 0.27 0.25 0.25 
17 0.68 1.29 1.08 1.20 1.14 1.17 1.15 1.15 
18 0.44 0.23 0.20 0.22 0.21 0.21 0.21 0.21 
19 0.30 0.31 0.36 0.30 0.33 0.32 0.32 0.32 
20 0.45 0.44 0.30 0.15 0.23 0.19 0.21 0.21 
Table 4-25: Means of the repetitions for the RMS intramuscular EMG activity for the right masseter 
for both step 1 and step 2 of the 2 step-levels jaw closing task and for the four blocks of tasks. ID: 
number of participant. Base = baseline block. Hyper = hypertonic block of infusion. Iso = Isotonic 
block of infusion. Base 2= Baseline 2. Highlighted: block with the increased RMS activity when a 
comparison is made between isotonic and hypertonic saline infusion blocks. 
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Right temporalis intramuscular electrode:  
ID 
right temporalis intra step 1   right temporalis intra step 2   
Base Hyper Iso Base 2 Base Hyper Iso Base 2 
1 0.77 0.81 0.83 0.63 0.73 0.68 0.70 0.55 
2 1.11 0.94 1.16 0.90 1.03 0.96 1.00 0.94 
3 1.19 4.57 1.93 2.28 2.10 2.19 2.15 2.24 
4 0.83 0.76 1.03 0.86 0.95 0.91 0.93 1.39 
5 0.26 0.45 0.42 0.71 0.57 0.64 0.60 1.21 
6 3.71 4.30 3.92 4.15 4.04 4.09 4.06 3.14 
7 0.62 1.11 1.03 0.37 0.70 0.54 0.62 0.19 
8 0.17 0.11 0.11 0.12 0.11 0.12 0.12 0.13 
9 0.87 0.17 0.22 0.23 0.22 0.23 0.22 0.23 
10 0.78 0.47 0.55 0.40 0.47 0.44 0.46 0.31 
11 1.67 1.67 1.89 1.31 1.60 1.46 1.53 0.35 
12 1.15 1.58 1.37 0.68 1.02 0.85 0.94 0.42 
13 0.61 0.48 0.73 0.62 0.68 0.65 0.67 0.75 
14 0.11 0.12 0.14 0.12 0.13 0.13 0.13 0.07 
15 0.30 0.42 0.39 0.33 0.36 0.34 0.35 0.21 
16 0.35 0.30 0.39 0.36 0.38 0.37 0.37 0.18 
17 0.72 1.22 0.91 0.94 0.93 0.94 0.93 0.14 
18 0.56 0.69 0.46 0.51 0.49 0.50 0.49 0.49 
19 0.15 0.18 0.21 0.17 0.19 0.18 0.18 0.08 
20 0.06 0.06 0.07 0.05 0.06 0.06 0.06 0.05 
Table 4-26: Means of the repetitions for the RMS intramuscular EMG activity for the right temporalis 
for both step 1 and step 2 of the 2 step-levels jaw closing task and for the four blocks of tasks. ID: 
number of participant. Base = baseline block. Hyper = hypertonic block of infusion. Iso = Isotonic 
block of infusion. Base 2= Baseline 2. Highlighted: increased RMS activity in comparison between 
isotonic and hypertonic saline. 
 
 
 
  
For the right masseter during step 1 of the 2 step-levels jaw closing task, 10 
participants (participant 1, 2, 5, 6, 9, 15, 16, 17, 18, 20) showed an increase in RMS 
activity which was consistent with VCT and 10 participants (participant 3, 4, 7, 8, 10, 
11, 12, 13, 14, 19) showed a decrease in RMS activity which was consistent with the 
PAM during hypertonic saline infusion in comparison with isotonic saline infusion. For 
the same comparison, at the right masseter during step 2 of the 2 step-levels jaw 
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closing task, 7 participants (participant 1, 2, 9, 12, 13, 16, 17) showed an increase in 
RMS activity which was consistent with VCT and 13 participants (participant 3, 4, 5, 6, 
7, 8, 10, 11, 14, 15, 18, 19, 20) showed a decrease in RMS activity which was 
consistent with the PAM. 
 
For the right temporalis, during step 1 of the 2 step-levels jaw closing task, 10 
participants (participant 3, 5, 6, 7, 8, 12, 15, 17, 18, 20) showed an increase in RMS 
activity which was consistent with VCT and 10 participants (participant 1, 2, 4, 9, 10, 
11, 13, 14, 16, 19) showed a decrease in RMS activity which was consistent with the 
PAM during hypertonic saline infusion in comparison with isotonic saline infusion. For 
the same comparison, at the right temporalis during step 2 of the 2 step-levels jaw 
closing task, 9 participants (participant 3, 5, 6, 9, 16, 17, 18, 19, 20) showed an 
increase in RMS activity which was consistent with VCT and 11 participants (participant 
1, 2, 4, 7, 8, 10, 11, 12, 13, 14, 15) showed a decrease in RMS activity which was 
consistent with the PAM. 
 
The overall means of the RMS EMG activity from the intramuscular recording from the 
right masseter muscle and right temporalis muscle across all participants during each 
step level during each recording session (baseline, hypertonic, isotonic, baseline 2) 
are shown in Figures 4-8 and 4-9. 
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Figure 4-8 The overall means of the root mean square (RMS) EMG activity from the right masseter (R 
Mass) across all participants during each step level (Step 1 and Step 2) during each recording session 
(baseline, hypertonic saline, isotonic saline, Baseline 2). 
 
Figure 4-9: The overall means of the root mean square (RMS) EMG activity from the right temporalis (R 
Temp) across all participants during each step level (Step 1 and Step 2) during each recording session 
(baseline, hypertonic, isotonic, Baseline 2). 
 
Interestingly, although no significant effect of the pain (hypertonic saline infusion block) 
between blocks, the means of the repetitions and the standard error were higher in the 
baseline 2 for the right masseter muscle step 1 and step 2, and higher for the 
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hypertonic block for the right temporalis muscle step 1 and step 2 as shown in the 
following tables (See in Tables 4-27, 4-28, 4-29, 4-30). 
 
RIGHT MASSETER STEP 1:   
Estimates 
Measure:   MEASURE_1   
blocks Mean Std. Error 
95% Confidence Interval 
Lower Bound Upper Bound 
1 Baseline .813 .174 .449 1.178 
2 Hypertonic .769 .179 .394 1.144 
3 Isotonic .871 .198 .458 1.285 
4 Baseline 2 1.196 .425 .306 2.086 
Table 4-27: The overall means of the root mean square (RMS) EMG activity from the right masseter 
across all participants during step 1.  
 
RIGHT MASSETER STEP 2: 
Estimates 
Measure:   MEASURE_1   
blocks Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Baseline .592 .109 .364 .821 
2 Hypertonic .530 .086 .350 .710 
3 Isotonic .563 .111 .331 .796 
4 Baseline 2 .972 .422 .089 1.855 
Table 4-28: The overall means of the root mean square (RMS) EMG activity from the right masseter 
across all participants during step 2. 
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RIGHT TEMPORALIS STEP 1: 
Estimates 
Measure:   MEASURE_1   
blocks Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Baseline .799 .180 .422 1.176 
2 Hypertonic 
1.020 .282 .430 1.610 
3 Isotonic 
.888 .202 .466 1.310 
4 Baseline 2 
.788 .210 .348 1.229 
Table 4-29: The overall means of the root mean square (RMS) EMG activity from the right temporalis 
across all participants during step 1. 
 
RIGHT TEMPORALIS STEP 2: 
Estimates 
Measure:   MEASURE_1   
blocks Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1 Baseline .616 .098 .410 .822 
2 Hypertonic .882 .235 .391 1.373 
3 Isotonic .612 .144 .311 .912 
4 Baseline 2 .653 .180 .276 1.030 
Table 4-30: The overall means of the root mean square (RMS) EMG activity from the right temporalis 
across all participants during step 2. 
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4.4 Single motor unit analyses:  
 
4.4.1 Muscles from which intramuscular recordings were made: 
 
Single motor units were recorded from two muscles in this study: right masseter and 
right temporalis. Table 4-31 shows the muscles from which intramuscular EMG 
recordings were able to be obtained from each participant. Single motor unit activity 
was able to be recorded from the temporalis muscle in 16 participants and from the 
masseter muscle in 17 participants. In the remaining participants, it was not possible 
to record an EMG signal from which SMUs could be discriminated in one or both 
muscles. This was because of technical issues that arose during the recording. 
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ID Masseter Temporalis 
1 Yes Yes 
2 No Yes 
3 Yes No 
4 No Yes 
5 Yes Yes 
6 Yes Yes 
7 Yes Yes 
8 Yes Lost 
9 Yes Lost 
10 Yes Yes 
11 Yes Yes 
12 Yes Yes 
13 Yes Yes 
14 Yes Yes 
15 No Yes 
16 Yes Yes 
17 Yes Yes 
18 Yes Yes 
19 Yes Yes 
20 Yes No 
Total:  17 16 
Table 4-31: Table of successful masseter and temporalis muscle intramuscular recordings, that is, 
whether good quality EMG activity (i.e. activity that allowed single motor unit discrimination) was 
recorded from the muscle or not. ID: number of the participant. No: No/poor quality EMG activity. Yes: 
EMG activity allowed single motor unit discrimination. Lost: signal was lost in the middle of the 
experiment so those EMG data for those participants were not considered. 
 
 
From the data of the 16 participants from which SMU recordings were obtained from 
the temporalis muscle, 83 SMUs were discriminated and they were classified in 
numeric order. From the data of the 17 participants from which SMU recordings were 
obtained from the masseter muscle, 58 SMUs were discriminated and they were also 
classified in numeric order. 
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4.4.2 Occurrence of single motor unit for right temporalis and right masseter muscle 
 
The main question of this study was whether the pain-induced reorganization of activity 
that has been previously demonstrated within one jaw muscle (right masseter) also 
occurs in other jaw muscles (right temporalis).  
 
Therefore, 83 units were discriminated from the temporalis muscle in one or more of 
the 4 blocks (baseline, hypertonic saline infusion, isotonic saline infusion and baseline 
2). Figure 4-10 shows a summary of the occurrences of these units.  
 
The analysis done involved the discrimination of SMUs in all blocks and a comparison 
between blocks of the following: SMU occurrence, threshold of onset of activity in 
SMUs, SMU firing rates, occurrence of SMU activity according to the Vicious Cycle 
Theory and The Pain Adaptation Model, and an analysis of the sequence of recruitment 
of SMUs.  
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Figure 4-10: Schematic figure to summarize the 83 single motor units characterized for the temporalis 
muscle in this study. 75 SMUs were present in at least one of the ramp tasks, and of these, 40 SMUs 
changed their occurrence (i.e. were absent in 1 or more blocks) and 35 did not change (i.e. were present 
in all blocks). From those 40 that changed, 16 changed in the same way (showed same pattern) for slow 
ramp and fast ramp and 24 did not change in the same way (changed in blocks and between slow ramp 
and fast ramp). 62 SMUs present in at least level 1 or level 2 of the 2 step-levels jaw closing task, in 
which 37 was present in step 1, where 15 units were present in all the blocks, 7 had a technical issue 
and 15 exhibited a de-recruitment in at least 1 of the blocks and 58 was present in step 2 (33 also 
present in step 1 + 25 new ones), where 32 units were present in all the blocks, 12 had a technical issue 
and 14 had a de-recruitment at some of the blocks. Unit = SMU; de-recruitment in a block: SMU not 
present for that block but was present for 1 or more of the other blocks; “changed” = either recruited in 
a block and not present in other blocks OR de-recruited in a block but was present in other blocks. 
“Same pattern” = the recruitment or de-recruitment within one (or more) block (s) happened in the same 
way for another task.   
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The EMG activity for the masseter muscle was also analysed for SMU occurrences but 
the data collected during the baseline 2 block were not analysed in this thesis. 
Therefore, from the masseter muscle, 58 units were discriminated from the 3 blocks 
(baseline, hypertonic saline infusion and isotonic saline infusion). Besides the 
occurrence, a comparison between blocks and analysis of occurrence of SMU activity 
according to the Vicious Cycle Theory and/or The Pain Adaptation Model was done. 
Figure 4-11 shows a summary of the occurrence of these units from the masseter 
muscle. 
 
Figure 4-11: Schematic figure to summarize the 58 single motor units characterized for the masseter 
muscle in this study. 50 SMU present in at least one of the ramps, in which 26 SMUs changed and 24 
did not change. From those 26 that changed, 10 changed in the same way (showed same pattern) for 
slow ramp and fast ramp and 16 did not change in the same way (changed in blocks and between slow 
ramp and fast ramp). 47 SMUs were present in at least one of the steps, in which 29 were present in 
step 1 (19 were present in all the blocks analysed and 10 had a de-recruitment for some of the blocks) 
35 Units present 
in step 2 (21 + 14 
new ones) 
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and 35 in step 2 (21 also present in step 1 + 14 new ones), where 30 units were present in all the blocks 
analysed and 5 had a de-recruitment at some of the blocks. Unit = SMU; de-recruitment in a block: SMU 
not present for that block but was present for 1 or more of the other blocks; “changed” = either recruited 
in a block and not present in other blocks OR de-recruited in a block but was present in other blocks. 
“same pattern” = the recruitment or de-recruitment within one (or more) block (s) happened in the same 
way for another task.   
 
4.4.3 Occurrence of single motor units in the right temporalis muscle: 
 
In total, 83 SMUs were discriminated from the temporalis muscle from 16 participants. 
Among those 83 SMUs, 75 SMUs were discriminated in at least one of the ramp jaw 
closing tasks, while 62 (54 also present in the ramps + 8 new SMUs) were 
discriminated for at least one step level (step 1 and/or step 2) of the 2 step-levels jaw 
closing task.  
 
There were 8 SMUs (4, 10, 34, 49, 50, 51, 69, 71) that were present exclusively for the 
2 step-levels jaw closing tasks, while 21 SMUs  (6, 14, 18, 22, 23, 24, 32, 33, 39, 47, 
48, 54, 58, 65, 66, 78, 79, 80, 81, 82, 83) were present in the ramp jaw closing tasks 
but were not present in the 2 step-levels jaw closing tasks. Units 33 and 44 were 
present in the fast ramp jaw closing task but not in the slow ramp jaw closing task and 
the units 9, 54, 58 and 70 were present in the slow ramp jaw closing task but not in the 
fast ramp jaw closing task.  
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For an easier understanding, the units presented for ramps jaw closing tasks (slow and 
fast) and the units presented for the 2 step-levels jaw closing task will be described 
separately in the next sections (section 4.4.3.1 and section 4.4.3.2 respectively). 
 
Figure 4-12: Summary of units (i.e. SMUs) in the tasks for the right temporalis muscle. Ramps = slow 
ramp and fast ramp jaw closing tasks; Steps = Step 1 of the 2 step-levels jaw closing task + Step 2 of 
the 2 step-levels jaw closing task. 
 
4.4.3.1 Occurrence of motor units in slow ramp and fast ramp tasks for the temporalis 
muscle:  
 
Table 4-32 lists the occurrences of the 75 SMUs in each recording block (baseline, 
hypertonic saline infusion block, isotonic saline infusion block, baseline 2) for the ramp 
tasks (slow and fast ramp jaw closing tasks) in the temporalis muscle. If a SMU was 
present in at least 2 of the 3 trials done or at least half of trials when more than 3 trials 
were done, then that SMU was marked as "+" (i.e. present). If not, that SMU was 
marked as "-" (i.e. not present).  
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  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS2 BS Hyper Iso  BS2  
1 
1 + + + + + + + + 
2 + + + + + + + + 
3 - + + + - + + + 
5 - + - - - + - - 
6 - + - - - + - - 
2 
7 + + + + + + + + 
8 + + + + + - + + 
9 - + - - - - - - 
4 
11 + + + + + + + + 
12 + + + + + + + + 
13 + + + + + + + + 
14 + + + + + + + + 
15 + + + + + + + + 
5 
16 + + + + + + + + 
17 + + + + + + + + 
18 + - + - + - + - 
19 + + + + + + + + 
20 + + + + + - + - 
21 - + + + - + + + 
22 - + + - - + + - 
6 
23 + + + + + + + + 
24 + - - - + - - - 
25 + - - + + - - - 
26 + + + + + + + + 
27 + + + + + - + + 
28 - + - + - + + + 
7 
29 + + + + + + + + 
30 + - + + + + + + 
31 + - - - + - - - 
10 
32 + - + + + - + + 
33 - - - - - - + - 
11 
35 + + + + + + + + 
36 + + + + + + + + 
37 + + + + + + + + 
38 + + + + + + + + 
39 + + + + + + + + 
12 
40 + + + + + + + + 
41 + + + + - + + + 
42 + + + + + + + + 
43 - + - - - + - - 
44 - - - - - + - - 
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  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS2 BS Hyper Iso  BS2  
13 
45 + + + + + + + + 
46 + + + + + + + + 
47 + + + + + + + + 
48 + + + + + + + + 
14 
52 + + TI TI + + + + 
53 - + TI TI + + + + 
54 - + TI TI - - - - 
15 
55 + + + + + + + + 
56 + + + - + + + + 
57 + + + - + + + - 
58 - + - - - - - - 
59 + + + - + + + - 
16 
60 + + + + + + + + 
61 + + + + - + + - 
62 + + - + + - - + 
63 + + + + + + + + 
64 - - + - + + + + 
17 
65 + - + - + - + - 
66 + + + + + - + - 
67 - + + + + + - - 
68 - + - + + + - + 
70 - + - - - - - - 
18 
72 + + + + + + + + 
73 + + + + + + + + 
74 + + + + + + + + 
75 + + + + + + + + 
19 
76 + + + + + + + + 
77 + + + + + + + + 
78 + + + + + + + + 
79 + + + - + - + - 
80 - + + + + + + + 
81 - + - + - + - + 
82 - + - + - + - + 
83 - + - + - + - + 
Table 4-32: All the SMUs (n=75) present in the slow ramp and fast ramp jaw closing tasks under each block. 
Highlighted are the units that were present in one speed of the slow or fast ramp jaw closing task but which 
were not present in the other. TI = technical issue in the recording. BS: baseline; hyper: hypertonic saline 
infusion block; iso: isotonic saline infusion block; BS2: baseline 2.  
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Among the 75 units present for the ramp jaw closing tasks, 35 SMUs did not change 
their pattern of occurrence, which means all 35 SMUs were present in both fast and 
slow ramp jaw closing tasks for all the blocks. Table 4-33 shows those 35 SMUs that 
were present in all the tasks for the 4 blocks. 
 
In addition, 3 participants (Participant 4, 11 and 18) showed no change in the pattern 
of recruitment of all the units discriminated from the temporalis muscle in each of those 
participants. Therefore, these participants presented the same units (SMUs 11, 12, 13, 
14, 15 – for participant 4; SMUs 35, 36, 37, 38, 39 for participant 11; and SMUs 72, 
73, 74, 75 for participant 18) for both tasks (slow ramp and fast ramp jaw closing tasks) 
during the four blocks (baseline, hypertonic saline infusion, isotonic saline infusion, 
baseline 2; see Table 4-33 - highlighted in grey). 
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  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS 2 BS Hyper Iso  BS 2 
1 
1 + + + + + + + + 
2 + + + + + + + + 
2 7 + + + + + + + + 
4 
11 + + + + + + + + 
12 + + + + + + + + 
13 + + + + + + + + 
14 + + + + + + + + 
15 + + + + + + + + 
5 
16 + + + + + + + + 
17 + + + + + + + + 
19 + + + + + + + + 
6 
23 + + + + + + + + 
26 + + + + + + + + 
7 29 + + + + + + + + 
11 
35 + + + + + + + + 
36 + + + + + + + + 
37 + + + + + + + + 
38 + + + + + + + + 
39 + + + + + + + + 
12 
40 + + + + + + + + 
42 + + + + + + + + 
13 
45 + + + + + + + + 
46 + + + + + + + + 
47 + + + + + + + + 
48 + + + + + + + + 
15 55 + + + + + + + + 
16 
60 + + + + + + + + 
63 + + + + + + + + 
18 
72 + + + + + + + + 
73 + + + + + + + + 
74 + + + + + + + + 
75 + + + + + + + + 
19 
76 + + + + + + + + 
77 + + + + + + + + 
78 + + + + + + + + 
Table 4-33: SMUs (n=35) that were present in all the tasks for the 4 blocks. In grey, participants who 
had no change in the pattern of occurrence for all the units discriminated from each of those participants. 
BS: baseline; hyper: hypertonic saline infusion block; iso: isotonic saline infusion block; BS2: baseline 
2. 
170 
 
Of the 75 SMUs, 40 exhibited some change in the pattern of SMU occurrence between 
the blocks, and of these 40 SMUs, 16 showed the same pattern for slow ramp and fast 
ramp (n=16) and 24 exhibited some change in the pattern of SMU occurrence between 
the blocks and between the slow and fast ramp jaw closing tasks (n=24) - See Tables 
4-34 and 4-35.  
 
From those 40 SMUs, 16 units (3, 5, 6, 18, 21, 22, 24, 31, 32, 43, 57, 59, 65, 82, 83, 
84) showed the same pattern of occurrence for slow and fast ramp jaw closing tasks, 
and the change in occurrence was only due to the block (yellow highlighted SMUs in 
Table 4-34). The remaining 24 units (8, 9, 20, 25, 27, 28, 30, 33, 41, 44, 52, 53, 54, 
56, 58, 61, 62, 64, 66, 67, 68, 70, 79, 80) had different patterns of occurrence for the 
different tasks as well as changes in occurrence between the blocks. Two units (33 
and 44) were found in the slow ramp jaw closing task, but not in the fast ramp jaw 
closing task, while 4 units (9, 54, 58 and 70) were found in the fast ramp jaw closing 
task but not in the slow ramp jaw closing task. 
 
For participant 14, it was possible to discriminate 3 units (52, 53, and 54). However, 
due to technical issues (noisy signal), the data from the slow ramp jaw closing tasks 
for the block of Isotonic saline infusion and baseline 2 were lost. These units are still 
mentioned in this thesis as unit 54 was present in hypertonic saline infusion slow ramp 
jaw closing task but not hypertonic saline infusion fast ramp jaw closing task, while unit 
52 was present in all the other tasks and unit 53 was not present in baseline slow ramp 
jaw closing task but it was present in baseline fast ramp jaw closing task. 
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  Slow ramp Fast Ramp 
Participan
t 
SM
U BS 
Hype
r Iso  BS 2 BS Hyper Iso  BS 2 
1 
3 - + + + - + + + 
5 - + - - - + - - 
6 - + - - - + - - 
2 
8 + + + + + - + + 
9 - + - - - - - - 
5 
18 + - + - + - + - 
20 + + + + + - + - 
21 - + + + - + + + 
22 - + + - - + + - 
6 
24 + - - - + - - - 
25 + - - + + - - - 
27 + + + + + - + + 
28 - + - + - + + + 
7 
30 + - + + + + + + 
31 + - - - + - - - 
10 
32 + - + + + - + + 
33 - - - - - - + - 
 
12 
 
41 + + + + - + + + 
43 - + - - - + - - 
44 - - - - - + - - 
14 
52 + + TI TI + + + + 
53 - + TI TI + + + + 
54 - + TI TI - - - - 
15 
56 + + + - + + + + 
57 + + + - + + + - 
58 - + - - - - - - 
59 + + + - + + + - 
16 
61 + + + + - + + - 
62 + + - + + - - + 
64 - - + - + + + + 
17 
65 + - + - + - + - 
66 + + + + + - + - 
67 - + + + + + - - 
68 - + - + + + - + 
70 - + - - - - - - 
19 
79 + + + - + - + - 
80 - + + + + + + + 
81 - + - + - + - + 
82 - + - + - + - + 
83 - + - + - + - + Table 4-34: Shows only those SMUs (n=40) that exhibited some change in the pattern of occurrence 
between blocks (n=16; yellow highlighted SMUs), or between the blocks and between the slow and fast 
ramp jaw closing tasks (n=24). TI = technical issue in the recording. BS: baseline; hyper: hypertonic saline 
infusion block; iso: isotonic saline infusion block; BS2: baseline 2. 
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    Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS 2 BS Hyper Iso  BS 2 
1 
3 - + + + - + + + 
5 - + - - - + - - 
6 - + - - - + - - 
5 
18 + - + - + - + - 
21 - + + + - + + + 
22 - + + - - + + - 
6 24 + - - - + - - - 
7 31 + - - - + - - - 
10 32 + - + + + - + + 
12 43 - + - - - + - - 
15  
57 + + + - + + + - 
59 + + + - + + + - 
17 65 + - + - + - + - 
19  
81 - + - + - + - + 
82 - + - + - + - + 
83 - + - + - + - + 
Table 4-35: Shows only those units (n=16) that did not exhibit a change in the pattern of occurrence 
across all 4 blocks when compared between the slow ramp and fast ramp jaw closing tasks. BS: 
baseline; hyper: hypertonic saline infusion block; iso: isotonic saline infusion block; BS2: baseline 2. 
 
According to Table 4-35, it is possible to notice that some units were present or were 
not present within the hypertonic saline infusion block. Units 5, 6 and 43, for example 
were present only during the hypertonic saline infusion block for slow and fast ramp 
jaw closing tasks. Units 81, 82 and 83 were present for the slow and fast ramp jaw 
closing tasks during hypertonic saline infusion and baseline 2 blocks. 
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Units 18, 32, 65 were not present in the hypertonic saline infusion block; unit 32 was 
present in all the other blocks, and units 18 and 65 were present in all the other blocks 
but not for baseline 2. 
 
Units 3, 21 and 22 were not present in the baseline, but were at least present in all the 
other saline infusion blocks.  
 
Unit 24 and 31 were present only in baseline, but were not present after the injection 
of the first solution (isotonic and hypertonic consequently) and remained not present 
for the other blocks.  
 
And lastly, units 57 and 59 were present in all the blocks but were not present in the 
baseline 2.   
 
For all the other participants (Participant 2, 5, 6, 7, 10, 12, 14, 15, 16, 17, 19), it was 
possible to note some change in the pattern of occurrence of units not only within a 
block, but also with different patterns between slow ramp and fast ramp (n=24; Table 
4-36). The solution applied first on these participants is also showed in this table. 
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    Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS 2 BS Hyper Iso  BS 2 
2 (I) 
8 + + + + + - + + 
9 - + - - - - - - 
5 (H) 20 + + + + + - + - 
6 (I) 
25 + - - + + - - - 
27 + + + + + - + + 
28 - + - + - + + + 
7 (H) 30 + - + + + + + + 
10 (I) 33 - - - - - - + - 
12 (I) 
41 + + + + - + + + 
44 - - - - - + - - 
14 (I) 
52 + + TI TI + + + + 
53 - + TI TI + + + + 
54 - + TI TI - - - - 
15 (H) 
56 + + + - + + + + 
58 - + - - - - - - 
16 (H) 
61 + + + + - + + - 
62 + + - + + - - + 
64 - - + - + + + + 
17 (I) 
66 + + + + + - + - 
67 - + + + + + - - 
68 - + - + + + - + 
70 - + - - - - - - 
19 (I) 
79 + + + - + - + - 
80 - + + + + + + + 
Table 4-36: Shows only those units (n=24) that exhibited a change in the pattern of occurrence between 
slow ramp and fast ramp. Letter in brackets indicates the solution applied first for that participant and is 
noted after the participant’s number as (H) for hypertonic saline being applied first and (I) when the 
isotonic solution was applied first. TI = technical issue in the recording. BS: baseline; hyper: hypertonic 
saline infusion block; iso: isotonic saline infusion block; BS2: baseline 2. 
 
Units 9, 58 and 70 were present only during hypertonic saline infusion slow ramp jaw 
closing tasks but were not present in any of the blocks for the fast ramp jaw closing 
tasks. Unit 44, on the other hand, was present only for the hypertonic saline infusion 
fast ramp jaw closing task but not in any of the other ramp jaw closing tasks. 
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Unit 30 was not present during hypertonic saline infusion slow ramp jaw closing task 
but was present for other blocks and tasks, and unit 79 was not present in the 
hypertonic saline infusion fast ramp jaw closing task but was for the hypertonic saline 
infusion slow ramp jaw closing task. 
 
Figure 4-13 summarizes schematically the 75 SMUs discriminated for the ramps jaw 
closing tasks in this study. 
 
 
Figure 4-13: Schematic figure to summarize the 75 SMUs discriminated for the ramps tasks in the right 
temporalis muscle in this study and changes in SMU occurrences or not in the blocks. Unit = SMU.  
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4.4.3.2 Occurrence of motor units in steps for temporalis muscle: 
 
The 62 motor units present in the 2 step-levels jaw closing tasks are described in Table 
4-37. Of the 62 SMUs, 54 were also present in one or more of the ramp jaw closing 
tasks and the remaining 8 were new SMUs that were only present in the 2 step-levels 
jaw closing task. 
 
  Step 1  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Step 2 
Participant SMU BS Hyper Iso  BS 2 BS Hyper Iso  BS 2 
1 
1 + + + + + + + + 
2 + + + + + + + + 
3 + - + - + - + + 
4 - - - - + - + - 
5 - + - - - + - + 
2 
7 + + + TI + + + TI 
8 - - - TI + + + TI 
9 + + + TI + + + TI 
10 - - - TI + + + TI 
4 
11 + + + TI + + + TI 
12 + + + TI + + + TI 
13 + + + TI + + + TI 
15 + + + TI + + + TI 
5 
16 + + + + + + + + 
17 - - - - + + + + 
19 - - - - + + + + 
20 - - - - + + + + 
21 - - - - + + + + 
6 
25 - - - - + + + + 
26 + + + + + + + + 
27 - - + + + + + + 
28 - - - - + + + + 
7 
29 + + + + + + + + 
30 + + + - + + + + 
31 - - - - - + + - 
10 34 - - - - + + + + 
 
11 
35 + + + + + ? ? + 
36 + + + - + + + + 
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  Step 1   
  
  
  
  
  
  
  
  
  
  
  
Step 2 
 SMU BS Hyper Iso  BS 2 BS Hyper Iso  BS 2 
11 
37 - - - - + + + + 
38 - - - - + + + - 
12 
40 + + + + + + + + 
41 - + - - + + + + 
42 + + + - + + + + 
43 - + - - - + - - 
44 - + - - - + - - 
13 
45 + + + + ? ? ? ? 
46 + + + + ? ? ? ? 
49 + + + + ? ? ? ? 
50 - - - - + - - - 
51 - - - - - + + + 
14 
52 - - - - + + + + 
53 - - - - + + + + 
15 
55 + + + TI + + + TI 
56 - - - TI + + + TI 
57 - - - TI + + + TI 
59 - - - TI + + + TI 
16 
60 + + + + + + + + 
61 - - - + - + - + 
62 + - - - + + + + 
63 + - + - + + + + 
64 - - - - + - + + 
17 
67 - - - - - + - - 
68 + + - - + + + + 
69 + + - - + + + + 
70 - - - - + - + + 
71 - - - - - + - + 
18 
72 + + + + + + + + 
73 + + + + + + + + 
74 + + + + + + + + 
75 + + + + + + + + 
19 
76 + - + - + + + + 
77 - - - - + + + + 
Table 4-37: Motor units (n=62) discriminated in 2 step-levels jaw closing tasks. In grey, all the motor 
units that were exclusively found for steps tasks and were not present in the ramp tasks. TI: technical 
issue. ? = when it was not possible to confirm the presence or absence of the unit for that task. BS: 
baseline; hyper: hypertonic saline infusion block; iso: isotonic saline infusion block; BS2: baseline 2. 
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From the 62 units described in Table 4-37, 37 units were discriminated for the step 1 
and 58 units were discriminated for the step 2; these 58 were made up of 33 present 
for step 1 plus an additional 25 newly recruited SMUs. Due to the greater force and 
higher level of EMG activity for step 2, it was not possible to confirm precisely if 4 small 
units (35, 45, 46, and 49) were present or absent. For those cases, a question mark is 
used in the table.  
 
For the step 1 of the 2 step-levels jaw closing task, from the 37 units discriminated, 15 
units ( unit 1, 2, 16, 26, 29, 35, 40, 45, 46, 49, 60, 72, 73, 74, 75) were present in all 
the four blocks, 15 units (unit 3, 5, 27, 30, 36, 41, 42, 43, 44, 61, 62, 63, 68, 69, 76) 
were not present in some of the blocks and for 7 units (unit 7, 9, 11, 12, 13, 15, 55) it 
was not possible to confirm if they were present in all of the blocks due to a technical 
issue (see Methods).  
 
For the step 2 of the 2 step-levels jaw closing task, from the 58 units discriminated, 32 
units (unit 1, 2, 16, 17, 19, 20, 21, 25, 26, 27, 28, 29, 30, 34, 36, 37, 40, 41, 42, 52, 53, 
60, 62, 63, 68, 69, 72, 73, 74, 75, 76, 77) were present in all of the four blocks, while 
14 units (unit 3, 4, 5, 31, 38, 43, 44, 50, 51, 61, 64, 67, 70, 71) were not present in 
some of the blocks. For 12 units (unit 7, 8, 9, 10, 11, 12, 13, 15, 55, 56, 57, 59) it was 
not possible to confirm if they were present in all of the blocks due to a technical issue 
(see Methods) or due to these units being obscured by the increased EMG activity 
accompanying the greater force on the level 2 – See figure -4-15.  
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Figure 4-14: Example of temporalis EMG activity recorded during the 2 step-levels jaw closing task. 
Note that the small units become obscured by the increased EMG activity accompanying the greater 
force at the level 2, and therefore they can be difficult or impossible to discriminate. 
 
Figure 4-15 summarizes the 62 SMUs discriminated for the 2 step-levels jaw closing 
tasks in the right temporalis muscle in this study. 
0.5 s 
500 mv  
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Figure 4-16: Schematic figure to summarize the 62 SMUs discriminated for the 2 step-levels jaw closing 
tasks in the right temporalis muscle in this study. Unit = SMU. 
 
4.4.3.3 Comparisons between blocks: 
 
For each of the slow ramp and fast ramp jaw closing tasks, and step 1 and step 2 of 
the 2 steps-levels jaw closing task, the hypertonic saline infusion block (H) was 
compared with each of the other blocks - baseline (B), Isotonic saline infusion (I) and 
Baseline 2 (BS 2) - in terms of the number of units during the hypertonic saline infusion 
block of tasks that  
 Exhibited no change in the pattern of occurrence between the 2 blocks,  
 Became present in the hypertonic saline infusion block (i.e. was recruited), or  
 Was not present (i.e. was de-recruited) during the hypertonic saline infusion 
block.  
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These analyses are shown for the baseline vs. hypertonic saline block in Table 4-38, 
the isotonic saline vs. hypertonic saline block in Table 4-39 and the baseline 2 vs. 
hypertonic saline block in Table 4-40. 
 
 B x H SR B x H FR B x H step 1 B x H step 2 
No change 48/73 
(65.8%) 
46/71 
(64.8%) 
29/37 
(78.4%) 
45/58 
(77.6%) 
Recruited  18/73 
(24.6%) 
13/71 
(18.3%) 
4/37 (10.8%) 8/58 (13.8%) 
De-recruited 7/73 (9.6%) 12/71 
(16.9%) 
4/37 (10.8%) 5/58 (8.6%) 
Table 4-38: Describes the comparison between the hypertonic saline infusion block with the baseline 
block for slow ramp, fast ramp, step 1 and step 2 of the 2-steps levels jaw closing tasks. For the slow 
ramp tasks, 65.8% of the units did not change, 64.8% of the units did not change for the fast ramp, and 
78.4% and 77.6% of the units did not change for step 1 and step 2 respectively. Recruited = SMU 
became present in the hypertonic saline infusion block; de-recruited = SMU was not present during the 
hypertonic saline infusion block but was present in baseline. 
 
 
 I x H SR I x H FR I x H step 1 I x H step 2 
No change 53/70 
(75.7%) 
53/71 
(74.6%) 
27/37 (73%)  48/58 
(82.8%) 
Recruited  12/70 
(17.1%) 
9/71 (12.7%) 6/37 (16.2%) 6/58 (10.3%) 
De-recruited 5/70 (7.2%) 9/71 (12.7%) 4/37 (10.8%) 4/58 (6.9%) 
Table 4-39: Describes the comparison between the hypertonic saline infusion block with the isotonic 
saline infusion block for slow ramp, fast ramp, step 1 and step 2 jaw closing tasks. For the slow ramp 
tasks, 75.7% of the units did not change, 74.6% of the units did not change for the fast ramp, and 73% 
and 82.8% of the units did not change for step 1 and step 2 respectively. Recruited = SMU became 
present in the hypertonic saline infusion block; de-recruited = SMU was not present during the hypertonic 
saline infusion block 
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 BS 2 x H SR BS 2  x H FR BS2 x H step 1 BS2 x H step 
2 
No change 56/70 (80%) 58/71(81.7%) 19/30 (63.3%) 38/46 
(82.6%) 
Recruited  11/70 
(15.7%) 
9/71 (12.7%) 9/30 (30%) 5/46 (10.8%) 
De-recruited 3/70 (4.3%) 4/71 (5.6%) 2/30 (6.7%) 3/46 (6.5%) 
Table 4-40: Describes the comparison between the hypertonic block with the baseline 2 block for slow 
ramp, fast ramp, step 1 and step 2 jaw closing tasks. A few units were excluded from step tasks due to 
technical issues. For the slow ramp tasks, 80% of the units did not change, 81.7% of the units did not 
change for the fast ramp, and 63.3% and 82.6% of the units did not change for step 1 and step 2 
respectively. Recruited = SMU became present in the hypertonic saline infusion block; de-recruited = 
SMU was not present during the hypertonic saline infusion block 
 
Figure 4-17 shows an example of the recruitment of SMUs during the hypertonic saline 
infusion block.  
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Figure 4-17: Shows the recruitment of a new unit. A: Slow ramp jaw closing task during isotonic saline 
block and showing the recruitment of 2 SMUs. B: Slow ramp jaw closing task during hypertonic saline 
A 
B 
0.5 s 
500 mv  
0.5 s 
500 mv  
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block and showing the recruitment of 3 SMUs. New SMU in yellow recruited in the hypertonic saline 
block but was not present in the isotonic saline block. X-axis: time in seconds (Sec). Y-axis: force 
transducer output in volts (V). 
 
4.4.3.4 Temporalis SMU activity and the vicious cycle theory and the pain adaptation 
model  
 
An analysis was performed to determine whether the change in the pattern of 
occurrence of SMUs recorded in the temporalis muscle could be explained on the basis 
of the principles outlined for the Vicious Cycle Theory or the Pain Adaptation Model. 
This analysis is summarized in Table 4-41 and was performed only for the comparison 
between the isotonic saline block and the hypertonic saline block.  
 
If the SMU was recruited during the hypertonic saline infusion block but was inactive 
(i.e. not present) in the isotonic saline infusion block, then the pattern of occurrence of 
the SMU was considered to be consistent with the Vicious Cycle Theory as the pain, 
according to this theory, would cause “muscle hyperactivity”. On the other hand, if the 
SMU becomes inactive (i.e. not present) during the hypertonic saline infusion block in 
comparison with the isotonic saline infusion block, this pattern of occurrence was 
considered to be consistent with the Pain Adaptation Model which proposes decreased 
agonist muscle activity in pain so as to result in slower and smaller movements to 
prevent further injury and help healing.  
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This analysis, however, only considered the presence or absence or the unit and did 
not consider the possible effect of the pain on the firing rates of those units that were 
present in the hypertonic saline infusion block as well as the isotonic saline infusion 
block.  
 
  Slow ramp Fast Ramp Step 1 Step 2 
Participant SMU VCT PAM VCT PAM VCT PAM VCT PAM 
1 
1             
2             
3         X  X 
4 - - - - - -  X 
5 X   X  X   X  
6 X   X  - - - - 
2 
7           
8      X - -   
9 X   - -     
10 - - - - - -   
4 
11           
12           
13           
14       - - - - 
15           
5 
16           
17       - -   
18   X  X - - - - 
19       - -   
20      X - -   
21       - -   
22       - - - - 
6 
23       - - - - 
24       - - - - 
25       - -   
26             
27      X   X   
28 X     - -   
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  Slow ramp Fast Ramp Step 1 Step 2 
Participant SMU VCT PAM VCT PAM VCT PAM VCT PAM 
7 
29             
30   X         
31       - -   
10 
32   X  X - - - - 
33  - -   X - - - - 
34  - -  - - - -   
11 
35           - - 
36             
37       - -   
38       - -   
39       - - - - 
12 
40             
41       X     
42             
43 X   X  X   X  
44 -  -  X  X   X  
13 
45           - - 
46           - - 
47       - - - - 
48       - - - - 
49  -  - - -     - - 
50  - -  - - - -   
51  - -  - - - -   
14 
52 LOST   - -   
53 LOST   - -   
54 LOST - - - - - - 
15 
55             
56       - -   
57       - -   
58 X   - - - - - - 
59       - -   
16 
60             
61           X  
62 X           
63         X   
64   X   - -  X 
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  Slow ramp Fast Ramp Step 1 Step 2 
Participant SMU VCT PAM VCT PAM VCT PAM VCT PAM 
17 
65   X  X - - - - 
66      X - - - - 
67     X  - - X  
68 X   X  X     
69  - -  - - X     
70 X   - - - -  X 
71 -  -  - - - - X  
18 
72             
73             
74             
75             
19 
76         X   
77       - -   
78       - - - - 
79      X - - - - 
80       - - - - 
81 X   X  - - - - 
82 X   X  - - - - 
83 X   X  - - - - 
total  12 5 9 9 6 4 6 4 
Table 4-41: Shows the 83 units discriminated from the temporalis muscle in this study. One “x” was 
marked when the pattern of recruitment of a certain unit was supportive of one of the models (VCT or 
PAM), the sign “-“ was used when the unit was not present for that specific block, and nothing was 
marked when the unit was present but its occurrence did not support either of those models. Note that 
the majority of the units were neither consistent with the Vicious Cycle Theory nor the Pain Adaptation 
Model. 
 
According to Table 4-41, it is possible to notice that 12 units supported the Vicious 
Cycle Theory for the slow ramp jaw closing tasks, 9 units for the fast ramp jaw closing 
tasks and 6 units for each of step 1 and step 2 of the 2 step-levels jaw closing tasks. 
On the other hand, 5 units supported the Pain Adaptation model on the slow ramp jaw 
closing tasks, 9 units for the fast ramp jaw closing tasks, and lastly 4 units supported 
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the Pain Adaptation Model for each of step 1 and 2 of the 2 step-levels jaw closing 
task.  
 
A further analysis was done separately according to the type of task and the number 
of SMUs recorded per participant, and whether the patterns of recruitments and de-
recruitments of all SMUs recorded at a site supported the Vicious Cycle Theory, the 
Pain Adaptation Model or neither of those models. This analysis is shown in Tables 4-
42, 4-43, 4-44, 4-45.  
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From the 70 SMUs studied in the slow ramp jaw closing task (table 4-42), 80% (n=56) 
of the units did not support either the Vicious Cycle Theory nor the Pain Adaptation 
Model, and only 17.1% (n=12) supported the proposals of the VCT and 7.1% (n=5) 
supported the proposals of the PAM. 
 
Slow ramp: (Units n= 70) 
 
Participant 
Number 
of Units VCT PAM Neither 
1 5 2/5  3/5 
2 3 1/3  2/3 
4 5   5/5 
5 7  1/7 6/7 
6 6 1/6  5/6 
7 3  1/3 2/3 
10 1  1/1 1/1 
11 5   5/5 
12 4 1/4  3/4 
13 4   4/4 
14  TI TI TI 
15 5 1/5  4/5 
16 5 1/5 1/5 3/5 
17 5 2/5 1/5 2/5 
18 4   4/4 
19 8 3/8  5/8 
Total  70 12 5 56 
Table 4-42: Units present for the slow ramp task and consistency or not with the Vicious Cycle Theory 
(VCT) and the Pain Adaptation Model (PAM). From the 70 units presented for this test, 80% (n= 56) of 
the units exhibited a pattern of occurrence that did not support either the Vicious Cycle Theory nor the 
Pain Adaptation Model, and only 17.1% (n=12) supported the proposals of the VCT and 7.1% (n=5) 
supported the proposals of the PAM.  
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From the 71 units studied during the fast ramp jaw closing task (Table 4-43), 75.7% 
(n= 53) of the units did not support either of the Vicious Cycle Theory nor the Pain 
Adaptation Model, and only 12.8% (n=9) supported the proposals of the VCT and 
12.8% (n=9) supported the proposals of the PAM. 
 
Fast ramp: (Units n= 71) 
 
Participant 
Number 
of Units VCT PAM Neither 
1 5 2/5  3/5 
2 2  1/2 1/2 
4 5   5/5 
5 7  2/7 5/7 
6 6  1/6 5/6 
7 3   3/3 
10 2  2/2 0/2 
11 5   5/5 
12 5 2/5  3/5 
13 4   4/4 
14 2   2/2 
15 4   4/4 
16 5   5/5 
17 4 2/4 2/4 0/4 
18 4   4/4 
19 8 3/8 1/8 4/8 
Total  71 9 9 53 
Table 4-43: Units presents for the fast ramp task and consistency or not with the Vicious Cycle Theory 
(VCT) and the Pain Adaptation Model (PAM). From the 71 units presents for this test, 75.7% (n= 53) of 
the units exhibited a pattern of occurrence that did not support either of the Vicious Cycle Theory nor 
the Pain Adaptation Model, and only 12.8% (n=9) supported the proposals of the VCT and 12.8% (n=9) 
supported the proposals of the PAM. 
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From the 37 units present for the step 1 of the 2 step-levels jaw closing task (Table 4-
44), 73% (n=27) of the units did not support either of the Vicious Cycle Theory nor the 
Pain Adaptation Model, and only 16.2% (n=6) supported the proposals of the VCT and 
10.8% (n=4) supported the proposals of the PAM. 
 
Step 1: (Units n = 37) 
 
Participant 
Number 
of Units VCT PAM Neither 
1 4 1/4 1/4 2/4 
2 2   2/2 
4 4   4/4 
5 1   1/1 
6 2  1/2 1/2 
7 2   2/2 
10 0   0/0 
11 2   2/2 
12 5 3/5  2/5 
13 3   3/3 
14 0   0/0 
15 1   1/1 
16 4  1/4 3/4 
17 2 2/2  0/2 
18 4   4/4 
19 1  1/1 0/1 
Total 37 6 4 27 
Table 4-44: Units presents for the step 1 of the 2 step-levels jaw closing task and consistency or not 
with the Vicious Cycle Theory (VCT) and the Pain Adaptation Model (PAM). From the 37 units presents 
for this test, 73% (n= 27) of the units exhibited a pattern of occurrence that did not support either of the 
Vicious Cycle Theory nor the Pain Adaptation Model, and only 16.2% (n=6) supported the proposals of 
the VCT and 10.8% (n=4) supported the proposals of the PAM. 
 
From the 58 units present for step 2 of the 2 step-levels jaw closing task (Table 4-45), 
82.8% (n= 48) of the units did not support either of the Vicious Cycle Theory nor the 
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Pain Adaptation Model, and only 10.3% (n=6) supported the proposals of the VCT and 
6.9% (n=4) supported the proposals of the PAM. 
 
Step 2: (Units n= 58) 
 
Participant 
Number 
of Units VCT PAM Neither 
1 5 1/5 2/5 2/5 
2 4   4/4 
4 4   4/4 
5 5   5/5 
6 4   4/4 
7 3   3/3 
10 1   1/1 
11 3   3/3 
12 5 2/5  3/5 
13 2   2/2 
14 2   2/2 
15 4   4/4 
16 5 1/5 1/5 3/5 
17 5 2/5 1/5 2/5 
18 4   4/4 
19 2   2/2 
Total 58 6 4 48 
Table 4-45: Units presents for the step 2 of the 2 step-levels jaw closing task and consistency or not 
with the Vicious Cycle Theory (VCT) and the Pain Adaptation Model (PAM). From the 58 units presents 
for this test, 82.8% (n=48) of the units exhibited a pattern of occurrence that did not support either of the 
Vicious Cycle Theory nor the Pain Adaptation Model, and only 10.3% (n=6) supported the proposals of 
the VCT and 6.9% (n=4) supported the proposals of the PAM.  
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4.4.3.5 Threshold analysis of temporalis SMU activity 
 
A repeated measures analysis of variance (ANOVA) of all discriminated SMU threshold 
values for each jaw task across baseline, hypertonic saline and isotonic saline infusion 
blocks was performed to determine the main effect of repeating the jaw task and also 
if there was any effect of the infusing saline into the masseter muscle.  
 
The results showed no significant effect on the threshold values of repeating the task 
during the baseline (p=0.89) and isotonic saline infusion (p=0.52) of the slow ramp jaw 
closing task, but showed a significant difference on repetitions for the hypertonic saline 
infusion block (p=0.7). For the fast ramp jaw closing task, no significant difference was 
found during the hypertonic saline block (p=0.65) but significant differences between 
repetitions was found during the baseline block (p=0.006) and the isotonic saline block 
(p=0.016). 
 
The overall mean of the thresholds for all the SMUs was calculated with multiple 
comparisons with Bonferroni corrections for each block in order to determine if there 
was an effect of block on SMU threshold for the slow ramp and fast ramp jaw closing 
tasks and no significant difference was found for either of the tasks (p>0.05). 
  
Of the 75 SMUs studied in the slow ramp and fast ramp jaw closing tasks (see Figure 
4-18, 4-19), a total of 37 SMUs were able to be assessed for threshold analysis. 
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Figure 4-18: Mean and SD (N) for threshold of onset of SMU activity in the slow ramp jaw closing task. 
 
For the slow ramp task it is possible to notice that the hypertonic threshold overall 
mean was lower compared with the other blocks, however, the main effect of session 
(baseline, hypertonic infusion, isotonic infusion) was not statistically significant 
(p>0.05) across all threshold values for the slow ramp tasks. 
 
A further analysis was done for each unit individually in order to determine if, even with 
no change in the overall activity, some units would possibly show an effect on their 
individual threshold values. This individual SMU analysis is shown in Table 4-46. 
  
0.0
10.0
20.0
30.0
40.0
Slow ramp mean
Slow ramp
Slow ramp
SD
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SMU Baseline Hypertonic Isotonic B SD H SD I SD 
11 22.0 24.6 23.1 0 7.1 3.4 
12 29.5 27.0 23.5 5.6 6.0 0.8 
13 46.8 49.4 39.6 5.6 1.3 5.4 
14 28.5 24.8 22.3 7.3 6.7 1.7 
15 40.1 35.2 29.0 4.1 8.7 4.7 
16 20.0 24.7 28.1 3.0 5.5 7.8 
17 45.2 43.0 50.5 1.7 2.8 1.9 
18 44.0 51.7 58.4 2.8 3.3 1.0 
19 49.4 42.7 48.8 2.2 1.9 5.6 
20 53.7 51.6 57.6 1.0 1.3 3.7 
23 46.0 18.4 20.4 7.5 8.0 3.3 
26 57.3 44.1 41.8 6.0 4.7 1.7 
27 54.4 50.0 46.6 6.4 0.1 7.6 
29 12.5 22.8 26.5 1.1 10.1 8.3 
35 2.4 2.8 1.4 0.3 0.9 0.2 
36 12.6 13.1 7.7 4.9 6.6 7.2 
37 36.0 33.8 27.3 5.6 4.6 2.9 
38 33.1 35.1 30.6 4.0 5.2 3.2 
39 23.9 26.6 26.9 2.0 2.7 2.3 
40 38.2 19.1 33.9 6.1 0.7 6.1 
41 38.7 26.1 39.4 5.1 1.7 4.6 
42 33.3 17.1 29.4 5.1 2.2 2.9 
45 24.4 25.6 30.0 5.9 0.3 3.5 
46 27.8 30.4 34.3 4.7 4.9 5.7 
47 30.0 33.1 29.7 4.7 2.8 2.2 
48 46.0 56.0 46.8 5.1 5.9 7.8 
55 20.1 23.0 24.9 2.0 3.8 1.7 
56 33.0 38.5 44.1 6.7 6.6 0.2 
57 46.4 47.8 52.1 7.3 3.0 4.8 
59 42.5 40.4 49.3 7.7 5.6 5.6 
66 41.0 40.5 32.1 9.8 2.4 21.0 
72 30.3 13.1 33.7 1.9 7.3 0.1 
73 31.5 16.9 41.9 4.0 6.0 6.5 
74 27.7 12.4 22.6 1.0 5.3 1.5 
75 37.2 21.0 35.2 4.8 7.2 0.0 
76 10.1 14.4 8.7 1.9 3.8 0.7 
78 33.0 37.1 28.9 6.5 2.5 7.3 
Table 4-46: Shows for each SMU recorded in the slow ramp jaw closing task, the mean thresholds of 
all repetitions for each block and the standard deviation. 
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For the slow ramp task (n=37), 17 SMUs had a higher mean of threshold for hypertonic 
when comparing with isotonic, while 20 SMUs exhibited a decrease in threshold mean 
for the hypertonic saline block when compared with the isotonic saline block.  
  
 
Figure 4-19: Mean and SD (N) for threshold of onset of SMU activity in the fast ramp jaw closing task. 
 
For the fast ramp task it is possible to notice that the isotonic threshold overall mean 
was lower compared with the other blocks, however, the main effect of session 
(baseline, hypertonic infusion, isotonic infusion) was not statistically different (p>0.05) 
across all threshold values for the slow ramp tasks. 
 
A further analysis was done for each unit individually in order to determine if, even with 
no change in the overall activity, some units would possibly show an effect on their 
individual threshold values. This individual SMU analysis is shown in Table 4-47. 
 
SMU Baseline Hypertonic Isotonic B SD H SD I SD 
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
Fast ramp mean
Fast ramp
Fast ramp SD
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7 38.8 40.6 24.2 1.6 6.7 7.6 
11 4.5 19.9 4.5 2.4 7.1 2.8 
12 27.4 31.7 22.6 7.0 2.8 6.1 
13 51.4 64.5 43.9 7.1 2.0 0.7 
14 5.7 13.2 5.3 4.2 13.5 3.7 
15 44.2 46.6 30.9 6.6 11.8 6.1 
16 21.5 29.0 31.9 1.7 4.7 4.4 
17 48.6 46.2 55.2 0.2 3.8 5.5 
19 59.1 53.0 55.3 4.0 2.2 3.3 
23 46.9 23.0 24.9 3.6 3.1 6.8 
26 53.6 47.3 43.0 3.4 11.8 7.3 
29 7.8 17.1 30.7 0.8 0.4 2.4 
35 2.3 2.9 2.6 0.4 0.5 1.4 
36 7.8 18.5 9.9 3.2 2.3 2.9 
37 30.1 33.6 18.2 5.9 7.5 5.9 
38 36.4 33.6 24.1 0.7 5.4 4.6 
39 22.0 29.9 35.9 2.8 7.6 6.4 
40 32.0 24.1 35.7 7.5 0.6 2.1 
42 32.9 24.5 34.4 2.8 2.1 1.5 
45 27.7 28.6 23.6 5.8 5.7 2.7 
46 35.2 29.5 25.9 6.1 7.8 3.6 
47 32.9 26.4 25.8 5.2 6.5 4.9 
55 26.6 31.0 26.6 6.2 0.5 5.2 
56 42.0 32.0 42.5 4.7 5.3 0.9 
57 49.8 63.9 49.2 1.7 7.4 4.9 
59 52.0 63.2 47.1 9.1 1.6 5.6 
66 58.3 35.2 49.7 0.0 6.5 6.4 
72 16.4 16.9 29.3 1.9 4.5 3.6 
73 29.8 21.9 39.1 3.2 5.3 4.4 
74 19.2 15.1 17.8 6.6 0.8 2.4 
75 34.4 25.9 38.2 4.8 0.8 2.4 
76 9.1 22.6 8.7 3.8 4.7 3.7 
77 21.4 20.7 15.0 6.1 3.1 3.6 
78 35.9 44.0 32.3 1.6 2.0 1.3 
80 42.4 33.7 28.9 2.7 2.6 1.1 
Table 4-47: Shows for each SMU recorded in the slow ramp jaw closing task, the means of repetitions 
for each block and the standard deviation. 
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For the fast ramp task (n= 35), 21 units had a higher mean of threshold for hypertonic 
when comparing with isotonic, where 14 units exhibited a decrease in threshold mean 
for the painful block when compared with the isotonic block.  
 
4.4.3.6 Firing rates for step tasks 
 
The data of 62 discriminated SMUs were further analyzed to calculate the firing rates, 
that is, how many times that unit was active per second, during the 2 s of stable period 
of the step 1 and step 2 of the 2 step-levels jaw closing task. From all the units 
analyzed, only those units that could be clearly discriminated are presented in the 
following analysis. The firing rates of some SMUs are not presented as it was not 
possible to confidently discriminate these SMUs throughout the entire stable period.  
 
The comparison in this thesis is on the difference between the hypertonic block and 
the isotonic block. Therefore, it was possible to study the activity of 20 SMUs under 
both these blocks during the step 1 and 15 SMUs during the step 2. 
 
 Table 4-48 lists the firing rates of the 20 SMUs characterized during the step 1 of the 
2 step-levels jaw closing task.  
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 Step 1: 
 
Participant SMU Hyper Iso  
Higher 
firing rate 
Solution 
inserted first 
1 
1 17.7 22.7 Isotonic Hypertonic 
2 18.8 19.2 Isotonic 
3 - 22.9 Isotonic 
5 16.2 - Hypertonic 
2 7 16.0 21.1 Isotonic Isotonic 
5 16 8.8 6.1 Hypertonic Hypertonic 
6 
26 20.1 15.5 Hypertonic Isotonic 
27 - 5.3 Isotonic 
7 
29 15.9 15.8 Hypertonic Hypertonic 
30 10.0 11.7 Isotonic 
11 
35 14.0 15.8 Isotonic Hypertonic 
36 19.5 18.1 Hypertonic 
13 
45 9.5 10.9 Isotonic Hypertonic 
46 11.0 9.3 Hypertonic 
49 12.0 9.0 Hypertonic 
15 55 15.1 19.5 Isotonic Hypertonic 
16 
60 11.0 15.0 Isotonic Hypertonic 
63 - 19.7 Isotonic 
17 69 16.0 - Hypertonic Isotonic 
19 76 - 8.7 Isotonic Isotonic 
Table 4-48:  Firing rates of SMUs analysed for step 1 of the 2 step-levels jaw closing task. In grey is 
shown the firing rates for units that were present in only one of the two blocks. Yellow highlight for 
hypertonic saline block: firing rate was lower than the isotonic saline block; Blue highlight: firing rate was 
higher. Hyper: hypertonic saline infusion block; Iso: isotonic saline infusion block.  
 
A qualitative analysis was carried out and of these 20 SMUs, 8 SMUs “1, 2, 7, 30, 35, 
45, 55, 60” showed an decrease in firing rates when comparing hypertonic vs. isotonic 
recording sessions, and 6 SMUs “16, 26, 29, 36, 46, 49” showed an increase in firing 
rates. Also, 4 single motor units “3, 27, 63, 76” were absent during the hypertonic 
session while 2 single motor units “5, 69” were absent for the isotonic session. There 
did not appear to be any association between whether there was a decrease in firing 
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rate or an increase in firing rate and the sequence of infusion, that is, whether 
hypertonic saline infusion was performed first, or isotonic saline infusion was 
performed first. 
 
Table 4-49 lists the firing rates of the 15 SMUs characterized during the step 2 of the 
2 step-levels jaw closing task. 
 
Step 2:  
 
Participant SMU Hyper Iso  
Higher 
firing rate 
Solution 
inserted first 
1 
1 22.2 10.0 Hypertonic Hypertonic 
2 19.0 11.0 Hypertonic 
3 - 12.0 Isotonic 
4 - 15.9 Isotonic 
5 19.1 - Hypertonic 
4 13 13.5 11.4 Hypertonic Isotonic 
10 34 18.0 18.1 Isotonic Isotonic 
11 
37 22.0 20.3 Hypertonic Hypertonic 
38 22.5 16.3 Hypertonic 
13 51 15.0 8.0 Hypertonic Hypertonic 
15 
55 23.3 21.5 Hypertonic Hypertonic 
56 18.3 17.3 Hypertonic 
57 14.0 17.3 Isotonic 
59 23.0 18.7 Hypertonic 
19 76 15.1 17.3 Isotonic Isotonic 
Table 4-49: Firing rates of SMUs analysed for step 2 of the 2 step-levels jaw closing task. In grey is 
shown the firing rates for units that were present in only one of the two blocks. Yellow highlight for 
hypertonic saline block: firing rate was lower than the isotonic saline block; Blue highlight: firing rate was 
higher. Hyper: hypertonic saline infusion block; Iso: isotonic saline infusion block. 
 
A qualitative analysis was carried out and of these 15 SMUs, 3 single motor units “34, 
57, 76” showed a decrease in firing rates, 9 single motor units “1, 2, 13, 37, 38, 51, 55, 
56, 59” showed an increase in firing rates when comparing hypertonic vs. isotonic 
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recording sessions. Also, 2 single motor units “3, 4” suffered a de-recruitment for 
hypertonic session while 1 single motor units “5” suffered a de-recruitment for the 
isotonic session. 
 
A repeated measures analysis of variance (ANOVA) of all discriminated SMU firing 
rates values for each jaw task across all of the blocks was performed to determine the 
main effect of repeating the jaw task and of the infusing saline into the masseter 
muscle.  
 
The results showed no significant effect on the firing values of repeating the task during 
the baseline, hypertonic saline infusion, or isotonic saline infusion of the 2 step-levels 
jaw closing task.  
 
The overall mean of the firing rates for all the SMUs was then calculated for each block 
in order to determine if there was an effect of block on SMU firing rates for the 2 step-
levels jaw closing tasks and no significant difference was found for either of the levels 
(p>0.05). 
 
No difference between repetitions: 
Step 1: 
Baseline: p=0.652 (n = 11) 
Hypertonic p=0.643 (n = 9) 
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Isotonic p=0.411 (n = 14) 
 
Step 2: 
Baseline: p=0.405 (n = 6) 
Hyper p=0.058 (n = 5) 
Isotonic p=0.89 (n=6) 
 
Multiple comparisons showed no significant difference between blocks in firing rates 
 
Step 1 between blocks: p=0.950 (n= 13) 
 
Step 2 between blocks: p=0.215 (n =8) 
 
4.4.3.7 Sequence of recruitment for each block  
 
The data was further analysed to determine whether the sequence of recruitment of 
the SMUs was altered when comparing baseline, hypertonic saline infusion and 
isotonic saline infusion blocks. Units were only considered if they were present in all 3 
of the baseline, hypertonic saline infusion and isotonic saline infusion blocks. 
Participants that only had one unit that was present in the three blocks were also not 
considered in this analysis as it is not possible to provide a recruitment sequence.  
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The data from 12 participants were able to be analysed for this recruitment analysis for 
the slow ramp jaw closing task based on the mean thresholds and this analysis is 
shown on Table 4-50. 
ID Baseline SR Hypertonic SR Isotonic SR BxH BxI HxI 
First 
solution 
1 1 / 2  2 / 1  2 / 1  Different Different Same H 
2 7 / 8  7 / 8  7 / 8  Same Same Same I 
4 
14 / 12 / 11 / 15 
/ 13  
14 / 11 / 12 / 15 
/ 13  
14 / 11 / 12 / 15 
/ 13  Different Different Same I 
5 16 / 17 / 19 / 20  16 / 19 / 17 / 20  16 / 17 / 19 / 20  Different Same Different H 
6 23 / 26 / 27  23 / 26 / 27  23 / 26 / 27  Same Same Same I 
11 
35 / 36 / 39 / 38 
/ 37  
35 / 36 / 39 / 37 
/ 38  
35 / 36 / 37 / 39 
/ 38  Different Different Different H 
12 42 / 40 / 41  42 / 40 / 41  42 / 40 / 41  Same Same Same I 
13 45 / 46 / 47 / 48  45 / 46 / 47 / 48  45 / 47 / 46 / 48  Same Different Different H 
15 55 / 56 / 57 / 59  55 / 56 / 59 / 57  55 / 56 / 59 / 57  Different Different Same H 
16 60 / 61 / 63  61 / 60 / 63  60 / 61 / 63  Different Same Different H 
18 74 / 72 / 73 / 75  74 / 72 / 73 / 75  74 / 72 / 73 / 75  Same Same Same H 
19 76 / 77 / 78  76 / 77 / 78  76 / 77 / 78  Same Same Same I 
Table 4-50 : Sequence of recruitment of SMUs in the temporalis muscle during the slow ramp jaw closing 
task (SR). Each SMU is indicated by a number and the order in which each SMU is recruited is indicated 
by the sequence of those numbers. The comparison between blocks is shown as “different” when at 
least one unit appeared in a different order in one of those blocks, and “same” when all the units 
appeared in the exactly the same order in both of those blocks. In order to analyse a possible post pain 
effect, the infusion injected first is also mentioned on the table. SR: slow ramp jaw closing task; B: 
baseline; I: isotonic saline infusion; H: hypertonic saline infusion. 
  
For the slow ramp jaw closing task, 6 participants had a different order when comparing 
the baseline with the hypertonic saline block, 5 participants had a different sequence 
of recruitment when comparing the baseline with the isotonic saline block and 4 
participants had a different sequence when comparing the hypertonic saline infusion 
block with the isotonic saline infusion block.  
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The data from 12 participants were able to be analysed for this recruitment analysis for 
the fast ramp jaw closing task based on the mean thresholds and this analysis is shown 
on Table 4-51. 
 
ID 
 Baseline FR Hypertonic  FR Isotonic FR BxH BxI HxI 
First 
solution 
1 1/2  2 / 1  1 / 2 Different Same Different H 
4 
11 / 14 / 12 /15 / 
13 
11 / 14 / 12 /15 / 
13 
11 / 14 / 12 /15 
/ 13 Same Same Same I 
5 16 / 17 / 19 16 / 17 / 19 16 / 19 / 17 Same  Different Different H 
6 23 / 27 / 26  23 / 26 / 27  23 / 26 / 27  Different Different Same I 
7 29 / 30  29 / 30  29 / 30  Same  Same  Same  H 
11 
35 / 36 / 39 / 37 / 
38 
35 / 36 / 38 / 39 / 
37 
35 / 36 / 37 / 38 
/ 39 Different Different Different H 
12 42 / 40  40 / 42  42 / 40  Different Same  Different I 
13 45 / 46 / 47  45 / 46 / 47  45 / 47/ 46  Same  Different Different H 
15 55 / 56 / 57 / 59 55 / 56 / 59 / 57  55 / 56 / 59 / 57  Different Different Same H 
16 60 / 63  60 / 63  60 / 63  Same  Same  Same  H 
18 74 / 72 / 73 / 75  74 / 72 / 73 / 75  74 / 72 / 73 / 75  Same  Same  Same  H 
19 76 / 77 / 78 / 80 77 / 76 / 80 / 78   77 / 76 / 80 / 78   Different Different Same I 
Table 4-51: Sequence of recruitment of SMUs in the temporalis muscle during the fast ramp jaw closing 
task (FR). Each SMU is indicated by a number and the order in which each SMU is recruited is indicated 
by the sequence of those numbers. The comparison between blocks is shown as “different” when at 
least one unit appeared in a different order in one of those blocks, and “same” when all the units 
appeared in the exactly the same order in both of those blocks. In order to analyse a possible post pain 
effect, the infusion inserted first was also mentioned on the table. FR: fast ramp jaw closing task; B: 
baseline; I: isotonic saline infusion; H: hypertonic saline infusion. 
 
For the fast ramp jaw closing task, it is possible to notice that 6 participants had a 
different order comparing baseline with hypertonic block, 6 participants had a different 
sequence of recruitment when comparing baseline with isotonic block and 5 
participants had a different sequence between hypertonic and isotonic.  
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4.4.4 Occurrence of single motor units in the right masseter muscle: 
 
In total, 58 SMUs were discriminated from the masseter muscle from 15 participants. 
Among those 58 SMUs, 50 units were discriminated in at least one of the ramp jaw 
closing tasks, while 47 (39 also present in the ramps + 8 new SMUs) were 
discriminated for at least one step level (step 1 and/or step 2) of the 2 step-levels jaw 
closing task – See figure 4-20. 
 
8 units (5, 6, 7, 8, 12, 17, 32, 33) were present exclusively for the step tasks, while 6 
units (1, 2, 3, 4, 30, 31) were present in the ramp jaw closing tasks but it was not 
possible to discriminate from other units in the step tasks.  Units 4, 30 and 43 were 
present in the fast ramp jaw closing task but not in the slow ramp jaw closing task and 
the unit 39 was present in the slow ramp jaw closing task but not in the fast ramp jaw 
closing task. 
 
For an easier understanding, the units presented for ramps jaw closing tasks (slow and 
fast) and the units presented for the 2 step-levels jaw closing task will be described 
separately on the following sections (section 4.4.4.1 and section 4.4.4.2, respectively). 
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Figure 4-20: Summary of units (i.e. SMUs) in the tasks for the right masseter muscle. Ramps = slow 
ramp and fast ramp jaw closing tasks; Steps = Step 1 of the 2 step-levels jaw closing task + Step 2 of 
the 2 step-levels jaw closing task. 
 
4.4.4.1 Occurrence of motor units in slow ramp and fast ramp tasks for the masseter 
muscle 
 
Table 4-52 lists the occurrences of the 50 SMUs in each recording block (baseline, 
hypertonic saline infusion block, isotonic saline infusion block) for the ramp tasks (slow 
and fast ramp jaw closing tasks) in the masseter muscle. If a SMU was present in at 
least 2 of the 3 trials done or at least half of trials when more than 3 trials were done, 
then that SMU was marked as "+" (i.e. present). If not, that SMU was marked as "-" 
(i.e. not present). 
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  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS Hyper Iso  
5 
1 + + + + - + 
2 + - + + - + 
3 + + + + + + 
4 - - - - + - 
6 
9 + + + + + + 
10 + + + + + + 
11 - + - - + + 
7 
13 + + + + + + 
14 + + + + + + 
15 + + + + + + 
16 - + - - + - 
8 
18 + + + + + + 
19 + + + + + + 
9 
20 + + + + + + 
21 + + + + + + 
22 + + + + + + 
10 
23 + + + + + + 
24 + + + + + + 
11 
25 + + + + + + 
26 + + + + + - 
27 - + + - + + 
12 
28 + + + + + + 
29 + + + - + + 
30 - - - + - - 
31 + + + + + + 
13 
34 + - - + - - 
35 + - - + - - 
36 - + + + + + 
14 
37 + + + + + + 
38 + - + + - + 
39 + - - - - - 
40 - + + + + + 
41 - + - - + - 
42 - + - + + + 
43 - - - + - - 
16 44 + + + + + + 
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  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS Hyper Iso  
17 
45 + + + + + + 
46 + - + + - + 
47 - - + - + + 
18 
48 + - + + - + 
49 + - + - - + 
50 - + - - + - 
51 - + - - + - 
19 
52 + + + + + + 
53 + + + + + + 
54 + + + + + + 
55 + - + + + + 
20 
56 + + + + + + 
57 + + + + + + 
58 - - + + + + 
Table 4-52: All the SMUs (n=50) present in the slow ramp and fast ramp jaw closing tasks under each 
block. Highlighted in grey are the units that were present in one speed of the slow or fast ramp jaw 
closing task but which were not present in the other. BS: baseline; hyper: hypertonic saline infusion 
block; iso: isotonic saline infusion block. 
 
Among the 50 units present for the ramp jaw closing tasks, 24 SMUs did not change 
their pattern of occurrence and were present in both fast and slow ramp jaw closing 
tasks for baseline, hypertonic saline infusion and isotonic saline infusion blocks. Table 
4-53 shows those 24 SMUs that were present in all the tasks for the 3 blocks. 
 
In addition, 4 participants (Participant 8, 9, 10 and 16) showed no change in the pattern 
of recruitment of all the units discriminated from the masseter muscle in each of those 
participants. Therefore, these participants presented the same units (SMUs 18, 19 – 
for participant 8; SMUs 20, 21, 22 - for participant 9; SMUs 23, 24 - for participant 10; 
and SMUs 44 for participant 16) for both tasks (slow ramp and fast ramp jaw closing 
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tasks) during the three blocks analysed (baseline, hypertonic saline infusion, isotonic 
saline infusion; see Table 4-53 highlighted). 
 
  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS Hyper Iso  
5 3 + + + + + + 
6 
9 + + + + + + 
10 + + + + + + 
7 
13 + + + + + + 
14 + + + + + + 
15 + + + + + + 
8 
18 + + + + + + 
19 + + + + + + 
9 
20 + + + + + + 
21 + + + + + + 
22 + + + + + + 
10 
23 + + + + + + 
24 + + + + + + 
11 25 + + + + + + 
12 
28 + + + + + + 
31 + + + + + + 
14 37 + + + + + + 
16 44 + + + + + + 
17 45 + + + + + + 
19 
52 + + + + + + 
53 + + + + + + 
54 + + + + + + 
20 
56 + + + + + + 
57 + + + + + + 
Table 4-53: SMUs (n=24) that were present in all the tasks for the baseline, hypertonic saline infusion 
and isotonic saline infusion block. In grey, participants who had no change in the pattern of occurrence 
for all the units discriminated from each of those participants. BS: baseline; hyper: hypertonic saline 
infusion block; iso: isotonic saline infusion block. 
 
210 
 
Of the 50 SMUs, the remaining 26 exhibited some change in the pattern of SMU 
occurrence between the blocks (n=10), or between the blocks and between the slow 
and fast ramp jaw closing tasks (n=16) – See Table 4-54 and 4-55.  
 
From those 26 SMUs, 10 units (2, 16, 27, 34, 35, 38, 41, 46, 48, 50) showed the same 
pattern of occurrence for the slow ramp jaw closing tasks and the fast ramp jaw closing 
tasks, and the change in occurrence was only due to the block (yellow highlighted 
SMUs in Table 4-54). The remaining 16 units (1, 4, 11, 26, 29, 30, 36, 39, 40, 42, 43, 
47, 49, 51, 55, 58) had different patterns of occurrence for the different tasks as well 
as changes in occurrence between the blocks. One unit (39) was found in the slow 
ramp jaw closing task, but not in the fast ramp jaw closing task, while 3 units (4, 30, 
43,) were found for fast ramp jaw closing task but not for the slow ramp jaw closing 
task. 
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  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS Hyper Iso  
5 
1 + + + + - + 
2 + - + + - + 
4 - - - - + - 
11 - + - - + + 
16 - + - - + - 
11 
26 + + + + + - 
27 - + + - + + 
12 
29 + + + - + + 
30 - - - + - - 
13 
34 + - - + - - 
35 + - - + - - 
36 - + + + + + 
14 
38 + - + + - + 
39 + - - - - - 
40 - + + + + + 
41 - + - - + - 
42 - + - + + + 
43 - - - + - - 
17 
46 + - + + - + 
47 - - + - + + 
18 
48 + - + + - + 
49 + - + - - + 
50 - + - - + - 
51 - + - - + - 
19 55 + - + + + + 
20 58 - - + + + + 
Table 4-54: Shows only those SMUs (n=26) that exhibited some change in the pattern of occurrence 
between blocks (n=10; yellow highlighted SMUs), or between the blocks and between the slow and fast 
ramp jaw closing tasks (n=16). BS: baseline; hyper: hypertonic saline infusion block; iso: isotonic saline 
infusion block. 
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  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS Hyper Iso  
5 2 + - + + - + 
7 16 - + - - + - 
11 27 - + + - + + 
13 
34 + - - + - - 
35 + - - + - - 
14 
38 + - + + - + 
41 - + - - + - 
17 46 + - + + - + 
18 
48 + - + + - + 
50 - + - - + - 
Table 4-55: Shows only those units (n=10) that did not exhibit a change in the pattern of occurrence 
across all 3 blocks between the slow ramp and fast ramp jaw closing tasks. BS: baseline; hyper: 
hypertonic saline infusion block; iso: isotonic saline infusion block. 
 
According to the tables above (4-54 and 4-55), it is possible to notice that some units 
were present or were not present within the hypertonic saline infusion block. Units 11, 
16, 41, 50, 51, for example, were present only during hypertonic saline infusion blocks 
for slow and fast ramps jaw closing tasks but were not present during baselines or 
isotonic saline infusion blocks. Units 2, 38, 46, 48, 55, on the other hand, were not 
present for slow and fast ramps jaw closing tasks during hypertonic saline infusion 
block but were present during baselines and isotonic saline infusion blocks for slow 
and fast ramps jaw closing tasks. 
 
Units 34 and 35 were not present in hypertonic and isotonic saline infusion but were 
present for the baseline block; while unit 27 was present in hypertonic saline infusion 
and isotonic saline infusion block but not present for the baseline block. 
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For all the other participants (Participant 5, 11, 12, 13, 14, 17, 18, 19, 20), it was 
possible to note some change in the pattern of occurrence of units not only within a 
block, but also with different patterns between slow ramp and fast ramp jaw closing 
tasks (n=16) – See table 4-56. 
 
  Slow ramp Fast Ramp 
Participant SMU BS Hyper Iso  BS Hyper Iso  
5 (H) 
1 + + + + - + 
4 - - - - + - 
11 - + - - + + 
11 (H) 26 + + + + + - 
12 (I) 
29 + + + - + + 
30 - - - + - - 
13 (H) 36 - + + + + + 
14 (I) 
39 + - - - - - 
40 - + + + + + 
42 - + - + + + 
43 - - - + - - 
17 (I) 47 - - + - + + 
18 (H) 
49 + - + - - + 
51 - + - - + - 
19 (I) 55 + - + + + + 
20 (H) 58 - - + + + + 
Table 4-56: Shows only those units (n=16) that exhibited a change in the pattern of occurrence between 
slow ramp and fast ramp. Letter in brackets indicates the solution applied first for that participant and is 
noted after the participant’s number as (H) for hypertonic saline being applied first and (I) when the 
isotonic solution was applied first. BS: baseline; hyper: hypertonic saline infusion block; iso: isotonic 
saline infusion block. 
 
Unit 5 was present only during hypertonic saline infusion fast ramp jaw closing task but 
was not present in the other blocks for slow ramp jaw closing task. Unit 1, on the other 
hand, was not present during hypertonic saline infusion fast ramp jaw closing task but 
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it was present in the slow ramp jaw closing tasks (all the blocks) and for the remaining 
blocks in the fast ramp jaw closing tasks.  
 
Figure 4-21 Summarizes schematically the 50 SMUs discriminated for the ramps jaw 
closing tasks in this study. 
 
 
Figure 4-21: Schematic figure to summarize the 50 SMUs discriminated for the ramps tasks in the right 
masseter muscle in this study. Unit = SMU.   
16 
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4.4.4.2 Occurrence of motor units in steps for masseter muscle: 
 
The 47 motor units present in the 2 step-levels jaw closing tasks are described in Table 
4-57. Of the 47 SMUs, 39 were also present in one or more of the ramp jaw closing 
tasks and the remaining 8 were new SMUs that were only present in the 2 step-levels 
jaw closing task. 
 
  Step 1  Step 2 
Participant SMU BS Hyper Iso  BS Hyper Iso  
5 
5 + - + - - - 
6 - + - + + + 
7 - - - + + + 
8 - - - + + + 
6 
9 + + + ? ? ? 
10 + + + ? ? ? 
11 - - - + + + 
12 - - - + + + 
7 
13 + + + ? ? ? 
14 + + + ? ? ? 
15 - - - ? ? ? 
16 - + + ? ? ? 
17 - - - + + + 
8 
18 + + + + + + 
19 + + + + + + 
9 
20 + + + + + + 
21 - - + + + + 
22 - + + + + + 
10 
23 + + + + + + 
24 + + + + + + 
11 
25 - + - + + + 
26 - - - - + + 
27 + + + + + + 
12 
28 + + + + + + 
29 + + + + + + 
32 + + + ? ? ? 
33 - - - - + + 
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Participant  Step 1  Step 2 
13 
SMU BS Hyper Iso  BS Hyper Iso  
34 + - - + - + 
35 + - - + - - 
36 + - + + - + 
14 
37 + + + + + + 
38 + + + + + + 
39 - - - ? ? ? 
40 - - - + + + 
41 - - - ? ? ? 
42 - - - + + + 
43 - - - ? ? ? 
17 
45 - - - + + + 
46 - - - + + + 
47 - - - + + + 
18 
48 ? ? ? ? ? ? 
49 ? ? ? ? ? ? 
50 ? ? ? ? ? ? 
51 ? ? ? ? ? ? 
19 
52 + + + + + + 
53 + + + + + + 
54 - - - + + + 
55 - + - ? ? ? 
20 
56 + + + + + + 
57 + + + + + + 
58 - - - + + + 
Table 4-57: Motor units (n=47) discriminated in the 2 step-levels jaw closing tasks. In grey, all the motor 
units that were exclusively found for the steps tasks and were not present in the ramp tasks. ? = when 
it was not possible to confirm the presence or absence of the unit for that task. BS: baseline; hyper: 
hypertonic saline infusion block; iso: isotonic saline infusion block. 
 
 
From the 47 units described in the Table 4-57, 29 units were discriminated for step 1 
and  35 units were discriminated for step 2; these 35 were made up of 21 present for 
step 1 plus and an additional 14 newly recruited SMUs. Due to the greater force and 
higher level of EMG activity for step 2, it was not possible to confirm precisely if 4 small 
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units (48, 49, 50, 51) were present or absent in the step 1 and if 14 units (9, 10, 13, 14, 
15, 16, 32, 39, 41, 43, 48, 49, 50, 51) were present or absent in step 2. For those 
cases, a question mark was used in the table.  
 
For the step 1 of the 2 step-levels jaw closing task, from the 29 units discriminated, 19 
units (9, 10, 13, 14, 18, 19, 20, 23, 24, 27, 29, 32, 37, 38, 52, 53, 57) were present in 
the three blocks, 3 units (6, 25, 55) were recruited only for the hypertonic block, 2 units 
(5, 36) were de-recruited only for the hypertonic block and the remaining 5 units (16, 
21, 22, 34, 35) were not present in some of the blocks.   
 
For the step 2 of the 2 step-levels jaw closing task, from the 35 units discriminated, 30 
units (6, 7, 8, 11, 12, 17, 18, 19, 20, 21, 22, 23, 24,25, 27, 28, 29, 37, 38, 40, 42, 45, 
46, 47, 52, 53, 54, 56, 57, 58) were present in the three blocks, 2 units (34 and 36) 
were de-recruited only for the hypertonic block, 1 unit (35) was recruited only for the 
baseline but was not present in the hypertonic or isotonic blocks, and 2 units (26 and 
33) were not present in the baseline block but were present for both blocks of infusion 
(hypertonic and isotonic).  
 
Figure 4-22 Summarizes schematically the 47 SMUs discriminated for the 2 step-levels 
jaw closing tasks in this study. 
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Figure 4-22: Schematic figure to summarize the 47 SMUs discriminated for the steps tasks in the right 
masseter muscle in this study. Unit = SMU. 
 
4.4.4.3 Comparisons between blocks: 
 
For each of the slow ramp and fast ramp jaw closing tasks, and step 1 and step 2 of 
the 2 steps-levels jaw closing task, the hypertonic saline infusion block (H) was 
compared with all the other blocks - baseline (B) and Isotonic saline infusion (I) - in 
terms of the number of units during the hypertonic saline infusion block of tasks that  
 Exhibited no change in the pattern of occurrence between the 2 blocks,  
 Became present in the hypertonic saline infusion block (i.e. were recruited), or  
 Was not present (i.e. was de-recruited) during the hypertonic saline infusion 
block.  
These analyses are shown in Tables 4-58 and 4-59. 
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 B x H SR B x H FR B x H step 1 B x H step 2 
No change 29/47 
(61.7%) 
30/49 
(61.2%) 
17/28 
(60.7%) 
30/35 
(85.7%) 
Recruited  9/47 (19.1%) 8/49 (16.3%) 4/28 (14.3%) 2/35 (5.7%) 
De-recruited 9/47 (19.1%) 11/49 
(22.4%) 
7/28 (25%) 3/35 (8.6%) 
Table 4-58: Describes the comparison between the hypertonic saline infusion block with the baseline 
block for slow ramp, fast ramp, step 1 and step 2 jaw closing tasks. For the slow ramp tasks, 61.7% of 
the units did not change, 61.2% of the units did not change for the fast ramp, and 60.7% and 85.7% of 
the units did not change for step 1 and step 2 respectively. Recruited = SMU became present in the 
hypertonic saline infusion block; de-recruited = were not present during the hypertonic saline infusion 
block 
 
 I x H SR I x H FR I x H step 1 I x H step 2 
No change 33/47 
(70.2%) 
37/49 
(75.6%) 
23/28 
(82.1%) 
33/35 
(94.3%) 
Recruited  6/47 (12.8%) 6/49 (12.2%) 2/28 (7.1%) 0/35 (0%) 
De-recruited 8/47 (17%) 6/49 (12.2%) 3/28 (10.8%) 2/35 (5.7%) 
Table 4-59: Describes the comparison between the hypertonic saline infusion block with the isotonic 
saline infusion block for slow ramp, fast ramp, step 1 and step 2 jaw closing tasks. For the slow ramp 
tasks, 70.2% of the units did not change, 75.6% of the units did not change for the fast ramp, and 82.1% 
and 94.3% of the units did not change for step 1 and step 2 respectively. Recruited = SMU became 
present in the hypertonic saline infusion block; de-recruited = were not present during the hypertonic 
saline infusion block 
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4.4.4.4 Masseter SMU activity and the vicious cycle theory and the pain adaptation model  
 
An analysis was performed to determine whether the change in the pattern of 
occurrence of SMUs recorded in the masseter muscle could be explained on the basis 
of the principles outlined for the Vicious Cycle Theory or the Pain Adaptation Model. 
This analysis is summarized in Table 4-60.  
 
If the SMU was recruited during the hypertonic saline infusion block but was inactive 
(i.e. not present) in the isotonic saline infusion block, then the pattern of occurrence of 
the SMU was considered to be consistent with the Vicious Cycle Theory as the pain, 
according to this theory, would cause “muscle hyperactivity”. On the other hand, if the 
SMU becomes inactive (i.e. not present) during the hypertonic saline infusion block in 
comparison with the isotonic saline infusion block, this pattern of occurrence was 
considered to be consistent with the Pain Adaptation Model which proposes decreased 
agonist muscle activity in pain so as to result in slower and smaller movements to 
prevent further injury and help healing.  
 
This analysis, however, only considered the presence or absence or the unit and did 
not consider the possible effect of the pain on the firing rates of those units that were 
present in the hypertonic saline infusion block as well as the isotonic saline infusion 
block.   
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  Slow ramp Fast Ramp Step 1 Step 2 
Participant SMU VCT PAM VCT PAM VCT PAM VCT PAM 
5 
1    X - - - - 
2  X  X - - - - 
3     - - - - 
4 - - X  - - - - 
5 - - - -  X - - 
6 - - - - X    
7 - - - - - -   
8 - - - - - -   
6 
9       - - 
10       - - 
11 X    - -   
12 - - - - - -   
7 
13       - - 
14       - - 
15     - - - - 
16 X  X    - - 
17 - - - - - -   
8 
18         
19         
9 
20         
21      X   
22         
10 
23         
24         
11 
25     X    
26   X  - -   
27         
12 
28         
29         
30 - - - - - - - - 
31     - - - - 
32 - - - -   - - 
33 - - - - - -   
13 
34 - - - - - -  X 
35 - - - - - - - - 
36      X  X 
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37         
38  X  X     
39 - - - - - - - - 
40     - -   
41 X  X  - - - - 
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Participant 
 
 
14 
 SLOW RAMP FAST RAMP STEP 1 STEP 2 
SMU VCT PAM VCT PAM VCT PAM VCT PAM 
42 X    - -   
43 - - - - - - - - 
16 44     - - - - 
17 
45     - -   
46  X  X - -   
47  X   - -   
18 
48  X  X - - - - 
49  X  X - - - - 
50 X  X  - - - - 
51 X  X  - - - - 
19 
52         
53         
54     - -   
55  X   - - - - 
20 
56         
57         
58  X   - -   
Total  6 8 6 6 2 3 0 2 
Table 4-60: Shows the 58 units discriminated from the masseter muscle in this study. One “x” was 
marked when the pattern of recruitment of a certain unit was supportive of one of the models (VCT or 
PAM), the sign “-“ was used when the unit was not present for that specific block, and nothing was 
marked when the unit was present but their occurrence did not support neither of those models. Note 
that the majority of the units were neither consistent with the Vicious Cycle Theory nor the Pain 
Adaptation Model. 
 
According to Table 4-60, it is possible to notice that 6 units supported the Vicious Cycle 
Theory for the slow ramp jaw closing tasks, 6 units for the fast ramp jaw closing tasks 
and 2 and 0 units for each of step 1 and step 2 of the 2 step-levels jaw closing tasks 
respectively. On the other hand, 8 units supported the Pain Adaptation model on the 
slow ramp jaw closing tasks, 6 units for the fast ramp jaw closing tasks, and lastly 3 
and 2 units supported the Pain Adaptation Model for each of step 1 and 2 of the 2 step-
levels jaw closing task.  
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A further analysis was done separately according to the type of task and the number 
of SMUs recorded per participant, and whether the patterns of recruitments and de-
recruitments of all SMUs recorded at a site supported the Vicious Cycle Theory, the 
Pain Adaptation Model or neither of those models. This analysis is shown in Tables 4-
61, 4-62, 4-63, 4-64.  
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From the 47 SMUs studied in the slow ramp jaw closing task (table 4-61), 70.2% (n=33) 
of the units did not support neither the Vicious Cycle Theory nor the Pain Adaptation 
Model, and only 12.8% (n=6) supported the proposals of the VCT and 17% (n=8) 
supported the proposals of the PAM. 
 
Slow ramp: (Units n = 47) 
 
Participant 
Number 
of Units VCT PAM Neither 
5 3  1/3 2/3 
6 3 1/3  2/3 
7 4 ¼  3/4 
8 2   2/2 
9 3   3/3 
10 2   2/2 
11 3   3/3 
12 3   3/3 
13 3   3/3 
14 6 2/6 1/6 3/6 
16 1   1/1 
17 3  2/3 1/3 
18 4 2/4 2/4 0/4 
19 4  1/4 3/4 
20 3  1/3 2/3 
Total  47 6 8 33 
Table 4-61: Units present for the slow ramp task and consistency or not with the Vicious Cycle Theory 
(VCT) and the Pain Adaptation Model (PAM). From the 47 units presented for this test, 70.2% (n=33) of 
the units did not support either the Vicious Cycle Theory nor the Pain Adaptation Model, and only 12.8% 
(n=6) supported the proposals of the VCT and 17% (n=8) supported the proposals of the PAM.  
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From the 49 SMUs studied in the fast ramp jaw closing task (table 4-62), 75.6% (n=37) 
of the units did not support neither the Vicious Cycle Theory nor the Pain Adaptation 
Model, and only 12.2% (n=6) supported the proposals of the VCT and 12.2% (n=6) 
supported the proposals of the PAM. 
 
Fast ramp: (Units n= 49) 
 
Participant 
Number 
of Units VCT PAM Neither 
5 4 ¼ 2/4 1/4 
6 3   3/3 
7 4 ¼  3/4 
8 2   2/2 
9 3   3/36 
10 2   2/2 
11 3 1/3  2/3 
12 4   4/4 
13 3   3/3 
14 6 1/6 1/6 4/6 
16 1   1/1 
17 3  1/3 2/3 
18 4 2/2 2/2 0/4 
19 4   4/4 
20 3   3/3 
Total  49 6 6 37 
Table 4-62: Units presents for the fast ramp task and consistency or not with the Vicious Cycle Theory 
(VCT) and the Pain Adaptation Model (PAM). From the 49 units presents for this test, 75.6% (n=37) of 
the units did not support either of the Vicious Cycle Theory nor the Pain Adaptation Model, and only 
12.2% (n=6) supported the proposals of the VCT and 12.2% (n=6) supported the proposals of the PAM. 
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From the 28 SMUs studied in the step 1 of the 2 step-levels jaw closing task (table 4-
63), 82.1% (n=23) of the units did not support neither the Vicious Cycle Theory nor the 
Pain Adaptation Model, and only 7.1% (n=2) supported the proposals of the VCT and 
10.8% (n=3) supported the proposals of the PAM. 
 
Step 1: (Units n = 28) 
 
Participant 
Number 
of Units VCT PAM Neither 
5 2 ½ 1/2 0/2 
6 2   2/2 
7 3   3/3 
8 2   2/2 
9 3  1/3 2/3 
10 2   2/2 
11 2 ½  1/2 
12 3   3/3 
13 3  1/3 2/3 
14 2   2/2 
19 2   2/2 
20 2   2/2 
Total  28 2 3 23 
Table 4-63: Units presents for the step 1 level task and consistency or not with the Vicious Cycle Theory 
(VCT) and the Pain Adaptation Model (PAM). From the 28 units presents for this test, 82.1% (n=23) of 
the units did not support either of the Vicious Cycle Theory nor the Pain Adaptation Model, and only 
7.1% (n=2) supported the proposals of the VCT and 10.8% (n=3) supported the proposals of the PAM. 
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From the 35 SMUs studied in the step 2 of the 2 step-levels jaw closing task (table 4-
64), 94.3% (n=33) of the units did not support neither the Vicious Cycle Theory nor the 
Pain Adaptation Model, 0% (n=0) supported the proposals of the VCT and 5.7% (n=2) 
supported the proposals of the PAM. 
 
Step 2: (Units n= 35) 
 
Participant 
Number 
of Units VCT PAM Neither 
5 3   3/3 
6 2   2/2 
7 1   1/1 
8 2   2/2 
9 3   3/3 
10 2   2/2 
11 3   3/3 
12 3   3/3 
13 3  2/3 1/3 
14 4   4/4 
17 3   3/3 
19 3   3/3 
20 3   3/3 
Total  35 0 2 33 
Table 4-64: Units presents for the step 2 level task. From the 35 units presents for this test, 94.3% 
(n=33) of the units did not support either of the Vicious Cycle Theory nor the Pain Adaptation Model, 
and only 0% (n=0) supported the proposals of the VCT and 5.7% (n=2) supported the proposals of the 
PAM. 
 
  
228 
 
4.5 Masseter and temporalis occurrence and consistency with VCT and PAM – a 
comparison 
 
A further analysis was done to compare the percentage of SMUs with their pattern of 
occurrence and consistency with the earlier theories mentioned in this study (i.e. VCT 
or PAM) between the two muscles analysed.  
 
4.5.1 Occurrence  
 
 
The following tables shows this comparison in the slow ramp and fast ramp jaw closing 
tasks and step 1 and step 2 of the 2 step-levels jaw closing task for each of the possible 
effects of hypertonic saline infusion on isotonic saline infusion. That is, where a SMU 
did not change its occurrence (Table 4-65), where a SMU was recruited during 
hypertonic saline infusion (Table 4-66), or where a SMU was de-recruited during 
hypertonic saline infusion (Table 4-67). 
 
 Slow ramp Fast ramp Step 1 Step 2 
Temporalis 75.7% 74.6% 73% 82.8% 
Masseter 70.2% 75.6% 82.1% 94.3% 
 
  
Table 4-65: Summary of SMU data from masseter and temporalis showing percentage of SMUs that did not 
change their pattern of occurrence between hypertonic and isotonic saline infusion. 
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 Slow ramp Fast ramp Step 1 Step 2 
Temporalis 7.2% 12.7% 10.8% 6.9% 
Masseter 17% 12.2% 10.8% 5.7% 
 
 Slow ramp Fast ramp Step 1 Step 2 
Temporalis 17.1% 12.7% 16.2% 10.3% 
Masseter 12.8% 12.2% 7.1% 5.7% 
 
  
Table 4-66: Masseter and temporalis as a comparison of recruitment percentage of SMUs that were 
recruited in the hypertonic saline infusion but not at isotonic saline infusion.   
Table 4-67: Masseter and temporalis as a comparison of recruitment percentage of SMUs that were de-
recruited in the hypertonic saline infusion but was present at isotonic saline infusion.  
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4.5.2 Consistency with VCT and/or PAM 
 
The following table 4-68 shows the comparison in the slow ramp and fast ramp jaw 
closing tasks and step 1 and step 2 of the 2 step-levels jaw closing task for the 
percentage of SMUs whose pattern of occurrence were either consistent with earlier 
theories or not (i.e. did not support either of them, did support the VCT or did support 
the PAM). 
 
4.6 Associations between psychological variables and jaw muscle activity patterns 
during pain  
4.6.1 Temporalis 
 
 Slow 
ramp M 
Slow 
ramp T 
Fast 
ramp M 
Fast 
ramp T 
Step 1 M Step 1 T Step 2 M Step 2 T 
Did not 
support 
either 
theory 
70.2% 80% 75.6% 75.7% 82.1% 73% 94.3% 82.8% 
Supported 
VCT 
12.8% 17.1% 12.2% 12.8% 7.1% 16.2% 0% 10.3% 
Supported 
PAM 
17% 7.1% 12.2% 12.8% 10.8% 10.8% 5.7% 6.9% 
Table 4-68: Summary of SMU data from masseter and temporalis as a comparison of the percentage 
of SMUs that did not support either theory, supported the Vicious Cycle Theory (VCT) or supported the 
Pain Adaptation Model (PAM).  M= masseter. T= temporalis.  
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A qualitative analysis was done to determine a possible correlation between a change 
in SMU characteristics (occurrences) between isotonic saline and hypertonic saline 
infusion, and psychological variables- See tables 4-69 and 4-70. The PCS and DASS-
21 scores of the individuals where the occurrence of SMU activity did not alter during 
any of the infusions for the temporalis muscle (participants 4, 11, 18) were compared 
with the same scores of those participants where the occurrence of SMU activity did 
change in at least one block of infusion (participants 1, 2, 5, 6, 7, 10, 12, 13, 14, 15, 
16, 17, 19). 
 Stress Depression Anxiety 
DASS-21 for 
participants that did not 
change 
2.3 
 
0.33 
 
1 
 
DASS-21 for 
participants who had 
some change 
1.5 
 
0.3 
 
0.4 
 
Table 4-69: DASS-21 scores comparison between participants who had no changes of the SMU 
occurrence between all the blocks and participants who had.  
 
 Rumination 
 
Magnification 
 
Helplessness 
 
Total 
 
PCS for 
participants that 
did not change 
8.3 
 
3.3 
 
7.7 
 
19.3 
 
PCS for 
participants who 
had some change 
2.5 
 
1.7 
 
2.8 
 
6.9 
 
Table 4-70: PCS scores comparison between participants who had no changes on the SMU 
occurrence between all the blocks and participants who had. 
 
It is possible to notice qualitatively those participants, who did not exhibit a change in 
the occurrence of their SMUs, had higher scores for all the categories in DASS-21 
questionnaire and on the PCS questionnaire. However, the population of participants 
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that exhibited no change in the SMU occurrence was small (n=3) and the firing rates 
or threshold values of the units was not considered for this matter.  
 
T-tests were done to compare the scores of the two groups of participants (group 1: 
participants who had no change on their occurrence of SMU; group 2: participants who 
had some change on their occurrence of SMU). 
 
No significant differences were found for each score of the DASS-21, Stress (p=0.5), 
Depression (p=1), Anxiety (p=0.3). However, significant differences were found for 3 
scores of the PCS, namely, Rumination (p=0.003), Helplessness (p=0.017), and Total 
(p=0.009), while only the score of Magnification was not considered significant different 
(p=0.149). 
 
4.6.2 Masseter 
 
A quantitative analysis was done to determine a possible association between a 
change in SMU characteristics (in terms of occurrences) and psychological variables 
– See tables 4-71 and 4-72. The PCS and DASS-21 scores of the individuals where 
the occurrence of SMU activity did not alter during any of the infusions for the masseter 
muscle (participants 8, 9, 10, 16) were compared with the same scores of those 
participants where the occurrence of SMU activity did change in at least one block of 
infusion (participants 5, 6, 7, 11, 12, 13, 14, 17, 18, 19, 20). 
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 Stress Depression Anxiety 
DASS-21 for 
participants that did not 
change 
0.5 
 
0 0 
DASS-21 for 
participants who had 
some change 
2 
 
0.2 
 
0.5 
 
Table 4-71: DASS-21 scores comparison between participants who had no changes of the SMU 
occurrence between all the blocks and participants who had. 
 
 Rumination 
 
Magnification 
 
Helplessness 
 
Total 
 
PCS for 
participants that 
did not change 
3.5 
 
2.25 
 
3.5 
 
9.25 
 
PCS for 
participants who 
had some change 
2.9 
 
2.1 
 
3.54 
 
8.5 
 
Table 4-72: PCS scores comparison between participants who had no changes on the SMU 
occurrence between all the blocks and participants who had. 
 
It is possible to notice qualitatively that participants who had not changed the 
occurrence of their SMUs, had lower scores for all the categories in DASS-21 
questionnaire and 3 higher scores (rumination, magnification and total) and 1 higher 
score (helplessness) on the PCS questionnaire. However, the population of 
participants that did not exhibit a change in the SMU occurrence was small (n=4) and 
the firing rates or thresholds values of the units was not considered for this matter.  
 
T-tests were done to compare the scores of the two groups of participants (group 1: 
participants who had no change on their occurrence of SMU; group 2: participants who 
had some change on their occurrence of SMU). 
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No significant differences were found for each score of the DASS-21, Stress (p=0.2), 
Depression (p=0.4), Anxiety (p=0.3) and for the 4 scores of the PCS, Rumination 
(p=0.8), Magnification (p=0.9), Helplessness (p=1.0), Total (p=0.9).  
 
4.6.3 Temporalis x masseter 
 
It is possible to notice qualitatively that those participants who had not changed the 
occurrence of their SMUs, had higher scores for all the categories in DASS-21 
questionnaire and on the PCS questionnaire. However, the population of participants 
that exhibited no change in the SMU occurrence was small (n=3) for the temporalis 
and for the masseter (n=4) and the firing rates of the units was not considered for this 
matter. Tables 4-73 and 4-74 summarize a comparison between the masseter and 
temporalis muscle. 
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DASS-21: 
 
NOT CHANGE x 
CHANGE 
Masseter Temporalis 
Stress not significant (p=0.2) not significant (p=0.5) 
Depression not significant (p=0.4) not significant (p=1) 
Anxiety not significant (p=0.3) not significant (p=0.3) 
Table 4-73: comparison of participants who had not changed the occurrence of their SMUs with 
participants who had for each score of the DASS-21 and its significant difference. Not that no significant 
difference was found for either masseter or temporalis muscle. 
 
 
PCS: 
 
NOT CHANGE x 
CHANGE 
Masseter Temporalis 
Rumination not significant (p=0.8) Higher and significant 
(p=0.003) 
Magnification not significant (p=0.9) not significant (p=0.149) 
Helplessness not significant (p=1.0) Higher and significant 
(p=0.017) 
Total  not significant (p=0.9) Higher and significant 
(p=0.009) 
Table 4-74: Comparison of participants who had not changed the occurrence of their SMUs with 
participants who had for each score of the PCS and its significant difference. Not that no significant 
difference was found for masseter but three scores were significant different for temporalis muscle being 
higher for participants that did not change their SMU occurrence. 
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5 DISCUSSION 
 
5.1 Main findings of thesis in relation to the hypotheses 
 
5.1.1 Firt hypothesis  
 
The first hypothesis of our study stated that “experimental noxious stimulation of the 
right masseter muscle, in comparison with control, does not modify the ability of 
individuals to execute isometric jaw-closing tasks.” 
 
The findings of the present study are consistent with the first hypothesis. Thus, it was 
shown that experimental noxious stimulation of the right masseter muscle, in 
comparison with control, did not modify the capability of individuals to execute 
isometric jaw-closing tasks. There was no significant effect of the experimental pain on 
the generation or fine control of the isometric jaw-closing tasks in terms of rates of 
force increase during fast and slow ramp jaw closing tasks and force amplitudes at the 
2 step levels in the 2 step-levels jaw closing task. These findings are in accordance 
with our first hypothesis. 
 
5.1.2 Second hypothesis 
 
The second hypothesis of our study stated that “experimental noxious stimulation of 
the right masseter muscle results in significant (p<0.05) changes in the activity patterns 
(i.e. SMU recruitment patterns and thresholds) in the right temporalis muscle (a non-
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painful synergistic muscle) and right masseter muscle during isometric ramp jaw 
closing tasks at two different rates of force increase (slow and fast).” 
 
The findings of the present study are consistent with the second hypothesis. Thus, it 
was shown that there were indeed some changes in the occurrences of SMU for the 
temporalis muscle during the hypertonic saline infusion in comparison with the isotonic 
saline infusion; however, the majority of the units did not change their occurrence in 
the ramp tasks. In fact, by comparing the hypertonic saline infusion and the isotonic 
saline infusion for the slow ramp jaw closing tasks, 75.7% of the units did not change 
their pattern of occurrence, while 17.1% of the units were recruited for the hypertonic 
saline block of infusion and 7.2% of the units were de-recruited for the hypertonic saline 
block of infusion. For the fast ramp jaw closing task, 74.6% of the units did not change 
their pattern of occurrence while 12.7% of the units were recruited for the hypertonic 
saline block of infusion and 12.7% of the units were de-recruited for the hypertonic 
saline block of infusion in comparison with the isotonic saline infusion block. No 
significant changes in the SMU threshold were noted between the hypertonic saline 
infusion and the isotonic saline infusion blocks during the isometric ramp jaw closing 
tasks at two different speeds (slow and fast). 
 
In regards to the masseter muscle, similar recruitments patterns were found where the 
majority of the units did not change their occurrence in the ramp tasks. In fact, by 
comparing the hypertonic saline infusion and the isotonic saline infusion for the slow 
ramp jaw closing tasks, 70.2% of the units did not change while 12.8% of the units 
were recruited for the hypertonic saline block of infusion and 17% of the units were de-
recruited for the hypertonic saline block of infusion. For the fast ramp jaw closing task, 
75.6% of the units did not change while 12.2% of the units were recruited for the 
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hypertonic saline block of infusion and 12.2% of the units were de-recruited for the 
hypertonic saline block of infusion in comparison with the isotonic saline infusion block. 
 
5.1.3 Third hypothesis 
 
The third hypothesis of our study stated that “experimental noxious stimulation of the 
right masseter muscle results in significant (p<0.05) changes in the activity patterns 
(i.e. SMU recruitment patterns and firing rates of single motor units, and root mean 
square EMG activity) in the right temporalis muscle (a non-painful synergistic muscle) 
and right masseter muscle during isometric 2 step-levels jaw closing tasks.” 
 
The findings of the present study are consistent with the third hypothesis. The findings 
of the present study indeed found some changes in the occurrences of SMUs for the 
temporalis muscle during the hypertonic saline infusion in comparison with the isotonic 
saline infusion; however, the majority of the units did not change their occurrence in 
the 2 step-levels jaw closing tasks. In fact, by comparing the hypertonic saline infusion 
and the isotonic saline infusion in the 2 steps of the 2 step-levels jaw closing tasks, 
73% and 82.8% of the units did not change for step 1 and step 2 respectively. For the 
step 1, 16.2% of the units were recruited for the hypertonic saline infusion block and 
10.8% of the units were de-recruited for the hypertonic saline infusion block. For the 
step 2, 10.3% of the units were recruited for the hypertonic saline infusion block and 
6.9% of the units were de-recruited for the hypertonic saline infusion block. No 
significant changes in the root mean square of EMG activity or SMU firing rates 
between the hypertonic saline infusion and the isotonic saline infusion blocks were 
found at each step level of the isometric 2 step-levels jaw closing tasks. 
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In regards to the masseter muscle, similar recruitments patterns were found where the 
majority of the units did not change their occurrence in the 2 step-levels jaw closing 
tasks. In fact, by comparing the hypertonic saline infusion and the isotonic saline 
infusion in the 2 steps of the 2 step-levels jaw closing tasks, 82.1% and 94.3% of the 
units did not change for step 1 and step 2 respectively. For the step 1, 7.1% of the 
units were recruited for the hypertonic saline infusion block and 10.8% of the units were 
de-recruited for the hypertonic saline infusion block. For the step 2, 0% of the units 
were recruited for the hypertonic saline infusion block and 5.7% of the units were de-
recruited for the hypertonic saline infusion block. No significant changes in the root 
mean square of the EMG activity from the masseter muscle were found at each step 
level of the isometric 2 step-levels jaw closing tasks. 
 
5.1.4 Fourth hypothesis 
 
The fourth hypothesis of our study stated that “experimental noxious stimulation of the 
right masseter muscle results in significant (p<0.05) changes in the activity patterns 
(i.e. recruitment patterns) in the right masseter (painful muscle) and in the right 
temporalis muscle (a non-painful synergistic muscle) that are not consistent with earlier 
theories of pain-motor interaction, namely, the Vicious Cycle Theory and The Pain 
Adaptation Model.” 
 
The findings of the present study are generally consistent with the 4th hypothesis. 
Thus, the findings of the present study were mostly not consistent with the earlier 
models of pain-motor interactions, namely, the Pain Adaptation Model and the Vicious 
Cycle Theory. There were examples of de-recruitments of SMUs in the temporalis 
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muscle during hypertonic saline infusion in comparison with isotonic saline infusion (5 
SMUs out of 70 SMUs for slow ramp, 9/71 for fast ramp, 4/37 for step 1 of the 2 step-
levels and 4/58 for the step 2 of the 2 step-levels jaw closing task) and examples of 
de-recruitments of SMUs in the masseter muscle (8/47 for slow ramp, 6/49 for fast 
ramp, 3/28 for step 1 of the 2 step-levels and 2/35 for the step 2 of the 2 step-levels 
jaw closing task). As these muscles are agonists in these tasks, these observations 
are consistent with the Pain Adaptation Model that proposes that during pain, agonist 
muscle activity is reduced in the generation of forces in an attempt to minimize the pain 
and this inhibition operates at the brainstem level by inhibiting reflex circuits and/or by 
modifying the central pattern generator for mastication (Lund et al. 1991). There were 
also examples of recruitments of SMUs in the temporalis muscle during hypertonic 
saline infusion in comparison with isotonic saline infusion (12/70 for slow ramp, 9/71 
for fast ramp, 6/37 for step 1 of the 2 step-levels and 6/58 for the step 2 of the 2 step-
levels jaw closing task) and in the masseter muscle (6/47 for slow ramp, 6/49 for fast 
ramp, 2/28 for step 1 of the 2 step-levels and 0/35 for the step 2 of the 2 step-levels 
jaw closing task). These observations are indeed consistent with the proposals of the 
Vicious Cycle Theory which proposes that pain causes a so-called muscle 
“hyperactivity” and this would be reflected in  increases in EMG activity. 
 
5.1.5 Fifth hypothesis 
 
The fifth hypothesis of our study stated that “experimental noxious stimulation of the 
right masseter muscle results in significant (p<0.05) changes in the activity patterns in 
the right temporalis muscle and right masseter muscle that are associated with the 
scores from some psychological measures.”  
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The findings of the present study are consistent with the fifth hypothesis. A qualitative 
analysis of the psychological variables was carried out. The PCS and DASS-21 scores 
of the individuals where the occurrences of SMU activity did not alter during any of the 
infusions for the temporalis muscle (participants 4, 11, 18), were compared with the 
same scores of those participants where the occurrences of SMU activity did change 
in at least one block of infusion (participants 1, 2, 5, 6, 7, 10, 12, 13, 14, 15, 16, 17, 
19). These analyses showed no significant differences for each score of the DASS-21, 
namely, Stress (p=0.5), Depression (p=1), Anxiety (p=0.3). However, significant 
differences were found for the PCS, namely, Rumination (p=0.003), Helplessness 
(p=0.017), and PCS Total score (p=0.009), while only the score of Magnification was 
not significantly different (p=0.149). A similar comparison for the individuals where the 
occurrences of SMU activity did not alter during any of the infusions for the masseter 
muscle showed that there were no significant differences for each score of the DASS-
21, namely, Stress (p=0.2), Depression (p=0.4), Anxiety (p=0.3) and for the 4 scores 
of the PCS, namely Rumination (p=0.8), Magnification (p=0.9), Helplessness (p=1.0), 
Total (p=0.9).  
 
5.1.6 Summary 
 
Taking all the findings together, the data suggest that experimental masseter muscle 
noxious stimulation in healthy adults is insufficient to prevent the performance of a set 
of standardized closing tasks and also does not appear to result in changes in the 
overall level of EMG activity (in terms of RMS activity) at one site within the masseter 
muscle and at one site within the temporalis muscle. The data also indicate that, during 
the noxious stimulation in comparison with control (i.e. baseline or isotonic saline 
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infusion), most single motor units at a site within the masseter and at a site within the 
temporalis muscle appear to be recruited during the task under both noxious 
stimulation and control conditions. In addition, there appears to be no overall effect on 
SMU thresholds during the ramp tasks, and no effect on SMU firing rates during the 
step 1 and 2 of the 2 step-levels jaw closing task. However, although the majority of 
the units were recruited in the tasks during the noxious stimulation block and during 
the control blocks, there was evidence at both muscle sites, during the noxious 
stimulation in comparison with control, for recruitment of new SMUs as well as de-
recruitment of SMUs during all tasks. While there were no overall significant effects on 
firing rates, individual SMUs could show small increases or decreases in firing rate 
during hypertonic saline infusion in comparison with isotonic saline infusion. Further, 
there was some preliminary evidence, at least for the temporalis muscle, that the 
changes in the recruitment patterns of SMU activity occurred in those individuals who 
had PCS scores significantly lower than those individuals who did not show any 
evidence of changes in recruitment patterns. These data provide some support for the 
observation that psychological factors may be playing a role in the pain-motor 
interaction. 
 
The effects noted in terms of recruitments/de-recruitments were not supportive of 
earlier models of pain-motor interaction (namely, Vicious Cycle Theory, Pain 
Adaptation Model). Rather the data point towards more complex effects of pain on 
motor activity which suggest that a reorganization of motor unit recruitments occurs 
both within the painful muscle, as has also been demonstrated for the masseter muscle 
in this present thesis and confirming previous work (Malik 2016; Minami et al. 2013), 
and in addition, as demonstrated in this present work, within other non-painful muscles. 
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The reorganization appears to involve a recruitment of one population of SMUs and a 
de-recruitment of another population of SMUs. 
 
There is good evidence that all the jaw closing muscles (namely, bilateral masseter, 
temporalis and medial pterygoid) are involved in the generation and control of the tasks 
employed in the present thesis (Hannam and McMillan 1994; Miller et al. 1982). The 
present data supporting a reorganization of SMU activity within non-painful muscles 
suggest that re-organization is not restricted to the painful jaw muscle but that the entire 
jaw motor system may undergo a re-organization of SMU recruitment patterns, and 
possibly firing rates, to allow successful task performance. Further, there is suggestive 
evidence that this reorganization might be influenced by the level of pain 
catastrophizing with those with higher PCS scores possibly exhibiting less ability to 
undergo re-organization of SMU activity, that is, these individuals with higher PCS 
scores did not exhibit a change in SMU recruitment patterns between hypertonic saline 
and isotonic saline infusion. The findings also provide another explanation as to how 
task dynamic features (i.e. force rates and force levels) can be unaffected in pain, that 
is, a reorganization of SMU activity may be operating in other agonists to the task and 
not just the agonist subjected to the noxious stimulus. 
 
These new data point to newer models as explanations for the effects of pain on motor 
activity. One such model is the Integrated Pain Adaptation Model, which considers the 
interaction of the individual’s biopsychosocial characteristics with the individual’s pain 
experience (i.e., the multidimensional nature of pain) and the anatomical and functional 
complexity of the individual’s sensory-motor system. 
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5.2 Demographics, questionnaires and infusion data: 
5.2.1 RDC/TMD 
 
The first effort at an evidence-based diagnostic method for TMDs was the Research 
Diagnostic Criteria for TMD (RDC/TMD) in 1992 (Dworkin and LeResche 1992) and is 
nowadays still a diagnostic system widely used in the literature (Fernandes Azevedo 
et al. 2017; Goiato et al. 2017; List and Dworkin 1996; Minami et al. 2013; Osiewicz et 
al. 2017; Sae-Lee et al. 2006; Yap et al. 2002). The RDC/TMD came from the accepted 
need for a diagnostic system that could distinguish cases from controls for 
epidemiological and clinical research purposes, and also differentially define and 
diagnose common subtypes of chronic pain–related TMDs (Ohrbach and Dworkin 
2016). Although the new DC/TMD (Schiffman et al. 2014) is available, the RDC/TMD 
was used in this present study, and all the participants were classified as free of TMD. 
 
5.2.2 DASS21 
 
The DASS 21 is a reliable questionnaire, besides the fact that is free to use and brief 
to administer (Nilges and Essau 2015). Its reliability is widely demonstrated in the 
literature (Le et al. 2017; Osman et al. 2012; Tonsing 2014), and its validation in several 
languages is readily found on the literature as, for example,  Chinese (Wang et al. 
2016), Arabic (Ali et al. 2017), Brazilian and Portuguese (Vignola and Tucci 2014). 
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Assessing the severity of the core symptoms of Depression, Anxiety and Stress 
showed that all of the participants in the current study had low scores for each of the 
scales. The highest mean values were for stress (1.5, SD: 1.9), followed by anxiety 
(0.5, SD: 0.7) and then depression (0.25, SD: 0.8).  
 
Recent studies (Ajilchi and Nejati 2017; Lei et al. 2015) have used a cut-off point where 
a patient would be considered positive for depression if their DASS-21 depression item 
score was ≥14, anxiety if their DASS-21 anxiety item score was  ≥10, and stress if their 
DASS-21 stress item score was ≥19. All the scores in this study were lower than that. 
 
Besides, the range of scores in this study (from 0.25 to 1.5) were lower than TMD 
chronic patient scores according to a previous report from a large sample of chronic 
pain patients and which exhibited a range of scores from 9 to 14 (Nicholas et al. 2008). 
However, one limitation is the fact that this study evoked noxious stimulation in healthy 
individuals and the comparison with chronic pain patients is limited. Yet, all participants 
in this study were not clinically depressed, anxious or distressed.   
 
5.2.3 PCS 
 
Considerable evidence has linked pain catastrophizing to pain responses, and recent 
experimental pain research has suggested that situational catastrophizing, measured 
during or immediately after laboratory pain procedures, is strongly related to pain 
ratings of standardized noxious stimuli (Campbell et al. 2010). 
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In fact, one study published in 2016, manipulated healthy participants and chronic 
tension-type headache patients by giving them 3 types of hypnotic suggestions: 
Negative (based on the 13 items in the Pain Catastrophizing Scale), Positive (coping-
oriented reversion of the Pain Catastrophizing Scale), and Neutral (neutral sentences). 
This study reported that a change in pain catastrophizing predicted changes in pain in 
patients and in healthy volunteers (Kjogx et al. 2016). 
 
In another study (Akhter et al. 2014), experimental muscle pain was induced by 
hypertonic saline infusion into the right masseter muscle. This study showed that, in 
comparison with lower pain catastrophizers, individuals with higher pain 
catastrophizing scores exhibited significant greater values for pain intensity and 
unpleasantness intensity ratings, for all the scores of the MPQ, for the perceived area 
of pain and for the number of referral sites for pain.  
 
Pain catastrophizing is widely shown to be associated with poor pain treatment 
responses in patients with chronic pain (Edwards et al. 2006; Haythornthwaite et al. 
2003; Mankovsky et al. 2012). However, pain catastrophizing is malleable and 
responsive to manipulation (Darnall et al. 2017) and levels of catastrophic thinking 
have been shown to vary in relation to exposure to a wide range of experimental or 
clinical pain stimuli (Campbell et al. 2010). 
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However, research at the University Centre for Research on Pain and Disability 
indicates that a total PCS score of 30 represents a clinically relevant level of 
catastrophizing (Sullivan MJL 1995) and the total mean score in this study was low at 
8.35 and within the 3 subscales, rumination and helplessness had the highest group 
mean (3.25) for both followed by magnification (1.85). Therefore, our data support the 
statement that all participants had low pain catastrophizing levels. It is important to 
mention that the variability in the PCS scores between participants was found which is 
in accordance with previous studies (Campbell et al. 2010; Hsieh et al. 2010; 
Kristiansen et al. 2014) and this can at least partially explain the high variability in the 
pain ratings scores with different infusion rates found in this study. This is in 
accordance with a previous study that stated that even small increments in pain 
catastrophizing score can influence pain perception to deep and tonic stimulations 
(Kristiansen et al. 2014). 
 
5.2.4 Infusions 
 
5.2.4.1 Use of the hypertonic saline 
 
In the present study, 5% hypertonic saline solution was successfully infused with the 
aid of an infusion pump into the central region of the right masseter muscle in 20 
participants.  
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The induction of a noxious stimulation of a muscle with the use of hypertonic saline 
infusion is widely used in a large number of research studies in the orofacial area 
(Akhter et al. 2014; Christidis et al. 2008; Dagsdottir et al. 2015; Inamoto et al. 2017; 
Minami et al. 2013; Shimada et al. 2013; Wiesinger et al. 2013), limb muscles 
(Castelein et al. 2017; Rice et al. 2015; Salomoni et al. 2016), neck muscles 
(Christensen et al. 2017; Gizzi et al. 2015; Lindelof et al. 2009) and lower back 
(Danneels et al. 2016; Larsen et al. 2017; Smith et al. 2005) as it produces a local area 
of transient pain similar in quality and intensity to clinical myalgia (Capra and Ro 2004).  
 
Although other substances might be used to induce pain in experimental studies, such 
as monosodium glutamate (Costa et al. 2017; Kumar et al. 2015a; Pasinato et al. 
2016),  or capsaicin (Arima et al. 2001; Romaniello et al. 2000), a major reason for the 
common use of hypertonic saline is that virtually no side effects are reported after 
hypertonic saline injection, so it can be considered safe (Christidis et al. 2008). And, in 
fact, none of the participants in the present study reported any undesirable side effects 
during and after the infusion.  
 
Another reason for its widespread use of the hypertonic saline in laboratory pain 
studies is that the quality of the induced pain by hypertonic saline is comparable to 
acute clinical muscle pain and shows localized and referred pain characteristics 
(Feinstein et al. 1954; Svensson et al. 1995). 
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It has been reported that injection of hypertonic saline into a jaw muscle results in an 
increase of pain to reach its maximum intensity, and then it decreases shortly after the 
infusion is stopped and declines to no pain within 5-10 minutes (Svensson and Arendt-
Nielsen 1995). These temporal features were observed in the present study. The 
mechanisms involved in the initiation of the saline-induced pain, however, are not 
completely understood. A direct activation of nociceptors and the release of 
neuropeptides and other mediators have been suggested (Tegeder et al. 2002). 
 
In this earlier study (Tegeder et al. 2002), the release of algesic substances in human 
experimental muscle pain after 2 sets of 50 concentric/eccentric contractions was 
compared after the injection hypertonic saline infusion. They provided evidence that 
the injection of hypertonic saline into a muscle directly stimulates muscle nociceptors 
and causes glutamate release, which is strongly associated with muscle pain (Dawson 
et al. 2013; Louca et al. 2014; Shimada et al. 2016). 
 
Lastly, one study found that the saline infusion probably causes nociceptive and non-
nociceptive excitation of muscle receptors. However, the excitation of non-nociceptive 
muscle afferents is assumed to have a smaller influence on the sensory-motor 
interactions compared to the excitation of nociceptive muscle afferents (Madeleine et 
al. 1999). 
 
5.2.4.2 Isotonic infusion as a control 
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Even though it is unlikely that the volume of infusion would cause any changes in pain 
perception, as the extracellular fluid formed by the infusion is still present for a few 
hours after the pain is vanished (Graven‐Nielsen 2006), this study used 0.9% isotonic 
saline infusion as a control for possible changes in the muscle activity due to the 
volume of infusion. Isotonic saline infusion is a good control for volume as an earlier 
study found that bolus injections of isotonic and hypertonic saline result in the same 
increase in intra-muscular pressure (Graven-Nielsen et al. 1997c). 
 
The higher concentration of the hypertonic saline infusion (5%) compared with the 
lower concentration of the isotonic saline infusion (0.9%) is therefore most likely the 
reason for the pain generated by the hypertonic saline and that the use of the isotonic 
saline infusion caused minimal or no pain in the participants of this study. Therefore, 
the comparison between hypertonic saline infusion and isotonic saline infusion 
provides an assessment of the net effect of pain on motor activity. This conclusion is 
also in accordance with previous studies (Amhamed et al. 2016; Castrillon et al. 2017; 
Minami et al. 2013; Sae-Lee et al. 2006; Sae-Lee et al. 2008a; Svensson et al. 2008; 
Svensson et al. 1998; Svensson et al. 1997).  
 
Pain has been induced in the human temporalis muscle by the local injection of (1) 
hypertonic saline and (2) potassium chloride, using isotonic saline as control (Jensen 
and Norup 1992). This study found that both hypertonic saline and potassium chloride 
induced significantly more pain than the isotonic saline.  
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5.2.4.3 Maintaining perceived pain 
 
In the present study, the same perceived pain intensity was achieved by using different 
amounts of saline into the right masseter of different participants. The need for a 
change in infusion rate of saline was determined after each trial by viewing the VAS 
score of each participant. If the participant marked a score on a position of the VAS 
that was visually equivalent to a value lower than 30/100 mm, the infusion rate of 
hypertonic saline was increased, and consequently more volume of hypertonic saline 
was infused. Similarly, after a VAS score was marked on a position equivalent to a 
value higher than 60/100 mm, the infusion rate was decreased.  
 
In the present study, the same range of pain perception (i.e. 30-60/100 mm on the 
VAS) was maintained by varying the injection rate so that a total volume of from 0.1 to 
1.9 ml of 5% hypertonic saline was infused.  In fact, inter-individual variations in scores 
of pain intensity have been reported (Akhter et al. 2014; Amhamed et al. 2016; Graven-
Nielsen et al. 1997a; Jensen and Norup 1992; Kumar et al. 2015a; Sae-Lee et al. 
2008a) and there is even evidence for intra-individual variability in scores of pain 
intensity, quality, distribution and sensory cutaneous changes after saline-induced 
muscle pain (Graven-Nielsen et al. 1997a). 
 
This inter-individual variation might be explained by the influence of an individual's 
genetic composition, prior learning, current physiological status, idiosyncratic 
appraisals, expectations, current mood states, and sociocultural environment (Turk 
2002). These influences manifest as variability in pain sensitivity, perception and 
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tolerance (Kim et al. 2004). Gender is also commonly cited as a possible cause for 
differences in pain perception between males and females (Cairns et al. 2001; Naliboff 
et al. 2003; Walsh et al. 2017).  
 
5.2.5 VAS 
 
Most of the pain assessment tools used by patients and research participants to self-
report their pain are only one dimensional, indicating only pain intensity. They are 
quick, easy to use, and economical. Examples include the numeric rating scale (NRS), 
the visual analog scale (VAS), Faces Pain Scale–Revised (FPS-R), Iowa Pain 
Thermometer (IPT), and Verbal Descriptor Scale (VDS) (Topham and Drew 2017).  
 
The verbal rating scale (VRS), although extensively used, has several disadvantages 
as compared to the VAS. Indeed, comparing those two assessments, it has been 
shown  (Ohnhaus and Adler 1975) that the VAS seems to assess more meticulously 
what a patient actually experiences regarding possible changes in the perception of 
pain intensity. It also appeared to be more satisfactory than the 4-point scale (FPS) for 
patient self-rating of pain intensity (Joyce et al. 1975). 
 
The visual analogue scale was used in this study to measure pain perception due to 
its simplicity and rapidity.  However, it is important to mention its limitations. For 
example, a previous study (Williams et al. 2000) has examined the use of simple pain 
ratings’ scales and has shown that such measures are based on narrow considerations 
and there are possible sources of error. They found that patients with chronic pain had 
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difficulty in rating pain by a single score and the score would possibly be influenced by, 
and with reference to, a range of internal and external factors and private meanings 
(Williams et al. 2000). 
 
In the present study, the mean pain intensity induced by infusion of 5% hypertonic 
saline was measured with the aid of the VAS and was associated with moderate pain 
intensity (30-60 mm on 100 mm VAS). The scores obtained are entirely consistent with 
previous reports of algesic chemical injections into the jaw muscles (Akhter et al. 2014; 
Amhamed et al. 2016; Svensson et al. 1996b). 
 
Three participants exhibited VAS scores >10/100 mm in one or more tasks of the 
isotonic saline infusion, but the hypertonic saline infusion scores were higher and 
therefore, it was considered that the net effect of pain was still being studied in these 
participants. Most of the isotonic saline infusion scores were at or near 0/100 mm and 
this is consistent with previous studies that have used isotonic saline injections into the 
jaw muscles (Graven-Nielsen et al. 1997a; Sae-Lee et al. 2006; Sae-Lee et al. 2008a). 
The higher pain scores in some participants can possibly be explained by the 
discomfort of the needle or by the increase of the intramuscular pressure within a 
confined anatomical compartment of the masseter during the performance of the jaw 
tasks (Graven-Nielsen et al. 1997b).  
 
5.2.6 Distribution of perceived pain 
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In the present study, all participants (n=20) described localised pain in the area of the 
right masseter that was infused with the hypertonic saline solution. However, 2 
participants (participant 2 and 17) also reported referred pain in the right anterior 
temporalis. 
 
Furthermore, for the isotonic saline infusion block, 4 participants (participant 2, 4, 6 
and 19) reported localised pain in the area of the right masseter, and one participant 
(participant 2) also reported referred pain in the right anterior temporalis. However, it 
was considered that the pain was probably due to discomfort associated with the 
needle insertion and this is in accordance with a previous study (Semciw et al. 2013) 
who reported a low level of discomfort after the insertion of intramuscular electrodes 
into the gluteus medius and gluteus minimus muscle. However, this discomfort was 
not considered to alter motor behaviour during locomotion in healthy and low back pain 
patients (Smith and Kulig 2015). 
 
Referred pain can be defined as pain occurring outside and remote from the local pain 
area (Graven‐Nielsen 2006) and is commonly associated with hypertonic saline 
infusion experiments in different muscles of the human body (Drew et al. 2017; Izumi 
et al. 2014; Macefield et al. 2007; Rubin et al. 2010; Rubin et al. 2012).  In fact, our 
results are consistent with previous studies (Graven-Nielsen et al. 1997b; Malik 2016; 
Minami et al. 2013; Sae-Lee et al. 2008b; Stohler et al. 1992; Svensson et al. 1996a) 
where the infusion of hypertonic saline into the masseter muscle induced pain that was 
localized at the injection site, but also the pain could be referred to the adjacent areas 
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of the temporal region, in or around the TMJ, ear, or sometimes referred to the posterior 
teeth or mandible. 
 
In their study, Jensen and Norup induced pain in 20 healthy subjects with 0.2 ml pain-
inducing solution injected into one temporal muscle and isotonic saline into the other. 
Forty-eight percent of the injections led to the referral of pain most often to the jaws. A 
positive correlation between the relative occurrence of referred pain and pain intensity 
was observed (p < 0.001) (Jensen and Norup 1992). Injection of hypertonic saline in 
the tibialis anterior (TA) produced referred pain in the ankle (Graven-Nielsen et al. 
1997b). Hypertonic saline injection into an intrinsic neck muscle induced trunk and 
axioscapular muscle referred pain (Christensen et al. 2015). 
 
Referred pain after noxious muscle stimulation is more likely to depend primarily on 
central mechanisms (Sessle 2006). This phenomenon of referral pain is a common 
clinical find in many musculoskeletal and visceral pain disorders and the underlying 
mechanism is thought to be due to convergence of peripheral afferents from skin, 
muscle, viscera onto common central neurones (Feinstein et al. 1954; Sessle 2006). 
Extensive convergent input from TMJ, muscle, and tooth pulp afferents via craniofacial 
nerves to cutaneous nociceptive neurones onto second order neurones in subnucleus 
caudalis could help explain the poor localization and referral and spread of pain 
involving the deep musculature (Sessle 2006). Furthermore, the development of new 
receptive fields due to central sensitization could mediate referred pain (Mense et al. 
2001). 
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5.2.7 McGill Pain questionnaire 
 
Multidimensional scales that include sensory, affective, and evaluative aspects are 
used in outpatient settings for the management of persistent pain. Examples include 
the McGill Pain Questionnaire, Chronic Pain Grade Scale, Short Form 36 Bodily Pain 
subscale, and Brief Pain Inventory (Topham and Drew 2017). 
 
In this study, the MPQ was used and the data indicate that hypertonic saline infusion 
had a greater effect on the evaluative descriptors from the MPQ as compared to the 
other dimensions. The difference in the MPQ Total pain rating indices indicates a 
difference between hypertonic (7.37) and isotonic saline (2.26) infusions for the mean 
scale scores and also a difference between hypertonic (7.89) and isotonic saline (2.54) 
for the mean weight score. 
 
These results are in agreement with a number of previous studies that shows 
significant pain rating index (PRI) differences between hypertonic saline and isotonic 
saline infusion (Akhter et al. 2014; Malik 2016; Sae-Lee et al. 2006). 
 
Although some studies found some differences in the MPQ values for acute pain 
compared with real chronic pain patients (Reading 1982; Wilkie et al. 1990), previous 
data have shown similarities in terms of the intensity, the sensory and the affective 
experience of experimental pain with the clinical chronic pain condition (Stohler and 
Kowalski 1999). 
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The most cited word in the present study for the hypertonic block of infusion was 
“annoying” (14/20) followed by “aching” (13/20), “pressing” (12/20) and “jumping” 
(8/20). “Boring” was cited by 3 people and “annoying” by 2 during the isotonic block of 
infusion. “Annoying” was also the most cited word in a study involving hypertonic saline 
infusion into trunk muscles (Hirata et al. 2015). “Aching” was also one of the most cited 
words from previous studies in the jaw motor system (Malik 2016; Sae-Lee et al. 
2008a). “Pressing” was also widely cited in another study (Kumar et al. 2015a). 
 
However, it is important to mention that the quality of pain and its impact using verbal 
descriptors are dependent on the individual's verbal repertoire. Incomprehension of the 
descriptors (Main 2016) and ambiguity of usage (Fernandez and Towery 1996) may 
be a factor influencing the words chosen.  
 
5.2.8 Advantages and limitations of Infusion models 
 
The relationship between clinical phenomena and the diverse findings of studies 
performed in animal and human models of experimental pain is often obscure 
(Portenoy 1989), and it can be difficult to translate the findings from experimental 
studies to the clinical situation. 
 
One ideal experimental pain stimulus should not be invasive, and should not produce 
tissue damage; should be specific for measure pain and no other sensations; should 
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be measurable, and demonstrate a relation between the noxious stimulus and the pain 
intensity; should vary from zero to maximal tolerable levels and lastly should be 
reproducible and easily repeatable with no change in the response over time (Arendt-
Nielsen and Sumikura 2002; McCain 1987). 
 
However, according to Arendt-Nielsen and Sumikura in 2002, we cannot directly 
measure pain. We can, instead, measure different components which together are 
important for the pain experienced. In the same study they also compared animal and 
human experimental pain studies and they state that the perceived pain intensity and 
quality that can be recorded in awake humans is the main advantage when compared 
to animal models. In animals, on the other hand, invasive techniques that are not 
possible to reproduce in humans, such as direct recordings from the spinal cord dorsal 
horn, can be applied (Arendt-Nielsen and Sumikura 2002). 
 
Experimental pain models have been used to demonstrate local and referred pain but 
the more significant clinical dilemma is diagnosis and treatment of chronic muscle pain. 
Important elements in the establishment of chronic pain are peripheral and central 
sensitization with signs of muscle hyperalgesia and allodynia (Capra and Ro 2004). 
However, single hypertonic injections in leg muscles did not produce significant 
muscular or subcutaneous hyperalgesia in experimental pain studies (Graven-Nielsen 
et al. 1997d) and therefore make it difficult to translate to clinical pain states. 
 
Nonetheless, experimental pain models have contributed to our understanding of 
central hypersensitivity in different chronic pain conditions. For example, Koelbaek 
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Johansen and co-workers, for instance, demonstrated that not only the pain was 
induced by hypertonic intramuscular saline but also the area of referred pain was 
significantly increased in whiplash patients compared to controls, which can possibly 
be explained by a central sensitization in those patients  (Koelbaek Johansen et al. 
1999). 
 
While the findings of the present thesis only directly apply to a group of young healthy 
individuals experiencing a brief experimental pain stimulus, a cautious extrapolation of 
the findings may be made possibly to individuals experiencing an acute episode of 
pain. 
 
5.3 Effects of pain on force rate and amplitude  
 
In the present study, there was no significant effect of the blocks (baseline, hypertonic 
saline infusion or isotonic saline infusion block) on the force amplitudes (N) in the slow 
ramp and the fast ramp jaw closing tasks or the force levels (N) achieved at each step 
level (step 1 and step 2) of the 2 step-levels jaw closing task. Therefore, despite the 
presence of mostly moderate levels of pain intensity, all individuals were able to 
perform all the tasks in this study and were able to maintain and reproduce the same 
force levels across all the blocks analysed. These findings are not consistent with the 
earlier proposals of the Pain Adaptation Model which would indicate a pain-induced 
reduction in force rates and/or force levels during the performance of the tasks.  
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The isometric jaw closing task in the present study is likely driven by the primary motor 
cortex (Avivi-Arber et al. 2011; Avivi-Arber and Sessle 2017; Sessle 2006), and there 
is good evidence in the spinal and trigeminal literature that the primary motor cortex is 
inhibited by noxious stimulation (Adachi et al. 2008; Nash et al. 2010; Svensson et al. 
1996a). It has been observed, for example, that noxious stimulation of the tongue 
inhibited the excitability of the tongue region of the primary motor cortex but did not 
affect the excitability of the region driving the digastric muscle (Adachi et al. 2008). It 
is possible that localised noxious stimulation within a muscle may selectively inhibit the 
region of the primary motor cortex driving the motor units in the region of the noxious 
stimulation. While this is speculative, the present findings of an absence of an effect of 
noxious masseter stimulation on biting task performance, possibly indicates that 
irrespective of pain in the masseter muscle, the primary motor cortex may undergo 
rapid neuroplastic changes to allow for the task to be completed with equal force 
production during the hypertonic saline infusion as during the isotonic saline infusion. 
This is also part of the neuroplasticity in the system with the possibility of rapid changes 
being able to occur in the recruitment patterns of motor units in association with the 
noxious stimulation. There are many motor units that are available in the jaw closing 
muscles that can be quickly recruited to contribute forces to allow the tasks performed 
in the present study in the presence of pain. 
 
Cortical neuroplastic changes have been associated with altered motor function or 
behaviour in other orofacial motor tasks, such as that which occurs following the 
acquisition of novel motor-skills Boudreau et al., 2007; Boudreau et al., 2010). Some 
of these cortical and/or behavioural effects can be modified by orofacial pain 
(Boudreau et al. 2007, 2010; Kumar et al. 2015). These neuroplastic changes may 
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result in increases or decreases in SMU activity at the site and at other sites and 
muscles involved in task performance. These higher centre influences may contribute 
to the modifications of EMG activity that have been observed in experimental and 
clinical pain (Lund and Stohler 2007; Mense 2007; Murray and Peck 2007; Svensson 
2007; van Dieen et al. 2003). These suprabulbar influences have been incorporated 
into a more recent model of pain-motor interaction, the Integrated Pain Adaptation 
Model (Murray and Peck 2007). This model suggests that during a painful condition, 
there is a reorganization of activity within muscles, which may involve not only any of 
the muscles that might be in pain but also the non-painful muscles. These changes in 
activity occur so as to maintain motor function and the performance of necessary 
kinematic-tasks (Svensson et al. 1996a). The EMG findings of the present study 
support this conclusion. 
 
Another possible reason for the lack of effect of pain on task performance could relate 
to the fact that the pain, induced by the hypertonic saline solution, is known by the 
participant to be short lasting even though it has intensity entirely comparable to that 
noted in patients with clinical TMD pain (Castrillon et al. 2008; Gustin et al. 2011). All 
the individuals tested were also healthy young individuals. Therefore, the knowledge 
and selection of the participants is likely to have been a factor in influencing the effects 
observed, for example, motivational aspects may have meant that the individuals were 
able to perform the task as well under hypertonic saline infusion as isotonic saline 
infusion. However, individuals who have a range of risk factors for TMD (Maixner et al. 
2011; Slade et al. 2007), may exhibit a different motor effect with the experience of a 
brief episode of noxious stimulation; such individuals may have demonstrated 
significantly reduced bite force parameters. This is a possible avenue for further study. 
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Another possible reason for the absence of a pain effect in the force generation in this 
present study could relate to the fact that the tasks were not performed at maximal 
force generation. The lower forces employed may not be able to demonstrate the effect 
that pain has on the force generation as proposed by the Pain Adaptation Model.  
 
Note that while there was no overall effect of the pain on these dynamic measures of 
the tasks, there was suggestive evidence of individual variability (see Tables 4-17, 4-
18, 4-21, 4-22) with some individuals showing increases in dynamic variables in pain 
(vs control) while others showed decreases. It remains to be determined whether these 
variations reflect individual pain-related effects. Individual variations in jaw kinematic 
or dynamic features during hypertonic saline infusion in comparison with isotonic saline 
infusion have been previously reported in isometric jaw closing tasks (Malik 2016) and 
in standardized jaw movements and in free and standardized chewing (Amhamed et 
al. 2016; Sae-Lee et al. 2008a). 
 
In fact there are many studies providing data that are in accordance with the view that 
experimental orofacial pain does not change the ability of individuals to perform a jaw 
motor task (Amhamed et al. 2016; Michelotti et al. 2014; Minami et al. 2013; Sae-Lee 
et al. 2008a; Salomoni and Graven-Nielsen 2012). Limb or trunk motor studies in pain 
also have reported that a motor task can be performed via different patterns of muscle 
activation, but without a change in the ability to perform a motor task (Christensen et 
al. 2017; Falla et al. 2008; Gizzi et al. 2015; Hodges and Moseley 2003). 
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There are also a number of studies in the jaw motor system that demonstrate only 
minimal or no effects on jaw kinematics or dynamics of experimental pain (Amhamed 
et al. 2016; Gizzi et al. 2015; Kumar et al. 2015a; Malik 2016; Michelotti et al. 2014; 
Minami et al. 2013; Sae-Lee et al. 2008a; Sohn et al. 2004; Svensson et al. 1996a; 
Svensson and Graven-Nielsen 2001; Wang et al. 2000) but also of clinical pain 
(Brandini et al. 2011; Pereira-Cenci et al. 2007; Stohler et al. 1988) – see (Murray and 
Peck 2007) for review. For example, to test the hypothesis that experimental pain in 
the masseter muscle or temporomandibular joint would decrease the anterior 
maximum voluntary bite force (MVBF), experimental pain was shown not to affect the 
MVBF, which was also in accordance with the subject-based reports (Kumar et al. 
2015b). A clinical study comparing TMD patients with healthy control individuals also 
demonstrated no differences in maximal bite force between the TMD and the control 
group (Pereira-Cenci et al. 2007).  
 
Not all studies report no or only minimal effects of pain on jaw kinematic or dynamic 
variables. For example, a recent study evaluating the changes in pain and force in 
patients with muscle pain and bruxism, prior to and after 30 days of treatment (with 
occlusal splints, patient education, and physiotherapy) provided evidence that the pain 
level decreased after treatment and this was correlated with a bite force increase in 
the molar region (Goiato et al. 2017). The findings of the present study for an isometric 
jaw closing task also contrast with our previous findings of significant effects of 
experimental masseter muscle pain on the kinematic variables of some jaw movement 
tasks, such as the jaw opening amplitude during standardized open-close jaw tasks 
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(Sae-Lee et al. 2008b) and during repetitive open-close jaw movements (Akhter et al. 
2014).  
 
Our study is also not consistent with the findings of a previous study where breaking 
of hard food in a group of masticatory muscle pain patients took a longer time than in 
a pain-free healthy control group (Shiau et al. 2003). In addition, a study of patients 
with signs and symptoms of TMD, compared with control, showed higher masticatory 
efficiency, increased chewing time and increased EMG activity of the masseter and 
temporalis muscles and featured an altered chewing pattern (Rodrigues et al. 2015). 
Another study actually found that the TMD patients chewed faster and with higher 
amplitude jaw movements in comparison with matched controls (Brandini et al. 2011). 
 
The inconsistencies between studies may relate to methodological differences 
between studies (e.g. dependent variables chosen), or may relate to true differences 
between tasks as to the effects that pain has on motor activity. This conclusion is 
consistent with the findings from a review of an extensive analysis of the literature on 
trunk muscle recruitment in low back pain patients. This extensive review concluded 
that neither one of the two models examined in this review (namely the Vicious Cycle 
Theory and The Pain Adaptation Model) adequately predicted the effects of back pain 
on trunk muscle activation (van Dieen et al. 2003). They also stated that the changes 
observed are likely to be task-dependent, related to the individual problem and hence 
highly variable between and probably within individuals. Therefore, more complex 
models of pain-motor interactions have been previously proposed (Murray and Peck 
2007).  
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5.4 Root Mean Square (RMS) analysis of EMG activity 
 
Root mean square analysis of EMG activity from the masseter and temporalis muscles 
during the 2 step-levels jaw closing task revealed no significant differences in the level 
of EMG activity between baseline, hypertonic saline infusion, isotonic saline infusion 
and baseline 2 from both muscles. Previous studies of experimentally induced pain in 
humans have shown increases  (Del Santo et al. 2007; Sae-Lee et al. 2008a; Sessle 
1999b; Svensson et al. 1997), decreases (Del Santo et al. 2007; Farina et al. 2005; 
Sae-Lee et al. 2008a) or no effects (Farina et al. 2004; Matre et al. 1999; Sae-Lee et 
al. 2008a; Schulte et al. 2004) on muscle activity. 
 
These RMS findings of the present study are generally inconsistent with many previous 
studies showing that pain does indeed have effects on overall EMG activity during a 
variety of tasks (Baad-Hansen et al. 2009; Farina et al. 2005; Graven-Nielsen et al. 
1997c; Sae-Lee et al. 2008b; Shimada et al. 2013; Sonnesen and Svensson 2013; 
Tucker et al. 2009). But the present study is in accordance with a previous study (Malik 
2016) that was performed and which used a similar methodology as in the present 
study and which found no significant effect of pain on RMS activity. Also, no differences 
have been reported in the RMS EMG activity of muscles contralateral to the muscle 
where pain was induced and in the same experimental paradigm as performed here 
(Sandoval 2017). The different experimental paradigms (e.g. the different tasks) for 
some of these other studies may be a factor contributing to the differing observations 
of the effects of pain on global EMG activity. Also an earlier study of the effects of 
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hypertonic saline induced pain on EMG activity during standardized jaw displacements 
(Sae-Lee et al. 2008a), provided evidence that under constrained goal-directed tasks, 
the pattern of pain-induced changes in jaw muscle EMG activity is not clear cut, but 
can vary with the task performed, jaw displacement magnitude, and the subject being 
studied. For example, this earlier study showed that the effect of experimentally 
induced muscle pain by hypertonic saline on agonist muscle activity could vary 
between tasks in comparison with isotonic saline infusion. The activity of the inferior 
head of the lateral pterygoid muscle was not affected during a contralateral and a 
protrusive jaw movement but was significantly affected during jaw opening (Sae-Lee 
et al. 2008).   
 
Although these collective results of RMS EMG activity in the present study did not 
reveal any significant differences between hypertonic saline and isotonic saline 
infusions, interestingly, the means were higher in the baseline 2 for the right masseter 
muscle step 1 and step 2 than all the other blocks within the same muscle, and higher 
for the hypertonic block for the right temporalis muscle step 1 and step 2 for all the 
other blocks within the same muscle 
 
These differences might reflect a number of factors. One possible factor is that the pain 
may have different effects on different jaw muscles and also may be task dependent 
in that some motor tasks may be more likely to show an effect than other tasks. This 
conclusion is entirely consistent with previous observations that pain has different 
effects on the EMG activity of different jaw muscles (Sae-Lee et al. 2008b; Svensson 
et al. 1997). In fact, Hannam and McMillan in 1994 pointed out other factors that may 
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explain these differences on the RMS activity such as the location of the SMU, its 
background firing rate, the timing of the stimulus, and the task used. The last one is a 
common feature of human jaw SMU behaviour and it reflects interaction between 
peripheral sensory information from orofacial and muscle afferents and corticobulbar 
drive (Hannam and McMillan 1994). 
 
Motivation and other higher centre influences might be other factors that could possibly 
influence the differences in RMS activity in this study. According to the methodology of 
this study, all the participants were verbally encouraged to follow the target as much 
as possible. This might have implications as different effects are likely to be observed 
during pain when participants are instructed to follow a target in comparison to free 
movements. For the former, the motivation to track the target may override any 
possible pain-related EMG or movement effect and this has been noted previously 
(Sae-Lee et al. 2008b). 
 
An individual analysis of RMS EMG activity indicated that potential individual effects of 
pain on RMS activity might be apparent and where pain could possibly induce different 
motor effects between individuals. It was possible to classify that changes were either 
consistent with The Vicious Cycle Theory (VCT) or The Pain Adaptation Model (PAM) 
within an individual. For example, at the right masseter and at the right temporalis 
during step 1 and step 2 of the 2 step-levels jaw closing task, there were many 
examples of an increase in RMS activity which was consistent with VCT as well as 
many examples of a decrease in RMS activity which was consistent with the PAM 
during hypertonic saline infusion in comparison with isotonic saline infusion.  
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These possible effects may simply reflect variation in EMG activity related to, for 
example, small variations in the force levels achieved in the step tasks. Alternatively, 
the present analysis suggested that these individual differences in EMG activity 
between hypertonic saline infusion and isotonic saline infusion actually reflect an 
individual pain-related effect and was not simply due to the fact that the participant 
exerted more or less force in a particular block.  For the masseter step 1, 10 
participants increased their RMS activity during hypertonic saline infusion and among 
them, 4 presented lower force during the hypertonic saline block and 6 presented lower 
force during the isotonic saline block. On the other remaining 10 participants, that 
decreased their RMS activity during the hypertonic saline infusion, 5 presented lower 
force during the hypertonic saline infusion and 5 presented lower force during the 
isotonic saline infusion. For step 2, 6 participants increased their RMS activity during 
hypertonic saline infusion and among them, 5 presented lower force during the isotonic 
saline block and only 1 presented lower force during the hypertonic saline block. On 
the remaining 14 participants, that decreased their RMS activity during the hypertonic 
saline infusion, 6 presented lower force during the hypertonic saline infusion and 8 
presented lower force during the isotonic saline infusion. 
 
For the temporalis step 1, 10 participants increased their RMS activity during 
hypertonic saline infusion and among them, 5 presented lower force during the 
hypertonic saline block and 5 presented lower force during the isotonic saline block. 
On the other remaining 10 participants, that decreased their RMS activity during the 
hypertonic saline infusion, 4 presented lower force during the hypertonic saline infusion 
and 6 presented lower force during the isotonic saline infusion. For step 2, 9 
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participants increased their RMS activity during hypertonic saline infusion and among 
them, 5 presented lower force during the isotonic saline block and 4 presented lower 
force during the hypertonic saline block. On the remaining 11 participants, that 
decreased their RMS activity during the hypertonic saline infusion, 3 presented lower 
force during the hypertonic saline infusion and 8 presented lower force during the 
isotonic saline infusion. 
 
This suggestive evidence of individual effects in the present study is consistent with 
previous findings and conclusions (Amhamed et al. 2016; Hodges and Tucker 2011; 
Sae-Lee et al. 2008a; Sae-Lee et al. 2008b; Wiesinger et al. 2013). The literature has 
also detected inter-individual differences not only in responses to pain but also in 
responses to intervention (Fillingim 2005). 
 
In summary, the findings of no overall effects of hypertonic saline infusion on RMS 
EMG activity are difficult to explain by earlier models. The possibility of individual 
effects are possibly more in accordance with more recent models that propose that 
motor behaviour is variable between different individuals and effects are mediated at 
multiple levels of the nervous system and these effects may depending the experience 
or perception of pain (Hodges and Tucker 2011; Murray and Peck 2007). One of these 
more recent theories also suggests that individual pain-related effects result from the 
interaction between the unique biopsychosocial dimensions of pain (sensory aspects 
and pain-related cognitions, mood) and the complex organization of sensorimotor 
systems. This resultant change in activity might arise because of reorganization in 
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activity at the level of the primary motor cerebral cortex (MI) in order to relieve the pain 
and thus maintain homeostasis (Murray and Peck 2007).  
 
5.5 Single motor units from temporalis 
 
To our knowledge, this is the first characterization of the effects of noxious stimulation 
of one jaw muscle on the activity of SMUs in a non-painful synergistic jaw muscle 
during a standardized jaw closing task. Table 4-27 and table 4-32 summarize the 
occurrence of each SMU from the right temporalis muscle under the ramp jaw closing 
tasks and 2 step-levels jaw closing task respectively. From these tables, a summary 
has been constructed and is shown in Table 5-1 which lists the percentages of SMUs 
that exhibited some change in the occurrence (recruitment and/or de-recruitment) of 
SMU activity during each of the tasks or did not change.  
 
 Ramps Step 1 Step 2 
Changed 40/75 (54%) 15/37 (40%) 12/58 (21%) 
Did not change 35/75 (46%) 15/37 (40%) 32/58 (55%) 
Table 5-1: For the 75 SMUs discriminated for the ramp jaw closing tasks, 40 SMUs (54%) exhibited 
some change in their occurrence and the remaining 35 SMUs (46%) did not change their occurrence 
during the tasks and between blocks. From the 37 SMUs discriminated for the step 1 of the 2 step-levels 
jaw closing task, 15 SMUs (40%) did not change their occurrence, and 15 SMUs (40%) did exhibit some 
change in their SMU occurrence, and in 7 SMUs it was not possible to confirm if they were present in 
all of the blocks due to a technical issue. From the 58 SMUs discriminated for the second step of the 2 
step-levels jaw closing task, 32 SMUs (55%) did not change the occurrence, 14 SMUs (21%) did exhibit 
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some change in their occurrence and 12 presented a technical issue that was not possible to state if 
their presence were confirmed during the 4 blocks or not. 
 
Also, by comparing specifically the hypertonic saline infusion with the isotonic saline 
infusion, table 5-2 summarizes the number of units and the percentage that were 
recruited only for the hypertonic saline infusion, that were de-recruited for the 
hypertonic saline infusion or that were present in both conditions (hypertonic and 
isotonic saline infusion): 
 
 I x H SR I x H FR I x H step 1 I x H step 2 
No change 53/70 
(75.7%) 
53/71 
(74.6%) 
27/37 (73%)  48/58 
(82.8%) 
Recruited  12/70 
(17.1%) 
9/71 (12.7%) 6/37 (16.2%) 6/58 (10.3%) 
De-recruited 5/70 (7.2%) 9/71 (12.7%) 4/37 (10.8%) 4/58 (6.9%) 
Table 5-2: Number of units and the percentage that were recruited only for the hypertonic saline infusion, 
that were de-recruited for the hypertonic saline infusion or that were present in both conditions. I: isotonic 
saline infusion; H: hypertonic saline infusion; SR: slow ramp jaw closing task; FR: fast ramp jaw closing 
task; Step 1: step 1 of the 2 step-levels jaw closing task; step 2: step 2 of the 2 step-levels jaw closing 
task. 
 
These present findings extend the findings from analogous studies in the lower limb 
and the jaw motor system. Proportionally, the number of units that were identified 
during both conditions (pain and no pain) in the present study, that is, their occurrences 
272 
 
were unaffected by pain, were higher than in a previous study (Tucker et al. 2009) 
which discriminated a total of 52 units in the quadriceps muscle and 34 in the flexor 
pollicis longus muscle (FPL) during low-force contractions with pain (hypertonic) and 
without pain (baseline). Of these units, only 20 (38.5%) in the quadriceps and 9 (26.5%) 
in the FPL units were identified during both trials while all the remaining units 
discharged only with or without pain, but not in both conditions. But the present study 
is indeed in accordance with other recent studies where the majority of the SMUs 
collected from the masseter were present in both conditions (pain and no pain) (Malik 
2016; Minami et al. 2013). This apparent difference between the earlier limb studies 
and the recent (Malik 2016; Minami et al. 2013) and present studies in the jaw, might 
be explained by methodological differences between the studies given the different 
motor systems being studied. The difference between studies may also reflect possible 
differences in the central control systems driving single motor units between masseter 
and limb and trunk muscles. For example, in comparison with the jaw motor system, 
the limb motor system may exhibit greater flexibility in recruitment patterns for a 
specific task. 
 
To our knowledge there have been no studies with intramuscular electrodes about the 
effects of noxious jaw muscle stimulation on SMU activity in non-painful synergistic jaw 
muscles. However, there have been many studies of possible effects on non-painful 
synergistic jaw muscles (and other muscles groups) obtained from surface EMG 
electrodes (Ciubotariu et al. 2004; Gizzi et al. 2015; Kumar et al. 2015b; Malik 2016; 
Sae-Lee et al. 2008a; Sandoval 2017; Schulte et al. 2004; Svensson and Arendt-
Nielsen 1995). Some of these earlier studies have shown effects of noxious jaw muscle 
stimulation on the EMG activity of non-painful synergistic muscles (Ciubotariu et al. 
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2004; Gizzi et al. 2015; Sae-Lee et al. 2008b) while other studies do not show effects 
(Hodges et al. 2008; Kumar et al. 2015b). For example, in a recent study (Kumar et al. 
2015b), experimental pain was induced in the left masseter and left TMJ with a 3-4 day 
interval between pain sessions. Analysing the surface EMG activity, the left masseter 
pain did not evoke a significantly different activity in the muscles analysed (left 
masseter, right masseter, left temporalis, digastric) during maximum voluntary bite 
force. However, the pain induced in the left TMJ resulted in significantly different EMG 
activity of the anterior temporalis and anterior digastric muscles. The findings of the 
present study shows that no effect was noted on the RMS EMG activity (see Tables 4-
25 and 4-26) of the temporalis muscle after noxious hypertonic saline injections into 
the masseter muscle, which is consistent with the earlier findings of no EMG effects 
on the surface EMG activity.  
 
However, other studies have shown effects on synergistic and antagonistic non-painful 
muscles (Kumar et al. 2015a; Sae-Lee et al. 2008b). For example, in a standardized 
jaw opening movement performed during hypertonic saline infusion into the right 
masseter muscle in comparison with isotonic saline infusion, not only was the surface 
EMG activity of the right masseter significantly affected but also the surface EMG 
activity of the left masseter, the right digastric and right inferior head of the lateral 
pterygoid muscle (Sae-Lee et al. 2008b). The presence of significant EMG effects 
noted in the jaw muscles in these earlier studies and the absence noted in the RMS 
EMG activity in the present study may relate to task differences. Thus, the study of 
Sae-Lee et al employed jaw opening and lateral and protrusive jaw movement tasks 
that involved tracking a target; there was no added resistance to the jaw movements 
in these tasks. The present study was an isometric jaw closing task demanding higher 
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force generation. It is possible that jaw muscle EMG activity at the level of an RMS or 
surface EMG analysis may not be affected by jaw muscle noxious stimulation where 
significant closing forces (e.g. 50-150 N) are required but may be more subject to 
changes in global EMG activity for light jaw movements as was demonstrated in the 
earlier study (Sae-Lee et al. 2008b). The analysis of SMU activity in the present study 
showed that most SMUs were unaffected in their occurrences during hypertonic saline 
vs. isotonic saline infusion. A SMU analysis has not been done for the studies of effects 
of noxious jaw muscle stimulation on the jaw muscle activity during light jaw 
movements as employed in the previous study (Sae-Lee et al. 2008b). However, this 
is an avenue for further investigation. 
 
5.5.1 Carry-over or possible persistent effect of pain; fatigue 
 
Despite the presence of pain in this study, a few factors should be considered for these 
pain experimental models. For example, there may be possible carry-over effects of 
the pain induced by the hypertonic saline infusion on subsequent pain-free recordings. 
The possibility of muscle fatigue may also be a factor, and the performance of the 
participant on executing a specific task.  
 
In terms of possible carry-over effects, SMUs 81, 82 and 83, for example, were present 
for slow and fast ramps during the hypertonic and baseline 2 blocks (see Table 4-32). 
For those units, the solution applied first was the isotonic saline, and the hypertonic 
saline infusion was done just before the baseline 2 block. One possibility therefore is 
that the hypertonic saline solution could have had a carry-over effect on the 
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subsequent baseline 2 block, and which manifest as the presence of those units in this 
block as well. As another example, SMUs 3, 21 and 22 were not present in the baseline 
(block 1), but were at least present in all the other infusion blocks (i.e. blocks 2 and 3) 
(Table 4-32). This pattern of recruitment could also reflect a carry-over effect of the 
solution applied first (hypertonic) and which may have resulted in a SMU remaining 
active in the next recording session of isotonic infusion if it became initially recruited in 
the previous hypertonic saline session.  
 
It is possible therefore, that carry-over effects could be a factor in the pattern of 
occurrence of SMU activity in the jaw motor system in the present study. If so, then the 
data suggest that, even though noxious jaw muscle stimulation resulting in pain may 
provide the trigger for rapid neuroplastic changes in the brain (manifesting as changes 
in recruitment patterns of SMUs), the removal of the noxious stimulation (and 
associated pain) may not be enough to result in an immediate return to the original 
motor output. The factors that trigger a return to normal motor output following the 
resolution of acute muscle pain are unknown  (Schabrun et al. 2017). However, the 
evidence in the present study for possible carry over effects is not consistent with a 
recent study that showed that a bolus injection of hypertonic saline into the masseter 
muscle in healthy individuals does not lead to post-pain changes in jaw movement or 
jaw-muscle activity during chewing that are caused by the previous experience of pain 
(Inamoto et al. 2017). This study did not find any significant main effects of group (pain 
infusion, control) on jaw movement and jaw-muscle activity during the opening and 
closing phases of chewing after resolution of pain, although the authors recommended 
other experimental designs examining possible persistent effects of pain on motor 
activity. Another factor to consider is the possible influence of practice or training 
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effects with repetitions of the task, which could also have played a role in the present 
study. Practice or training effects were minimised by alternating the sequence of 
infusion between participants.  
 
Nonetheless, there is evidence in the literature that changes in muscle activity 
associated with experimental or clinical low-back pain or knee pain can persist beyond 
the period of the pain, and this evidence suggests a possible carry-over effect (Hides 
et al. 1996; Hodges et al. 2003; MacDonald et al. 2009; Moseley and Hodges 2005; 
2006; Tucker et al. 2012; Tucker and Hodges 2009). For example, in an earlier study 
(Tucker and Hodges 2009), changes in SMU recruitment patterns were noted during 
experimental pain in comparison with control and these effects persisted even after the 
pain had subsided. 
 
In the jaw motor system, previous rat and human studies have shown prolonged 
decreases in face primary motor cortex (face M1) excitability that outlasted the duration 
of the stimulus following noxious jaw or tongue muscle stimulation (Adachi et al. 2008; 
Nash et al. 2010). Recently the neuroplastic capabilities of the face SI and face MI 
have been reviewed (Avivi-Arber et al. 2011). This neuroplasticity allows for functional 
adaptation (or maladaptation) of the orofacial sensorimotor system to an altered oral 
state or oral motor behaviour and it is likely that longer term changes occur in the face 
MI during noxious stimulation of the orofacial area. Analogous findings of changes in 
motor cortex excitability have been reported in limb motor cortex studies (Farina et al. 
2001; Le Pera et al. 2001). 
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Another factor to consider in the interpretation of these SMU data is the possibility of 
fatigue as an explanation for changes in SMU activity patterns between blocks. This 
factor was partly controlled by alternating the sequence with which the hypertonic 
saline and isotonic saline solutions were administered between successive 
participants. In addition, only 3 trials were performed for each task and the tasks were 
mostly at low force levels in relation to the maximum forces that most people can 
perform (Kumar et al. 2015b; Takaki et al. 2014). Therefore, it is considered that fatigue 
is unlikely to be a major factor in the patterns of recruitment of SMUs. Nonetheless, 
some of the data could be interpreted in terms of the occurrence of fatigue in some 
participants in the present study. For example, SMUs 57 and 59 were present in all the 
blocks but were not present in the second baseline.  
 
Fatigue is a common symptom in chronic pain disorders and there are strong positive 
correlations between fatigue levels and pain intensity (Boggero et al. 2014; Boggero 
et al. 2017; de Leeuw et al. 2005) and exhausting muscle contraction is also found to 
induce change in its EMG activity. For example, a recent study involved a 20-minute 
tooth-clenching task (50% of maximal voluntary contraction force) and analysed 
pain (Numeric rating scale 0-10) and fatigue (Borg's Ratings of Perceived Exertion 6-
20) throughout microdialysis. They concluded that tooth-clenching increased jaw 
muscle pain and fatigue (Louca Jounger et al. 2017). However, the duration and 
magnitude of clenching in this study was much greater than in the present study where 
the total time involved in exerted bite forces was around 7 minutes. 
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5.5.2 SMU activity and the vicious cycle theory and the pain adaptation model 
 
An analysis was done unit by unit from the temporalis muscle to see if the data 
supported or not the earlier models (namely, the Vicious Cycle  
Theory and Pain Adaptation Model). The summary table (Table 4-41) show that there 
was only little evidence for support for both of these earlier models.  These findings 
are consistent with an extensive review of the chronic back pain literature, where the 
effects of pain on trunk muscle activation were neither consistent with the vicious cycle 
theory nor with the pain adaptation model (van Dieen et al. 2003). 
 
In fact, from the 83 units discriminated from the temporalis muscle in this study, the 
majority of the units (56/70 for the slow ramp jaw closing task, 53/71 for the fast ramp 
jaw closing task, 27/37 for the step 1 of the 2 step-levels jaw closing task and lastly, 
48/58 for the step 2 of the 2 step levels jaw closing task) were neither consistent with 
the Vicious Cycle Theory nor the Pain Adaptation Model. This analysis was based on 
the presence or not of a SMU during task performance for a comparison of hypertonic 
saline infusion with isotonic saline infusion. As indicated above, this analysis has a 
limitation that it does not take into account possible changes in firing rates of SMUs, 
which could support or not one of the earlier theories. 
 
The Pain Adaptation Model proposes that during pain, agonist muscle activity is 
reduced in the generation of forces in an attempt to minimize the pain and this inhibition 
operates at the brainstem level by inhibiting reflex circuits and/or by modifying the 
central pattern generator for mastication (Lund et al. 1991). The present data show 
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that these possible inhibitory effects on α-motoneuronal activity from nociceptive 
activity were insufficient to prevent the descending drive, likely to be from the face area 
of the primary motor cortex, from activating and recruiting many of the SMUs required 
during the three tasks developed in this study (slow ramp, fast ramp and 2 step-levels 
jaw closing task). The goal-directed nature of the tasks therefore was able to reverse, 
or minimize the effects of, any possible inhibitory effects in the brainstem as proposed 
by the Pain Adaptation Model.  
 
The finding of a small number of SMUs that was present during the isotonic saline 
infusion but was not during the hypertonic saline infusion, is indeed consistent with the 
Pain Adaptation Model. This finding is consistent with other recently reported studies 
where noxious masseter or tongue muscle stimulation results in inhibitory influences 
at the level of the primary motor cortex (Adachi et al. 2008; Nash et al. 2010) and where 
inhibitory effects on agonist jaw muscle activity have been noted with noxious jaw 
muscle stimulation (Sae-Lee et al. 2008b). 
 
The ability to continue to perform the ramp and step tasks during the hypertonic saline 
infusion even with the cessation of SMU activity can possibly mean that other SMUs 
are recruited either within the masseter or in other jaw closing muscles, and this has 
been demonstrated in the present study for the temporalis muscle. Potentiation of 
twitch force is another possibility for maintenance of force and it has been shown to be 
a pain-related compensatory mechanism to maintain constant force output during 
painful isometric contractions when SMU firing rates decrease (Sohn et al. 2004; 
Turkawski and van Eijden 2000). 
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The number of neural strategies possible to perform a task might decrease as the force 
magnitude increases as more and more units necessarily become recruited. It is 
possible that the force levels used in the present study, and/or the nature of the biting 
task may have been why most units were unaffected by the noxious stimulation. In 
terms of the nature of the specific biting tasks performed in the present study, it is 
possible that a specific pattern of recruitment of SMUs is best suited and therefore 
possibly less likely to be modifiable by an external intervention, e.g. a noxious stimulus. 
Most of the findings (in terms of occurrences) did not appear to be consistent with the 
pain adaptation model and this was noted for both of the muscles analysed (masseter 
and temporalis). This suggests that the ability to override any inhibitory effects on SMU 
activity during tasks is a generalized feature throughout all agonist muscles involved 
in jaw tasks. Clearly, more studies are needed to confirm this tentative assumption. 
 
In the case of the Vicious Cycle Theory, the present findings showed that the 
occurrence of most of the SMUs recorded in the temporalis muscle during the different 
jaw tasks exhibited a pattern that was not consistent with a critical component of the 
vicious cycle theory that pain leads to increased jaw muscle activity. This finding is 
consistent with the findings from a number of previous studies where in general, the 
vicious cycle hypothesis was not supported (Graven-Nielsen and Arendt-Nielsen 2008) 
– for reviews see (Murray and Peck 2007; Murray et al. 2014). 
 
The small number of SMUs that was not present during the isotonic saline infusion but 
that was recruited during the hypertonic saline infusion, provide a pattern of activity 
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that was indeed consistent with the Vicious Cycle Theory. This finding of recruitment 
of SMUs in the presence of noxious stimulation is consistent with some other studies. 
For example, the activation of the sternocleidomastoid during a multidirectional 
isometric task in chronic neck pain patients found increased muscle activity across all 
movement directions, thus, supporting the vicious cycle theory (Falla et al. 2010). In 
addition, evidence of increased agonist and antagonist muscle activity has been 
reported with hypertonic saline induced experimental masseter muscle pain during 
some standardized jaw movement tasks (Sae-Lee et al. 2008b).  
 
Therefore, rather than supporting these earlier models that propose uniform increases 
or reductions in muscle activity during pain throughout a muscle, the new data show 
that both recruitments and de-recruitments of SMU activity can occur in the agonist 
muscles of the present study and that these effects likely involve all the muscles 
involved in task performance. While these earlier models did not imply restriction of 
pain-related motor effects to just the muscle in pain, these earlier models appear to 
assume that uniform effects do occur throughout a muscle.  The data of the present 
study do not support this view but rather provide support for more recent models 
proposing a re-organization of the recruitment strategy adopted by the brain in the 
control of motor units in the presence of pain (Hodges and Tucker 2011; Murray and 
Peck 2007). 
 
5.5.3 Thresholds of SMU activation 
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The analysis of the mean threshold values of the SMUs recorded from the temporalis 
muscle for the slow and fast ramp jaw closing tasks during all recording blocks was 
also performed for testing for any interactions between the infusion blocks. There were 
no significant differences between blocks. This is consistent with a few studies where 
the thresholds did not appear to change due to pain (Malik 2016; Sohn et al. 2000). In 
both these studies, SMUs were recorded from the masseter muscle during infusion of 
hypertonic saline or capsaicin into the same muscle and during performance of a biting 
task. There were no effects noted on SMU thresholds from the masseter during these 
tasks under pain in comparison with control. Variation in the threshold of firing of SMUs 
during pain is an additional mechanism to maintain force output despite the de-
recruitment of other SMUs. Thus, for example, a reduction in threshold of a particular 
SMU would mean that force would be generated earlier from that SMU, and this might 
compensate for the loss of activity of other SMUs. 
 
A possible explanation for the finding that the recruitment threshold of the SMUs did 
not seem to decrease during painful contraction in the present study, could be that the 
recruitment of additional SMUs was sufficient to maintain constant force output without 
changing the recruitment threshold. Changes in firing rate of some existing SMUs 
might also contribute; however, there was no evidence of a change in firing rate of 
SMUs during hypertonic saline infusion in comparison with isotonic infusion (see 
section 5.5.4). Another possibility is that individual SMUs might be differentially 
affected in terms of threshold by the nociceptive stimulus. This was not analysed in the 
present study but could be an avenue of further investigation that would involve 
repetition of more trials of a task so that statistical analysis could be carried out on 
individual SMUs. 
283 
 
 
There was a significant difference in repeating the ramp tasks for one or more of the 
blocks. While this was only noted for a few of such analyses, it may relate to some 
greater variability in task performance under certain conditions. This was not analysed 
in the present thesis but is a possible avenue for further research. Alternatively, a 
person has a broad range of neural strategies for performing one specific task, and it 
might be different based on many factors, such as the presence of pain, the task 
performed, how motivated the person was to perform that task or due to neuromuscular 
adaptations related to learning optimal muscle activation patterns. Changes in neural 
strategies may also have contributed to this variability in repeating the tasks. 
  
5.5.4 Firing rates 
 
A qualitative analysis of the effects of hypertonic saline infusion, in comparison with 
isotonic saline infusion, on firing rates was carried out and of these 20 SMUs that were 
studied in this way at step 1 of the 2 step-levels jaw closing task, 8 single motor units 
showed a decrease in firing rates, and 6 single motor units showed an increase in firing 
rates when comparing hypertonic vs. isotonic recording sessions. Also, 4 single motor 
units “3, 27, 63, 76” were absent during the hypertonic block while 2 single motor units 
“5, 69” were absent for the isotonic block. For the 15 SMUs studied at step 2 of the 2 
step-levels jaw closing task, 3 single motor units showed a decrease in firing rates, and 
9 single motor units showed an increase in firing rates when comparing hypertonic vs. 
isotonic recording sessions. The remaining units were de-recruited in one of the blocks. 
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These possible effects may simply reflect variation in firing rates activity related to, for 
example, small variations in the force levels achieved in the step tasks. Alternatively, 
the present analysis suggested that these individual differences in firing rates activity 
between hypertonic saline infusion and isotonic saline infusion actually reflect an 
individual pain-related effect and was not simply due to the fact that the participant 
exerted more or less force in a particular block.  
 
For the step 1, from the 8 SMUs that decreased their firing rates activity during 
hypertonic saline infusion, 2 presented lower force during the hypertonic saline block 
and 6 presented lower force during the isotonic saline block. On the remaining 6 SMUs, 
that increased their firing rates activity during the hypertonic saline infusion, 2 
presented lower force during the hypertonic saline infusion and 4 presented lower force 
during the isotonic saline infusion.  
 
For the step 2, from the 3 SMUs that decreased their firing rates activity during 
hypertonic saline infusion, all 3 presented lower force during the isotonic saline block. 
On the remaining 9 SMUs, that increased their firing rates activity during the hypertonic 
saline infusion, 2 presented lower force during the hypertonic saline infusion and 7 
presented lower force during the isotonic saline infusion. 
 
Overall there was no significant difference in firing rates of SMUs when comparing the 
hypertonic and the isotonic saline infusion blocks. This finding is consistent with 
previous findings (Malik 2016; Minami et al. 2013) who found no significant difference 
in firing rates of SMUs between pain (hypertonic) and no pain (Isotonic) sessions in 
the masseter muscle during the performance of a biting task. However some SMUs 
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discriminated from this more recent study (Malik, 2016) showed increases (4 at right 
masseter inferior/right masseter posterior and 8 at RMS/RMA) and decreases (5 at 
RMI/RMP and 3 at right masseter superior/right masseter anterior) in firing rates during 
the hypertonic infusion session in comparison to the isotonic infusion session. These 
changes in firing rates observed at a SMU level may reflect actual pain-related changes 
in activity and as such are in agreement with the current study which also found 
increases and decreases in firing rates.  
 
One possible explanation for the absence of an overall effect of pain on the firing rates 
is that the same force is achieved by the recruitment of additional higher threshold 
motor units during the painful contraction while lower threshold motor units are de-
recruited (or vice-versa). This reorganization could also explain why surface EMG 
amplitude remained constant despite the pain in this study. 
 
This explanation does not appear to be consistent with the findings of a study that 
shows that changes in firing rates of low threshold motor units in muscles with a 
synergistic function to the painful muscle do not appear to account for the maintenance 
of force during a painful constant force contraction as motor unit firing rate was reduced 
in synergist muscles (Hodges et al. 2008). This also suggests the effect of nociceptor 
stimulation is not localized and has a broad effect on synergist muscles (Hodges et al. 
2008). 
 
5.5.5 Sequence of recruitment  
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The data from 12 participants were able to be analysed for an analysis regarding the 
sequence of recruitment of SMUs during the slow ramp and fast ramp jaw closing tasks 
based on the mean thresholds. 
 
For the comparison of hypertonic saline infusion and isotonic saline infusion during the 
slow ramp jaw closing tasks, there were 12 participants where the sequence of 
recruitment could be established. Of these 12, 8 participants exhibited recruitment 
sequences that remained the same under both blocks, and 4 participants changed their 
recruitment sequence. Interestingly, from the 8 sequence orders obtained that did not 
change, the isotonic saline solution was applied first in 5 of them, and for the remaining 
3 hypertonic saline was applied first. However, for the 4 participants where the order 
of recruitment did change, the first solution applied was the hypertonic saline.  
 
For the comparison of hypertonic saline infusion and isotonic saline infusion during the 
fast ramp jaw closing tasks, there were 12 participants where the sequence of 
recruitment could be established. Of these 12, 7 participants exhibited recruitment 
sequences that remained the same under both blocks, and 5 participants changed their 
recruitment sequence. Interestingly, from the 7 sequence orders obtained that did not 
change, the isotonic saline solution was applied first in 3 of them, and for the remaining 
4 hypertonic saline was applied first. However, for the 5 participants where the order 
of recruitment did change, the hypertonic saline solution was applied first in 4 of them, 
and only 1 had isotonic saline solution applied first. 
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These data from both tasks suggest that there may be an effect on the sequence of 
recruitment simply from the order in which the solutions are applied. When hypertonic 
saline is applied first, then the data is suggestive that it may be more likely for there to 
be a change in recruitment sequence. It is unclear the reason for this other than 
possibly some psychological effects related to the first experience of an infusion. 
 
Changes in the recruitment order have been previously reported for the masseter 
muscle in association with hypertonic saline infusion (Malik 2016) and has also been 
reported in the limb literature (Falla et al. 2008; Madeleine et al. 2006; Samani et al. 
2009; Tucker and Hodges 2009). A study of neck muscle activity in pain (Stephenson 
and Maluf 2010) also indicate that changes in recruitment and de-recruitment order in 
trapezius motor units can occur during short- as well as long-duration contractions.  
 
All of this together suggested that pain interacts in a unique way in the individual with 
the complex and individualized organization of the sensorimotor system and pain 
experience (Hodges and Tucker 2011; Mogil 1999; Murray and Peck 2007; Raber and 
Devor 2002; Sae-Lee et al. 2008a; Sae-Lee et al. 2008b; Wiesinger et al. 2013). 
 
5.6 Single motor units from masseter  
 
A re-organization of EMG activity of the masseter muscle after the injection of 
hypertonic saline, with increases and decreases occurring within the painful muscle 
has also been demonstrated in a previous study although with a simpler set of tasks 
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(Malik 2016; Minami et al. 2013). Therefore, even though it was not our main question 
in this study, the recruitment of SMUs from the right masseter was analysed during 
baseline, hypertonic and isotonic blocks of infusion to confirm or not the earlier findings 
and to establish comparative data for the findings from the temporalis muscle as both 
were recorded simultaneously. 
 
5.6.1 Occurrence 
 
Table 4-52 and table 4-57 summarize each SMU occurrence from the right masseter 
muscle under ramps jaw closing tasks and 2 step levels jaw closing task respectively. 
Three block conditions (baseline, hypertonic infusion and isotonic infusion) were 
analysed. 
  
Five units were present only during hypertonic blocks for slow and fast ramps but were 
not present during baseline or isotonic blocks. Another 5 SMUs were not present for 
slow and fast ramps during hypertonic but were present during baselines and isotonic 
blocks for slow and fast ramps tasks. Units 34 and 35 were not present in hypertonic 
and isotonic blocks of infusion but were present for baseline block; while unit 27 was 
present in hypertonic and isotonic block of infusion but not present for baseline block. 
Unit 5 was present only during hypertonic fast ramp but was not present in the other 
blocks for slow ramp. Unit 1, on the other hand, were not present during hypertonic 
fast ramp but it was present in slow ramp all the blocks and for the remained blocks in 
fast ramp.  
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These patterns of change in activity are comparable to previous reports from the 
masseter muscle (Malik 2016). The present findings extend these earlier findings by 
carrying out the experiments in another group of participants as well as studying 
different rates of ramp tasks. The findings provide evidence that in all tasks, a 
reorganization of SMU activity with recruitments and de-recruitments can occur within 
the masseter muscle during experimental pain. 
 
5.6.2 SMU activity and the vicious cycle theory and the pain adaptation model 
 
An analysis was also done unit by unit from the masseter muscle to see if the data 
supported or not the earlier models (vicious cycle theory and pain adaptation model). 
As was established for the temporalis muscle data, there was only little evidence for 
support for both of these earlier models.  
 
In fact, from the 58 units discriminated from the masseter muscle in this study, the 
majority of the units (33/47 for the slow ramp jaw closing task, 37/49 for the fast ramp 
jaw closing task, 23/28 for the first step of the 2 step-levels jaw closing task and lastly, 
33/35 for the second step of the 2 step levels jaw closing task) were neither consistent 
with the Vicious Cycle Theory nor the Pain Adaptation Model. Again, together with the 
temporalis muscle, the findings obtained from the masseter muscle in this present 
study did not provide strong support for either of the earlier theories. Rather the 
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evidence supported the ideas of a reorganization of motor unit activity within the jaw 
muscles in experimental muscle pain. 
 
5.7 Comparison between the masseter and temporalis muscles occurrence and 
consistence with VCT and PAM – as an important comparison 
 
According to th e tables 4-65, 4-66, 4-67, the percentages of SMUs that did not change 
occurrence, or were recruited or de-recruited during the hypertonic saline infusion 
block were similar between masseter and temporalis muscles for all the tasks 
analysed. This suggests that a reorganization of the activity occurs in a proportionally 
similar way in the painful muscle as well as in synergistic muscles. This could be 
considered unexpected in that it might be presumed that the painful muscle might 
undergo a greater amount of reorganization than any of its synergists. 
 
Regarding the consistency with the earlier theories, according to the table 4-68, the 
percentages of units that did or not did not support either the Vicious Cycle Theory or 
the Pain Adaptation Model were similar for all the tasks within a muscle. However, 
there were possibly some differences between muscles, in that the SMUs from the 
temporalis supported the VCT with a relatively higher percentage in step 1 (16.2%) 
and step 2 (10.3%) of the 2 step-levels jaw closing task, than the masseter whose 
percentages were 7.1% in step 1 and 0% in step 2. Furthermore, the masseter 
supported the PAM with a relatively higher percentage (17%) in the slow ramp jaw 
closing task than the corresponding values for the temporalis at 7.1%. The reason for 
this difference is unclear although it might suggest that, in comparison with the painful 
muscle, the SMUs within the non-painful synergistic muscle were more likely to 
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undergo changes in activity (i.e. recruitment during pain) that would lend stronger 
support for the VCT during the 2 levels of the 2 step-levels jaw closing task. The SMUs 
of the painful muscle appeared possibly more likely to undergo a change in activity (i.e. 
de-recruitment) that would provide support for the PAM during the slow ramp jaw 
closing task. Although about 75% of SMUs in both muscles were unaffected in their 
occurrence in pain vs control, the above observations possibly suggest that pain may 
be more likely to inhibit the muscle activity of the painful muscle and increase the 
activity of the non-painful synergistic muscle at least in the set of tasks performed in 
the present study. These preliminary observations are an avenue of further research. 
 
5.8 Psychological variables 
 
A novel observation in the present study was the preliminary data suggesting that those 
participants who did not exhibit a change in recruitment patterns (i.e. no evidence of 
recruitment of new SMUs nor de-recruitment of SMUs) during hypertonic saline 
infusion in comparison with isotonic saline infusion, were found to exhibit significantly 
higher PCS scores than those participants who did exhibit a change in recruitment 
patterns (i.e. evidence of recruitment and/or de-recruitment of SMUs) (see Tables 4-
69, 4-70, 4-71, 4-72). Given the small sample size, further studies are necessary to 
determine whether indeed this is a consistent observation in higher pain 
catastrophizing individuals. A recent study found a significant, positive correlation 
between PCS scores and the change in EMG activity of the left temporalis muscle (r = 
0.541; P = 0.031) and right temporalis muscle (r = 0.531; P = 0.034) in free chewing at 
the closing phase after injection of hypertonic saline (Inamoto et al. 2017).  
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One interpretation of the absence of evidence for recruitments/de-recruitments of 
SMUs in pain in higher pain catastrophizing individuals is that these individuals may 
exhibit a loss of fine control or subtle modulation of motor unit activity during pain. The 
individuals exhibiting evidence of recruitments and de-recruitments during pain were 
those with lower pain catastrophizing scores. These individuals may exhibit a greater 
ability to modulate SMU activity in the presence of pain.  
 
A recent study has shown that experimental pain in asymptomatic individuals with 
higher pain catastrophizing scores is not only associated with increased VAS pain 
scores, pain mapping areas and McGill pain rating indices than lower pain 
catastrophizing individuals but that the higher pain catastrophizing individuals also 
exhibit slower jaw velocity and greater variability of repetitive jaw movements than the 
lower pain catastrophizing individuals (Akhter et al. 2014). These repetitive jaw 
movements carried out in this earlier study are likely driven largely from the primary 
motor cortex (face MI) - for review, (Avivi-Arber and Sessle 2017). Noxious jaw muscle 
stimulation is known to have significant effects on face MI activity with brief increases 
in signal intensity followed by prolonged decreases (Nash et al. 2010) and these effects 
are consistent in general terms with observations in the rat with noxious stimulation of 
the tongue (Adachi et al. 2008) and in limb muscle studies (Farina et al. 2005; Tucker 
and Hodges 2009). Further, there is recent evidence that the changes in MI activity 
with noxious jaw muscle stimulation correlated with pain catastrophizing scores 
(Henderson et al. 2016). While it is not clear whether the motor mechanisms involved 
in higher pain catastrophizers in the present study are in some way different from those 
in lower pain catastrophizers, one interpretation of the present data is that the ability 
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of the face MI to exert fine control over SMU recruitment patterns may become 
impaired in higher pain catastrophizing individuals in pain. This might indeed account 
for a greater variability of jaw movements as previously noted in simulated chewing 
movements in higher pain catastrophizers in pain (Akhter et al. 2014). This may also 
account therefore for the inability to modify or modulate motor unit activity in pain as 
noted in the present study for SMU recruitment patterns.   
 
5.9 More complex models of pain-motor interaction  
 
The findings of the present study support the ideas of the Integrated Pain Adaptation 
Model which proposes that the experience of pain (e.g., acute/chronic, localization - 
muscle/joint, prior experience, beliefs, emotional contributions, motivation, social 
context, genetic) will affect motor activity differently in each person. A recent clinical 
study of chronic TMD patients, specifically those with severe symptomatology, 
provided evidence for a reorganized activity, mainly resulting in worse functional 
performances (Mapelli et al. 2016), which is in also in accordance with a new model 
that proposes a new theory to explain the adaptation to pain (Hodges and Tucker 
2011). 
 
Therefore, the authors that first proposed this model also suggested that all chronic 
pain patients should not be treated exactly the same way, even when they have the 
same physical diagnosis (Sae-Lee et al. 2008b), and this approach of treating 
everyone differently has previously demonstrated successful outcomes (Dworkin et al. 
2002). 
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6 CONCLUSIONS 
 
The relation between pain and muscle activity is not clearly understood and earlier 
models explaining this association, namely the Vicious Cycle theory and the Pain 
Adaptation Model, are not strongly supported by the literature. While both theories 
propose uniform increases or decreases in activity throughout a painful muscle, recent 
evidence in both the spinal and trigeminal literature suggests that there are likely to be 
complex changes of activity within a painful muscle indicating a re-organization of 
activity. It is unclear however whether this reorganization of activity within a painful jaw 
muscle also occurs in other non-painful jaw muscles.  
 
Another issue with these earlier theories is that they do not take psychological factors 
into consideration and yet psychological factors are known to be important in the onset 
and progression of TMD. It is not known whether psychological factors might influence 
the reorganization that appears to be occurring within the jaw muscles during pain.  
 
The present study has employed EMG recordings of single motor unit activity from the 
masseter and temporalis muscles during experimentally induced jaw muscle pain to 
assess whether changes in SMU activity (e.g. recruitments and de-recruitments of 
SMUs) can occur not only within the painful masseter muscle but also in the non-painful 
temporalis muscle. Associations between the changes in activity and some 
psychological variables were also analysed. 
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The experimental infusion paradigm of hypertonic saline employed in the masseter 
muscle for our study did not affect the ability to perform the biting tasks employed (slow 
ramp jaw closing task, fast ramp jaw closing task, 2 step-levels jaw closing task) in 
terms of force amplitudes and force rates in comparison with control infusions of 
isotonic saline. In addition, there was no group effect on the root mean square EMG 
activity from the masseter and temporalis muscles, major agonists of the tasks. 
Furthermore, in comparison with isotonic saline infusion, there was no effect of the 
hypertonic saline infusion into the masseter on the occurrences of most of the SMUs 
within the masseter and temporalis muscles during the tasks, as well as no group effect 
on temporalis SMU thresholds during the ramp tasks and no group effect on temporalis 
SMU firing rates during the step tasks. However, during hypertonic saline infusion in 
comparison with isotonic saline infusion, evidence was provided for both recruitment 
and de-recruitment of SMU activity for about 50% of SMUs within the masseter and for 
about 54.2% of SMUs within the temporalis muscle. The changes in occurrence of 
SMUs in general did not support the Vicious Cycle Theory or the Pain Adaptation 
Model. However, where changes in occurrence of SMUs did occur, a qualitative 
observation was that the changes within the temporalis muscle, the non-painful 
synergistic muscle, were more likely to undergo recruitments during pain in some of 
the tasks, while the SMUs of the painful masseter muscle appeared possibly more 
likely to undergo a de-recruitment of SMU activity at least in the slow ramp task. Finally, 
suggestive evidence was provided for associations between SMU occurrence in pain 
and PCS scores in that those participants who did not exhibit a change in recruitment 
patterns (i.e. no evidence of recruitment of new SMUs nor de-recruitment of SMUs) 
during hypertonic saline infusion in comparison with isotonic saline infusion, were 
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found to exhibit significantly higher PCS scores than those participants who did exhibit 
a change in recruitment patterns.  
 
Taken together, these findings suggest that in the presence of noxious stimulation of 
one jaw muscle, reorganization of SMU activity occurs throughout the jaw motor 
system during task performance and it might be suggest that non-painful muscles 
should be treated in TMD patients to help the entire jaw motor system undergo a 
reorganization back to normal function. Preliminary data suggests that the changes 
may be different in the painful vs. non-painful synergistic muscles and the effects may 
be influenced by the level of pain catastrophizing. These new data are more in line with 
more recent models of pain-motor interaction (Hodges and Tucker 2011; Murray and 
Peck 2007) than the earlier Vicious Cycle Theory or the Pain Adaptation Model. This 
new information may help to improve our understanding of the effects of pain on jaw 
muscle activity and thereby may have implications for understanding changes in jaw 
muscle activity in TMD.  
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7 LIMITATIONS: 
 
7.1 Differences between short-term experimental pain and chronic pain patients 
 
There are differences between short-term experimental pain and chronic pain patients 
that limit the conclusions that can be drawn from this study for the chronic pain 
population. However, while there are differences between human experimental pain 
models and chronic pain patients, the findings from human experimental pain models 
can, at least in part, help us to understand clinical pain states as the pain evoked 
shares many clinical features with those seen in chronic clinical muscle pain. 
 
It is important to mention, however, that there are studies in the literature that show 
similarities between experimental pain models and clinical pain patients. For example, 
a recent study (Louca et al. 2014) investigated if hypertonic saline-induced myalgia 
also results in the same levels of biomarkers as found in the muscles of chronic myalgia 
patients. They observed that 5-HT, glutamate and glycerol levels increased after the 
saline injections and similar increases have been reported in chronic myalgia patients 
(Ernberg et al. 1999; Gerdle et al. 2008). Furthermore, some of the McGill Pain 
Questionnaire pain descriptors reported for experimental jaw muscle pain (Sae-Lee et 
al. 2008b) are the same as those identified in another study (Gustin et al. 2011) which 
evaluated chronic pain patients with Temporomandibular Disorders.  The presence of 
referred pain is also common in experimental pain (Jensen and Norup 1992) as well 
as chronic conditions (McMahon et al. 1995). Finally, experimentally induced 
nociception from back muscles, or the resulting pain perception, appears able to 
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change the control of trunk muscles in a manner resembling that observed in clinical 
low back pain (Hodges and Moseley 2003; van Dieen et al. 2003). 
 
Therefore while there are differences between human experimental pain models and 
chronic pain patients, experimental pain models may be able, at least in part, to help 
us to understand clinical pain states as the pain evoked shares many clinical features 
with those seen in chronic clinical muscle pain. And it is hoped that these studies will 
generate important baseline information and hypotheses for future clinical studies. 
 
7.2 Isotonic saline infusion associated with some levels of pain 
 
This study compared experimentally induced pain with pain-free blocks and isotonic 
saline was used for the pain-free block so that the same conditions existed between 
both blocks, and the only difference between the blocks was pain. However, the 
isotonic saline did induce some pain in some participants, which might be caused by 
the discomfort of the needle and the expansion of the muscle due to the volume of the 
isotonic saline and therefore in some participants it was not possible to be considered 
as totally free pain condition. 
 
7.3 Small sample 
 
Also, due to the small sample size, it is difficult to generalize some of the findings of 
this study and further studies should be performed on a larger number of volunteers. 
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This would also assist in providing additional data supporting or not some of the 
preliminary conclusions. 
 
7.4 Intramuscular electrodes on antagonist side 
 
Despite the fact that the present study has allowed us to accurately observe the effect 
of experimental right masseter muscle pain on single motor unit activity at the right 
masseter and right temporalis muscles, we did not study the effect of pain on SMU 
activity within contralateral muscles.  
 
7.5 Multiple recording 
 
Another limitation of the present study is that we recorded SMUs from only one site in 
each of the masseter and temporalis muscles in each participant, and therefore, we 
limit our conclusions to one area of the muscle and our data cannot provide an overall 
assessment across different compartments of the muscles. Also, multi-channel surface 
EMG obtained over large regions of the masseter and temporalis muscles would be a 
useful future investigative tool to map the global changes in EMG activity across the 
muscles in association with noxious stimulation. 
 
7.6  Baseline 2  
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In the current study baseline 2 was only analyzed for RMS activity from masseter and 
from temporalis, and for SMU occurrence from the temporalis and comparison 
between blocks within the temporalis muscle. However, it was not analyzed for force 
amplitude values; force rates values; force levels values; thresholds and firing rates of 
the SMUs from the temporalis; SMUs occurrence from the masseter muscle and 
comparison between blocks within the masseter muscle. This is a possible avenue for 
future studies. Also, in this study the 2 infusions ran immediately next to each other 
and were only separated by 10 min. Future studies could consider having another 
control block of trials between both infusion blocks. This could be used to establish a 
new baseline for the subsequent infusion block. 
 
7.7 Maximal voluntary biting force 
 
No information on maximal voluntary biting force was obtained in this study. However, 
based on the reference values found by Kowaga et al., 2006 for maximum bite force, 
we calculated that the force levels in the present study were approximately 13% of the 
maximum bite force on the slow ramp, 15% on the fast ramp, 10% on step 1 and 12% 
on the step 2 of the jaw closing tasks. Nonetheless, it is important to mention that 
maximum bite force levels vary with method, sex, age, anatomical and physiologic 
characteristics of the subjects and therefore, precise information on maximal voluntary 
biting force should be obtained in further studies (Kogawa et al., 2006). 
 
7.8 Use of upper and lower splints leading to a bite-raise 
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The use of the splints devices in the upper and lower jaw will have had caused a bite-
raise that resulted in the jaw being opened an estimated ~8mm. This increase in the 
bite might have had implications for the SMU activity as during the rest period prior 
to the tasks, the participant might have had affected baseline activity simply due to 
the fact that the jaw was opened. However, it is important to reinforce that the analysis 
was performed within participants, i.e. the same amount of increase of the bite was 
used during all the blocks of tasks for the same participant. Therefore, the presence 
of possible activity that was possibly due to the bite raise, did not represent a problem 
in the interpretation of differences of SMU activity during hypertonic stimulation in 
comparison with the other blocks analysed in this study. 
 
7.9 Changes in the infusion rates 
 
The changes in the infusion rates throughout the infusion blocks were not recorded 
in this study. As a suggestion for future studies, this information may be valuable as 
it would allow the researcher to analyse if the different task or different forces applied 
would require a higher or a lower rate of infusion. This may provide information, 
therefore, as to possible differences between tasks of the perceived pain. 
 
7.10 Psychological findings 
 
The relationship between the psychological variables with the SMU findings are 
intriguing but are only based on very few participants and can only be viewed as 
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preliminary data. We would like to suggest further investigation including also some 
subjects with high PCS scores to enable testing for possible correlations of SMU 
patterns in individuals covering a wide range of PCS scores. 
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8 Appendix 
8.1 Clinical Research Diagnostic Criteria (RDC) Examination/ RDC/TMD history 
questionnaire  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CLINICAL RESEARCH DIAGNOSTIC CRITERIA (RDC) EXAMINATION 
 
 
1. Do you have pain on the right side of your face,    None  0 
the left side or both.      Right  1 
            Left  2 
            Both  3 
 
 
2. Could you point to the areas where you feel pain?   Right   Left 
         None  0 None  0 
         Jaw Joint 1 Jaw Joint 1 
         Muscles 2 Muscles 2 
         Both  3 Both  3 
 
(Examiner feels area subject points to, if it is unclear whether it is joint or muscle.) 
 
 
3. Opening Pattern   Straight      0 
       Right Lateral Deviation (uncorrected)   1 
       Right Corrected (“S”) Deviation   2 
       Left Lateral Deviation (uncorrected)   3 
       Left Corrected (“S”) Deviation     4 
       Other       5 
       Type(specify) __________________________________ 
 
 
 
4. Vertical Range of Motion   Maxillary incisor used   (0) 1.1 
             (1) 2.1 
 
(a) Unassisted opening without pain ______ mm  
         MUSCLE PAIN            JOINT PAIN 
              None   Right   Left   Both      None   Right   Left   Both 
(b) Maximum unassisted opening ______ mm  0        1        2       3       0        1        2        3 
 
(c) Maximum assisted opening     ______ mm  0        1       2       3             0        1         2       3 
 
(d) Vertical incisal overlap      ______ mm 
 
 
304 
 
 
 
  
CLINICAL RESEARCH DIAGOSTIC CRITERIA (RDC) EXAMINATION 
 
 
5. Joint Sounds (palpation)      RIGHT   LEFT 
(a)  Opening    None        0         0 
      Click        1         1 
 Coarse Crepitus               5           5 
      Fine Crepitus       6            6 
 
Measurement of Opening Click   _____ mm  _____ mm 
 
 
(b)  Closing    None        0        0 
      Click        1         1 
 Coarse Crepitus               5            5 
      Fine Crepitus       6            6 
 
Measurement of Closing Click   _____ mm  _____ mm 
 
 
(c) Reciprocal click eliminated on protrusive opening 
 
     No      No 
    Yes     Yes 
        
 
6. Excursions     MUSCLE PAIN           JOINT PAIN 
          None   Right   Left   Both          None   Right   Left   Both 
(a) Right Lateral Excursion     ______ mm       0         1        2       3     0        1        2        3 
 
(b) Left Lateral Excursion       ______ mm       0         1        2       3               0        1         2       3 
 
(c) Protrusion           ______ mm       0         1        2       3               0        1         2       3 
 
           
(d) Midline Deviation         ______ mm  (0)   RIGHT         (1)    LEFT         (2)   NA   
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CLINICAL RESEARCH DIAGOSTIC CRITERIA (RDC) EXAMINATION 
 
7. Joint Sounds on Excursions 
 
Right Sounds:           Coarse    Fine 
        None        Click        Crepitus Crepitus
  
    Excursion Right    0      1          5      3 
    Excursion Left     0      1          5      3 
    Protrusion     0      1          5      3 
 
 
Left Sounds:           Coarse    Fine 
        None        Click        Crepitus Crepitus
  
    Excursion Right    0      1          5      6 
    Excursion Left     0      1          5      6 
    Protrusion     0      1          5      6 
 
 
 
 
 
 
DIRECTIONS FOR ITEMS 8-10 
 
The examiner will be palpating (touching) different areas of your face, head and neck. We would 
like you to indicate if you do not feel pain of just feel pressure (0), or pain (1-3). Please rate how much 
pain you feel for each of the palpations according to the scale below. Circle the number that 
corresponds to the amount of pain you feel. We would like you to make a separate rating for both the 
right and left palpations. 
 
 
0 = No Pain/ Pressure Only 
1 = Mild Pain 
2 = Moderate Pain 
3 = Severe Pain 
 
 
PLEASE GIVE PATIENT RATING CARD 
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CLINICAL RESEARCH DIAGOSTIC CRITERIA (RDC) EXAMINATION 
 
8. Extraoral muscle pain with palpation: 
          RIGHT    LEFT 
a. Temporalis (posterior)      0  1  2  3  0  1  2  3 
 “Back of temple” 
b. Temporalis (middle)      0  1  2  3  0  1  2  3 
 “Middle of temple” 
c. Temporalis (anterior)      0  1  2  3  0  1  2  3 
 “Front of temple” 
d. Masseter (superior)      0  1  2  3  0  1  2  3 
 “Cheek/under cheekbone” 
e. Masseter (middle)      0  1  2  3  0  1  2  3 
  “Cheek/side of face”   
f. Masseter (inferior)      0  1  2  3  0  1  2  3 
 “Cheek/jawline 
g. Posterior mandibular region (Stylohyoid/posterior digastric region)  0  1  2  3  0  1  2  3 
  “Jaw/throat region” 
h. Submandibular region      0  1  2  3  0  1  2  3 
 (Medial pterygoid/Suprahyoid/anterior digastric region) “Under chin” 
i.  Sternocleidomastoid (origin)     0  1  2  3  0  1  2  3 
 “Under ear” 
j.  Sternocleidomastoid (body)     0  1  2  3  0  1  2  3 
 “Side of neck” 
k. Trapezius (origin)      0  1  2  3  0  1  2  3 
 “Back of head” 
l.  Trapezius (body and insertion)     0  1  2  3  0  1  2  3 
 “Neck and shoulders 
9. Joint pain with palpation: 
a.  Lateral pole        0  1  2  3  0  1  2  3 
 “Outside” 
b. Posterior attachment      0  1  2  3  0  1  2  3 
 “Inside ear” 
10. Intraoral muscle pain with palpation: 
a. Lateral pterygoid area  “Behind upper molars”  0  1  2  3  0  1  2  3 
b. Tendon of temporalis “Tendon”    0  1  2  3  0  1  2  3 
c. Tongue “Tongue”     0  1  2  3 0  1  2  3 
  
11. Is pain on same side as reported in question 2?  Yes   No 
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RDC/TMD HISTORY QUESTIONNAIRE  
 
Please read each question and respond accordingly. For each of the questions below circle 
only one response. 
1. Would you say your health in general is:      
Excellent  Very good  Good   Fair   Poor    
2. Would you say your oral health in general is:    
Excellent  Very good  Good   Fair   Poor   
3. Have you had pain in the face, jaw, temple, in front of the ear or in the ear in the past 
month?           No  
          Yes  
[If no pain in the past month go to question 14] 
If Yes, 
4 a. How many years ago did your facial pain begin for the first time? _______years 
ago 
 
 
b. How many months ago did your facial pain begin for the first time?  _______months 
ago 
 
5. Is your facial pain persistent, recurrent or was it only a one-time problem? Persistent  
           Recurrent  
           One-Time  
6. Have you ever gone to a physician, dentist, chiropractor or other health professional for 
facial ache or pain?       No 
Yes, in the last six months 
Yes, more than six months ago 
7. How would you rate your facial pain on a 0 to 10 scale at the present time, that is right 
now, where 0 is "no pain" and 10 is "pain as bad as could be"?  
NO PAIN          PAIN AS BAD
           AS COULD BE 
 0 1 2 3 4 5 6 7 8 9  10 
 
8. In the past six months, how intense was your worst pain rated on a 0 to 10 scale where 0 
is  
"no pain" and 10 is "pain as bad as could be"?  
NO PAIN          PAIN AS BAD
           AS COULD BE 
 0 1 2 3 4 5 6 7 8 9  10 
 
9.  In the past six months, on the average, how intense was your pain rated on a 0 to 10 
scale where 0 is "no pain" and 10 is "pain as bad as could be"? [That is, your usual pain at 
times you were experiencing pain].  
NO PAIN          PAIN AS BAD
           AS COULD BE 
 0 1 2 3 4 5 6 7 8 9  10 
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10. About how many (e.g. 60) days in the last six months have you been kept from your 
usual activities (work, school or housework) because of facial pain?  _________DAYS 
11. In the past six months, how much has facial pain interfered with your daily activities rated 
on a 0 to 10 scale where 0 is "no interference" and 10 is "unable to carry on any activities"?  
NO INTERFERENCE       UNABLE TO CARRY 
ON ANY ACTIVITIES 
0 1 2 3 4 5 6 7 8 9 10 
 
12. In the past six months, how much has facial pain changed your ability to take part in 
recreational, social and family activities where 0 is "no change" and 10 is "extreme change"?  
NO CHANGE         EXTREME 
CHANGE 
 0 1 2 3 4 5 6 7 8 9  10 
13. In the past six months, how much has facial pain changed your ability to work including 
housework) where 0 is "no change" and 10 is "extreme change"? 
NO CHANGE         EXTREME 
CHANGE 
 0 1 2 3 4 5 6 7 8 9  10 
14 a. Have you ever had your jaw lock or catch so that it won't open all the way?  
No  
       Yes  
If Yes,  b. Was this limitation in jaw opening severe enough to interfere with your ability to 
eat? 
 No  
       Yes  
15 a. Does your jaw click or pop when you open or close your mouth or when chewing? 
No  
Yes 
b. Does your jaw make a grating or grinding noise when it opens and closes or when 
chewing?              No  
Yes 
c. Have you been told, or do you notice that you grind your teeth or clench your jaw while 
 sleeping at night?          
   No  
Yes 
d. During the day, do you grind your teeth or clench your jaw? 
No   
    Yes    
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f. Do you have noises or ringing in your ears?        No 
Yes   
g. Does your bite feel uncomfortable or unusual? 
No  
             Yes  
16 a. Do you have rheumatoid arthritis, lupus, or other systemic arthritic disease? 
No 
            Yes  
b. Do you know of anyone in your family who has had any of these diseases? 
No  
       Yes  
c. Have you had or do you have any swollen or painful joints) other than the joints close to 
your  ears (TMJ)?             No  
             Yes  
If Yes,  d. Is this a persistent pain which you have had for at least one year?     No 
Yes 
17 a. Have you had a recent injury to your face or jaw?                    
No  
             Yes  
If Yes, 
b. Did you have jaw pain before the injury?                      No     
             Yes  
18. During the last six months have you had a problem with headaches or migraines? 
No  
              Yes  
19. What activities does your present jaw problem prevent or limit you from doing? 
a. Chewing  No g. Sexual activity No 
 Yes  Yes 
b. Drinking  No h. Cleaning teeth or face No 
 Yes  Yes 
c. Exercising No i. Yawning No 
 Yes  Yes 
d. Eating hard foods No j. Swallowing No 
 Yes  Yes 
e. Eating soft foods No k. Talking No 
 Yes  Yes 
f. Smiling/laughing  No I. Having your usual facial appearance No 
 Yes  Yes 
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21. How good a job do you feel you are doing in taking care of your health overall?    
  Excellent 
   Very good 
   Good 
   Fair 
   Poor 
22. How good a job do you feel you are doing in taking care of your oral health?  
  Excellent 
  Very good 
  Good 
  Fair 
  Poor 
23. When were you born?   Day_________Month_______Year__________ 
 
24. Are you male or female?   Male    
      Female  
 
25. In what country were you born?   ________________________________ 
  
26  a. Does this country best represent your race, national origin or ancestry? 
       Yes 
       No 
If No, 
b. What is your country of national origin or ancestry? ________________________________ 
      
27. What is the highest grade or year of regular school that you have completed?  
Never attended or Kindergarten 
Primary School   
High School   
University   
28 a. During the past 2 weeks, did you work at a job or business not counting work around the house 
(include unpaid work in the family farm/business)?  
       Yes  
      No 
      N/A 
If No,  b. Even though you did not work during the past 2 weeks, did you have a job or business?  
       Yes  
       No  
       N/A 
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If No, 
c. Were you looking for work or on layoff from a job during those 2 weeks?  
       Yes, looking for work  
       Yes, layoff 
       Yes, both on layoff and looking for work  
       No 
       N/A 
 
 
29. Are you married, widowed, divorced, separated or never been married?  
 
       Married / spouse or defacto in household  
       Married / spouse or defacto not in household  
       Widowed  
       Divorced  
       Separated  
       Never Married  
       N/A 
 
 
 
312 
 
8.2 Screening questionnaire 
 
SCREENING QUESTIONNAIRE 
 
 
Please indicate whether you have used any of the following in the past 24 
hours: 
      (circle one)  (if YES) 
CAFFEINE (e.g. tea/coffee)   YES / NO When ______   Qty 
__________ 
ALCOHOL     YES / NO When ______   Qty 
__________ 
MEDICATION      YES / NO            
                                                                             If YES, please 
specify:_______________________ 
        
Have you ever received treatment for TMD and/or orofacial pain (e.g. trigeminal 
neuropathic pain)? 
YES / NO   (circle one) If YES, please 
specify: 
 
  
Have you ever had TMD and/or orofacial pain? 
YES / NO (circle one)  If YES, please 
specify: 
 
  
Have you ever received treatment for other pain disorders? 
YES / NO (circle one)  If YES, please 
specify: 
 
 
Are you pregnant or expecting for pregnancy? 
YES / NO (circle one)  If YES, please 
specify: 
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Are you currently taking any medication prescribed by a doctor? 
YES / NO  (circle one) If YES, please 
specify: 
 
       
Have you ever received treatment for any of the following: 
      (circle one) (If YES – give details please) 
HEART PROBLEMS    YES / NO
 __________________________ 
RESPIRATORY PROBLEMS   YES / NO 
 __________________________ 
DIABETES     YES / NO
 __________________________ 
BLOOD PRESSURE    YES / NO
 __________________________ 
BLEEDING DISORDERS    YES / NO 
 __________________________ 
COMMUNICABLE DISEASES (e.g. Hepatitis) YES / NO
 __________________________ 
NEUROLOGICAL DISORDERS (e.g. Parkinson’s)   YES / NO __________________________ 
PSYCHIATIC DISORDERS (e.g. Depression) YES / NO 
 __________________________ 
RHEUMATIC FEVER     YES / NO 
 __________________________  
SYSTEMIC DISORDERS (e.g. chronic malignancies) 
BLOOD PRESSURE    YES / NO
 __________________________ 
 
Do you have any medical conditions that the current researchers should be made 
aware of? 
YES / NO   If YES, please 
specify: 
 
(circle one) 
Do you suffer from migraine YES / 
NO 
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Do you suffer from sinusitis?                   YES / 
NO 
Have you had full body or cranial CT scans in the last 12 months? YES / 
NO 
Do you have a medical condition where it is anticipated that CT scans 
may be required? 
YES / 
NO 
Do you have any heart pacemaker, defibrillator or wires other than 
sternal wires? 
YES / 
NO 
Do you have metallic foreign body in the eye? YES / NO 
Do you have deep brain stimulator, cerebral aneurysm clips or 
cochlear implant?  
YES / NO 
Do you have prosthetic implants or dentures? YES / NO 
Do you feel claustrophobic when you are in a confined, noisy 
environment? 
YES / NO 
 
 Name of Participant      
 
 Signature      Date   
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8.3 DASS 21 
 
 
 
DASS (Lovibond & Lovibond, 1995) 
Please read each statement and circle a number 0, 1, 2 or 3, which indicates how much 
the statement applied to you over the past week. There are no right or wrong answers. 
Do not spend too much time on any statement. The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I was aware of dryness of my mouth 0 1 2 3 
2 I couldn't seem to experience any positive feeling at all 0 1 2 3 
3 I experienced breathing difficulty (e.g. excessively rapid 
breathing, Breathlessness in the absence of physical 
exertion) 
0 1 2 3 
4 I tended to over-react to situations 0 1 2 3 
5 I found it difficult to relax 0 1 2 3 
6 I felt that I had nothing to look forward to 0 1 2 3 
7 I felt that I was using a lot of nervous energy 0 1 2 3 
8 I felt I wasn't worth much as a person 0 1 2 3 
9 I felt that l was rather touchy 0 1 2 3 
10 I felt scared without any good reason 0 1 2 3 
11 I found it hard to wind down 0 1 2 3 
12 I was aware of the action of my heart in the absence of 
physical exertion (e.g., sense of heart rate increase, heart 
missing a beat) 
0 1 2 3 
13 I felt down hearted and blue 0 1 2 3 
14 I felt I was close to panic 0 1 2 3 
15 I was unable to become enthusiastic about anything 0 1 2 3 
16 I was intolerant of anything that kept me from getting on 
with what I was doing 
0 1 2 3 
17 I felt that life was meaningless 0 1 2 3 
18 I found myself getting agitated 0 1 2 3 
19 I was worried about situations in which I might panic and 
make a fool of myself 
0 1 2 3 
20 I experienced trembling (e.g., in the hands) 0 1 2 3 
21 I found it difficult to work up the initiative to do things 0 1 2 3 
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8.4 PCS 
 
 
  
Pain Catastrophizing Scale 
Sullivan MJL, Bishop S, Pivik J. (1995) 
 
Everyone experiences painful situations at some point in their lives.  Such experiences may 
include headaches, tooth pain, joint or muscle pain.  People are often exposed to situations that 
may cause pain such as illness, injury, dental procedures or surgery. 
 
Instructions:    
We are interested in the types of thoughts and feelings that you have when you are in pain.  Listed 
below are thirteen statements describing different thoughts and feelings that may be associated 
with pain.  Using the following scale, please indicate the degree to which you have these thoughts 
and feelings when you are experiencing pain. 
 
 
RATING  0  1  2  3  4  
MEANING  Not at all  To a slight 
degree  
To a 
moderate 
degree  
To a great 
degree  
All the time  
 
When I’m in pain …  
 
Numbe
r  
Statement  Rating 
1  I worry all the time about whether the pain will end.    
2  I feel I can’t go on.    
3  It’s terrible and I think it’s never going to get any better    
4  It’s awful and I feel that it overwhelms me.    
5  I feel I can’t stand it anymore    
6  I become afraid that the pain will get worse.    
7  I keep thinking of other painful events    
8  I anxiously want the pain to go away    
9  I can’t seem to keep it our of my mind    
10  I keep thinking about how much it hurts.    
11  I keep thinking about how badly I want the pain to stop    
12  There’s nothing I can do to reduce the intensity of the pain.   
13 I wonder whether something serious may happen.  
 
317 
 
8.5 McGill Questionnaire 
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8.6 McGill Questionnaire – analysis 
 
Category Group Score / Words 
Sensory 
1 
1 Flicking 
2 Quivering 
3 Pulsing 
4 Throbbing 
5 Beating 
6 Pounding 
2 
1 Jumping 
2 Flashing 
3 Shooting 
3 
1 Pricking 
2 Boring 
3 Drilling 
4 Stabbing 
5 Lancinating 
4 
1 sharp 
2 cutting 
3 Lacerating 
5 
1 Pinching 
2 Pressing 
3 Gnawing 
4 Cramping 
5 Crushing 
6 
1 Tugging 
2 Pulling 
3 Wrenching 
7 
1 Hot 
2 Burning 
3 Scalding 
4 Searing 
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8 
1 Tingling 
2 Itchy 
3 Smarting 
4 Stinging 
9 
1 Dull 
2 Sore 
3 Hurting 
4 Aching 
5 Heavy 
10 
1 Tender 
2 Taut 
3 Rasping 
4 Splitting 
Affective 
11 
1 Tiring 
2 exhausting 
12 
1 Sickening 
2 Suffocating 
13 
1 Fearful 
2 Frightful 
3 Terrifying 
14 
1 Punishing 
2 Grueling 
3 Cruel 
4 Vicious 
5 Killing 
15 
1 Wretched 
2 Blinding 
Evaluative 16 
1 Annoying 
2 Troublesome 
3 Miserable 
4 Intense 
5 Unbearable 
Miscellaneous 17 
1 Spreading 
2 Radiating 
3 Penetrating 
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4 Piercing 
18 
1 Tight 
2 Numb 
3 Drawing 
4 Squeezing 
5 Tearing 
19 
1 Cool 
2 Cold 
3 Freezing 
20 
1 Nagging 
2 Nauseating 
3 Agonising 
4 Dreadful 
5 Torturing 
Table 8-1: Pain Rating Index –PRI and words values in ascending order. 
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8.7 Force transducer catalogue  
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